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Abstract 
 
E. coli is a versatile bacterium that has three metabolic modes: aerobic, anaerobic and 
fermentation. The major environmental factor that controls the switching between these 
metabolic modes is oxygen availability. E. coli in the intestinal tract is completely anaerobic 
but certain parts of the intestinal tract close to the gut are microaerobic. The change from 
anaerobic to aerobic or microaerobic is very rapid and leads to major metabolic change. The 
changes have been characterized by using NMR. A quenching technique has been developed 
by using ethanol/NaCl to cool the cells very rapidly after removal from the chemostat to 
inactivate the metabolic activity. The measurement error from most sources is small with 
acceptable error from extraction of intracellular metabolites. The technique is being used to 
studying the transition from anaerobic to aerobic at different levels of oxygen. Changes in 
the major intracellular and extracellular metabolites have been measured, where the 
metabolic activity inside the cells showed not much change. The metabolic profile of 
pyruvate that goes up and down in response to the switch led to the study of movement of 
pyruvate inside the cells. Tagging of the pykF gene with GFP and 3xFLAG tag (in particular) 
indicated that the localisation of the PykF protein changes from cytoplasm to cell 
membrane. This explained why the concentration of pyruvate is low inside the cells, 
suggesting that the pyruvate is transported out directly when oxygen is introduced. 
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INTRODUCTION 
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1.0 Introduction 
 
1.1 Metabolomics 
 
Metabolomics can be defined as a comprehensive and quantitative analysis of all 
metabolites in a biological system. Nicholson et al. (1999) have made a distinction between 
metabolomics and metabonomics, the latter representing also the time dependence of 
metabolite concentrations. Comprehensive analysis of the metabolome, which is the 
complete set of metabolites in an organism or cell, covers the identification and 
quantification of all intracellular and extracellular metabolites. This large-scale analysis of 
metabolites is an important addition to extensive studies of DNA sequences (genome), 
mRNA (transcriptome) and proteins (proteome) (Figure 1.1). 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: The ‘Omics’ cascade. Information flow in the cell. Adapted from Dettmer et al. 
(2007). 
What can happen 
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The term ‘metabolome’ is generally used to represent the molecules of low molecular mass 
(usually less than 1,000 Da) present in a biological sample. The most common samples 
studied are body fluids such as blood and urine, where often the aim is to identify 
biomarkers for disease. Both samples are relatively easy to collect and each biofluids is 
unique in the type of information it has to offer. However, samples can be taken from any 
biological system, includings faecal extract, breast milk, amniotic fluid, umbilical cord blood 
and various cells and tissues. It has been estimated that the number of metabolites present 
in microbial metabolomes based on genome information ranges from 241 for a simple 
bacterium, like Mycoplasma pneumoniae, to 794 for the well-studied Escherichia coli 
(Goodacre et al., 2004). But in practise, this number is likely to be a factor of two or three 
times higher, considering that many unknown functions remain present in every genome. In 
other words, in prokaryotes, the metabolome is estimated to consist of at least 1000 
metabolites. In eukaryotic metabolomes, the number is very much larger, partly because 
the human body contains ten times more bacterial cells than human cells, and therefore 
contains many ‘bacterial’ metabolites as well as human metabolites (Nicholson and Wilson, 
2003). Wishart et al. (2009) reported the estimated number of metabolites present in the 
human metabolome is around 7800. This number is incomplete as it does not include many 
lipids, drugs and food nutrients, thus it is expected that the number will increase 
significantly.  The metabolome may consist of amino acids, lipids, carbohydrates, alcohols 
and natural compounds (such as antibiotics, pigments and cofactors) (Wishart et al., 2013; 
Durot et al., 2009). Metabolites differ widely in their chemical and physical properties, and 
also in their concentrations in the cell: in bacteria, the concentrations of different 
metabolites range from nM (ie, roughly one molecule per cell) to 100 mM, a dynamic range 
of 108. Thus, it is difficult to say exactly how large the metabolome is for any organism, but it 
is estimated to be lower than the number of genes and proteins. 
 
The concentrations of metabolites in the cell change in response to changes in enzyme 
concentrations and activities, and change much more rapidly than do the concentrations of 
enzymes or RNA. For example, it is estimated that the concentrations of glycolytic 
intermediates in yeast can change by a factor of two within one second (Dekoning and 
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Vandam, 1992). Thus, measurements of the concentrations of metabolites provide a good 
measure of cell metabolism, and hence identify the response of a cell or tissue to genetic or 
environmental changes, much more rapidly and precisely than do changes in proteome or 
transcriptome. Recently, studies of the metabolome have been increasing rapidly in 
popularity, for this reason (Hellerstein, 2004; Bundy et al., 2007b; Trotter et al., 2011; 
Yukihira et al., 2010). The challenges in metabolomic studies come because there are large 
variations in the chemical nature of the metabolites, their molecular weight, and their 
concentrations, which in eukaryotes can vary over nine orders of magnitude (pM-mM). The 
fact that metabolite concentrations can change very rapidly also introduces big problems. 
Finally, in cell metabolism, one metabolite can be involved in many pathways, meaning that 
after the concentrations of metabolites have been measured, it is not easy to relate these 
changes to changes in specific metabolic pathways. Thus, metabolomics presents challenges 
both in the collection of data and in their analysis. 
 
Metabolomics studies show biological changes resulting from environmental perturbations 
(e.g changes in diet, drug consumption or development of disease), genetic and gut 
microbiota pressure. Numerous novel metabolic pathways and metabolites that have not 
been identified by other biochemical experiments are being discovered which can lead to 
further investigations. Metabolomics has a very big potential to be an important tool for 
early diagnosis of disease, predictor of treatment response or drug development. The quick 
response of metabolome to any changes make this ‘omics’ a very promising field in future. 
Metabolomic applications can be seen in three broad areas; clinical, biomedical and 
environmental. The clinical application of metabolomics is very important as this technique 
would help to increase the understanding of health in humans and the significant impact 
has been demonstrated by a high number of publications. Urine is a primary sample that 
enables noninvasive monitoring of any changes inside the body. Lindon et al. (1999) 
described an interesting study of transplant patients to differentiate between patients 
undergoing graft rejection and those suffering from cyclosporin toxicity, which marked the 
transition between traditional clinical and clinical metabolomics applications. NMR coupled 
with a recognition technique was used to monitor urine (collected from patients that were 
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given cyclosporin) and the result clearly could differentiate between patients undergoing 
graft rejection and taking cyclosporin. In the past 20 years, human inborn errors of 
metabolism have been studied using NMR (Holmes et al., 1997; Lindon et al., 1999) and 
more detailed study has been carried out on methods to identify inborn errors of 
metabolism by Constantinou et al. (2004). The relationship between serum metabolic 
profiles and hypertension has been investigated by Brindle et al. (2003) and Grainger (2006) 
looking at the severity of coronary heart disease. 
 
There have also been rapid advances in biomedical applications. Cancer has been a popular 
subject as all researchers are trying to find more information about the metabolism of the 
disease. Griffin and Shockcor (2004) have profiled the metabolites of cancer cells in order to 
understand tumor development and progression. Early stage diagnosis of cancer is very 
important because the survival percentage is higher than when it is diagnosed late. 
Research carried out by Tiziani et al. (2009) has analysed blood serum by using NMR and 
managed to identify changes in system metabolic responses to cancer. Research in gut 
microflora in metabolism started many years ago (Coates, 1975; Gonthier et al., 2003; 
Dumas et al., 2006). Understanding the relationship between gut microbiota and host helps 
in developing an approach to improve health and fight the disease. A recent study by 
Nicholson et al. (2012) has characterised the metabolic interactions between host and gut 
microbiota. They are looking at the biological statistic that links microbes and the 
metabolites that are produced. Other recently reported research on host-microbe 
interactions includes a systems-level characterisation of a host-microbe metabolic symbiosis 
in the mammalian gut (Heinken et al. 2013) and uses metabolomic approaches to 
characterise metabolic interactions between the host and its commensal microbes (Xie et al. 
2013).  
 
The application of metabolomics technology has made significant impact into the 
environmental field. Environmental metabolomics basically looks at the interactions of living 
organisms with their environment. Metabolomics has many advantages as it can provide an 
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insight into an organism’s response to disease, toxicity or genetic manipulation. Previously, 
it has been applied to both the terrestrial (Bundy et al., 2007a) and aquatic environments 
(Viant et al. 2003; Rosenblum et al., 2006). A review by Lin et al. (2006) mentioned several 
applications in biomarker development and risk assessment of toxicant exposure, disease 
diagnosis and metabolic response to environmental stressors. Viant (2008) described the 
advanced technologies being used in environmental metabolomics. His group also reported 
a first international NMR-based environmental metabolomics comparison in 2009 to 
evaluate the accuracy and precision of 1H NMR measurements, based on these factors; data 
collection, data processing and multivariate analysis. The literatures mentioned above 
demostrates that metabolomics research is increasing in number and it can be applied in 
many other unexpected area that can benefit and improve our life.  
 
Methods for analysis of metabolites require several different analytical techniques, because 
of the problems described above of the range of chemical composition and concentrations 
involved. At the transcriptome and proteome level, high-throughput methods are already in 
use and the development of more comprehensive analysis methods is currently rising very 
fast compared to metabolomics analysis methods (Kaderbhai et al., 2003). Fiehn (2002) 
described four approaches in metabolomics; target analysis, metabolite profiling, 
metabolomics and metabolic fingerprinting. Target analysis includes identification and 
quantification of known metabolites in the sample. Metabolite profiling, on the other hand, 
aims to do rapid analysis of a larger set of compounds, with the objective to identify 
unknown metabolites that characterize given samples. This approach has been applied 
widely; to plants (Bolling and Fiehn, 2005), microbes (Fischer and Sauer, 2003), urine (Kind 
et al., 2007) and plasma samples (Dumas et al., 2006), in order to identify and quantify 
unknown compounds. Metabolic fingerprinting is looking into a large set of intracellular 
metabolites that has been detected by a selected technique. Metabolomics can be 
performed as a linker between genotype and phenotype (Fiehn, 2002) and is widely used in 
many fields of research, including microbes and plants. Metabolomics data sets offer a more 
complete view on how cells function, thus bringing new solutions for biotechnology. 
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Since metabolomics links molecular biology with chemistry  and physics, electronic 
databases are very important in metabolomics research. Similar to other ‘omics’ discipline, 
quality databases could help in the interpretation and understanding of many complex 
biological processes. There are many types of databases available; (i) metabolic pathway 
databases, e.g KEGG database, BioCyc database and Reactome database; (ii) compound-
specific databases, e.g Lipid Maps, KEGG Glycan, DrugBank, ChEBI and PubChem; (iii) 
spectral databases, e.g Biological Magnetic Resonance Bank (BMRB), Madison 
Metabolomics Consortium Database (MMCD), MassBank and Metlin and (iv) organism-
specific databases, e.g Biochemical Genetic and Genomics (BiGG), SYSTONOMAS and Human 
Metabolome Database (HMDB). These electronic resources contain information on a wide 
range of organisms.  
 
1.2 Microbial metabolomics 
 
Microbes are widely used in biotechnology, in fields such as fermentation, foods and 
biomass fuel production. They are ideal organisms to carry out systems biology studies 
because they are easy to manipulate and have important roles in life, and have simpler 
metabolomes than higher organisms. For example, the Sauer group have been actively 
involved in investigating the regulation of metabolic fluxes in microbes. Their work included 
analysis of metabolic fluxes on riboflavin-producing Bacillus subtilis (Sauer et al., 1997) and, 
studies on metabolic integration (Sauer, 2006), and established a protocol for 13C-based 
metabolic flux analysis (Zamboni et al., 2009). They have modelled bacterial metabolism to 
understand systems biology, thus providing valuable information on the regulatory network, 
multiple pathways and metabolic fluxes (Gerosa and Sauer, 2011).  
 
The aim of microbial metabolomics generally is to obtain biological information to facilitate 
the understanding of microbial interactions and cellular functions. In general it requires 
knowledge of both extracellular and intracellular metabolites. Metabolite concentrations of 
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intracellular metabolites become very significant in microbial metabolomics, as they play 
vital roles in regulating microbial metabolism. Any attempt at modelling the rates of 
metabolic systems requires a detailed knowledge of concentrations. The level of most 
intracellular metabolites lies below 1 mM (Bennett et al., 2009; Holms, 1996), thus 
presenting a big challenge in determining intracellular metabolite concentrations. Microbial 
cells usually are grown in liquid culture to relatively low titres, limiting the detection of 
metabolites present at low concentrations, since intracellular volumes take up no more than 
3% of the total sample volume (Russell and Cook, 1995). Therefore the standard procedure 
for analysing intracellular metabolites is to separate the cells from the medium before 
analysing cellular contents, for example by centrifugation. It is essential to quench cellular 
metabolism rapidly, immediately after sampling, since the turnover rates of many 
metabolites are on the subsecond scale. For example, cytosolic glucose is converted at 
approximately 1.0 mM s-1, and cytosolic ATP at approximately 1.5 mM s-1 (de Koning and 
van Dam, 1992). Therefore, the quenching step in metabolite analysis must be done within a 
very short time (<1 s) to ensure all the biochemical reactions will be stopped immediately 
after sampling. 
 
Microbial metabolomics can be performed in a number of different ways, depending on the 
data of interest. This then determines the type of fermentation experiment, the method of 
sampling and the analysis of data. Lowry et al. (1971) analysed E. coli metabolites during 
logarithmic growth on a variety of carbon and nitrogen sources, to assess the regulatory role 
of various metabolites. The E. coli metabolome has been investigated extensively using 
qualitative analysis (Simao et al., 2005; Dwivedi et al.,2010 ). Metabolomics offers not only 
qualitative data but also quantitative data of intracellular metabolites that can provide the 
information needed to model the metabolic network operating under in vivo conditions. 
Many scientific researchers have described models for the central metabolism of different 
organisms, such as Saccharomyces cerevisiae (Dobson et al., 2010), Escherichia coli (Usuda 
et al., 2010), Aspergillus niger (Andersen et al., 2008) and Lactococcus lactis (Oliveira et al., 
2005). Models have also been described from metabolome measurements for biosynthetic 
pathways leading to shikimate in Streptococcus pneumoniae, L-phenylalanine and L-
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threonine in E. coli, and L-valine and L-lysine in Corynebacterium glutamicum (Chassagnole 
et al., 2001a; Magnus et al., 2006; Noble et al., 2006; Yang et al., 1999). 
 
For quantitative analysis, it is important to define the physiological state of the biological 
system used for the measurements; in particular using a well-controlled steady-state 
culture. A steady-state chemostat is commonly used to cultivate microorganisms, e.g. E. coli, 
with the aim to fix the specific growth rate while varying a culture condition (see Section 
1.4.2). The steps necessary for quantification of intracellular metabolites can be summarized 
as follows: harvesting the sample, quenching of metabolism in the sample, determination of 
intracellular volume, extraction of metabolites, and finally the quantitative analysis of 
metabolites (Weuster-Botz and de Graaf, 1996). Each step has a very important role in 
obtaining an accurate picture about microbial metabolism.  
 
1.3 Methods for Metabolomics 
 
Several robust and reliable rapid sampling instruments have been developed and various 
quenching and separation procedures have been proposed and applied in the past several 
years. As mentioned above, it is important to start from a well-defined steady state. 
However it is also useful to be able to measure the time dependence of metabolic changes, 
because this provides the data which allows modelling of the rates of metabolic reactions. In 
general in microbial systems, the rates can be very rapid, making it important to be able to 
sample and quench very rapidly. Such systems are described in the following sections. In our 
case, rapid quenching is also important, but rapid sampling is not so critical, because the 
changes that we will be interested in are happening on a slower timescale. 
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1.3.1 Rapid sampling 
 
To understand microbial metabolism, quantitative information on both extracellular and 
intracellular concentrations is required, which can be achieved through rapid sampling. 
Generally, analysis of intermediary metabolites, such as glycolytic intermediates and sugar 
phosphates, is complicated by their short time constants caused by high exchange rates and 
low pool sizes (de Koning and van Dam, 1992; Weibel et al., 1974). Due to this, rapid 
sampling techniques have been developed so that collected samples represent in vivo 
conditions as closely as possible.  
 
There are many manually operated devices for rapid sampling from bioreactors that have 
become popular in the past several years. Theobald et al. (1993) described a simple 
sampling technique which took only 2 to 5 s intervals between samples that consists of a 
homemade sample port coupled to the bioreactor. It used a sampling tube containing the 
quenching solution under vacuum that provokes a rapid displacement of the sample from 
the bioreactor into the tube. Iversen (1981) designed a sampling valve with a minimal dead 
space. However, the disadvantage of these systems is that they have a limitation on 
sampling frequency. Weuster-Botz (1997) proposed a better idea to perform all steps 
(sampling, quenching and extraction of metabolite) in a continuous way. He used a long 
tube connected to the bioreactor to fix the highly dynamic metabolite patterns, resulting 
from an immediate disturbance of the culture in the bioreactor. Automated sampling 
devices were developed a few years later to improve the sampling device that was proposed 
by Theobald et al. (1993) with a better sampling reproducibility. Schaefer et al. (1999) 
therefore developed sampling tubes that were fixed in transport racks with a maximum 
sampling frequency of 4.5 samples s-1 to achieve much shorter intervals between samples. 
Lange et al. (2001) also invented a new system that consists of a submerged capillary port 
that is placed inside a stainless steel cylinder to fit a standard bioreactor and silicon tubing 
that connects to a waste container and to the sampler tube adapter. 
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Another sampling device was based on the stopped-flow technique combined with a 
modified rapid-freezing method, proposed by Buziol et al. (2002). The device serves as a 
mixing chamber, where the sample was directed to a sampling tube containing liquid 
nitrogen (-196°C), which acts as a quenching liquid. This device helps the culture to remain 
at a steady state because the organisms are stimulated by the glucose in the mixing 
chamber. It also has a short time span between glucose stimulus and first sample that is less 
than 100 ms. Another group that applied this stopped-flow technique is Dekoning and 
Vandam (1992). They incubated starved yeast cells in a quench apparatus to measure the 
changes of glycolytic intermediates after adding a pulse of glucose within a time frame of 
15-5000 ms. Visser et al. (2002) developed a rapid sampling and perturbation device 
(BioScope) which is a mini plug-flow reactor that can be coupled to the steady-state 
bioreactor. The system was equipped with 11 sample ports, including one sample port 
before the mixing chamber where the perturbing agent was mixed with the culture broth. 
The newest development is reported by Schaub et al. (2006) who used a coiled single tube 
heat exchanger connected to the bioreactor to produce a continuous sampling, quenching 
and extraction procedure.  
 
1.3.2 Quenching 
 
Many intracellular metabolites are characterized by a rapid turnover and sometimes low 
pool sizes. In this situation, the aim of quenching is to inactivate the intracellular enzymes so 
that the metabolite profile is frozen. The most commonly used method for rapid quenching 
of microbial metabolic activity in culture samples is achieved by instant change of sample 
temperature or pH, or by rapid addition of organic solvents, accomplished by mixing the cell 
sample with an appropriate quenching solution. In general, removal of the extracellular 
metabolites present in the broth is performed by centrifugation of the quenching solution to 
obtain a cell pellet. Centrifugation is often performed at temperatures below -20 °C in order 
to make sure no conversion of metabolites occurs. The cells occupy a smaller volume than 
the medium, and therefore for accurate measurement of intracellular metabolites it is 
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important to separate the cells from the medium before analysis. However, the 
centrifugation must be done quickly to reduce the risk of metabolic change: centrifugation 
at too low a temperature runs the risk that ice crystals may form and damage the cell 
membrane, leading to leakage of intracellular contents. 
 
The most popular quenching method is based on cold aqueous 60% (v/v) methanol at 
temperatures of -40 or -50 °C (Buchholz et al., 2001; de Koning and van Dam, 1992; Schaefer 
et al., 1999), and has been widely used for E. coli and S. cerevisiae. For example, Dekoning 
and Vandam (1992) have used this to measure glycolytic and other low molecular weight 
metabolites in yeast cells. However, this method was found to be not very suitable for 
prokaryotic microbes, resulting in loss of intracellular compounds (Bolten et al., 2007; 
Wittmann et al., 2004). The leakage of metabolites during quenching is likely to be 
dependent on cell wall and membrane structure. Even for yeast cells that are thought to be 
more robust, leakage of metabolites during quenching has been observed to occur. Canelas 
et al. (2008) have quantified metabolite leakage during cold methanol quenching of the 
yeast S. cerevisiae, by determining the levels of a large range of metabolites in total broth 
and different sample fractions, using isotope dilution mass spectrometry (IDMS). They 
confirmed that leakage does occur during quenching in pure methanol. The impact of the 
cold shock phenomenon, whereby the decrease in temperature results in an increase of the 
permeability of the cell membrane, has led to suggestions that this method is not 
appropriate. Release of metabolites after rapid cooling to 0°C has been observed by 
Taymaz-Nikerel et al. (2009) for E. coli. Bolten et al. (2007) found that the cold methanol 
quenching method could result in either higher or lower concentrations compared with 
filtration. Since the filtration procedure took nearly 30 s per sample, this method also does 
not appear to be suitable for steady-state measurements of metabolites with short turnover 
times. Alternative methods that have been used for quenching of E. coli include rapid 
freezing of the sample in liquid nitrogen (Chassagnole et al., 2002b) and rapid heating of the 
broth (Schaub et al., 2006). Rapid quenching in liquid nitrogen requires thawing of frozen 
sample followed by separation of the cells from the medium by centrifugation. It is likely 
that ice crystals may damage the cell membranes during the freezing, thus leading to 
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metabolite leakage and hence inaccurate quantification of the metabolites.  The direct 
spraying of cell samples into perchloric acid also inactivates metabolism and extracts 
metabolites simultaneously (Theobald et al., 1993; Weuster-Botz, 1997), though it has 
disadvantages as discussed in the next section. 
 
Recently, several attempts have been made to develop new quenching procedures, with the 
aim to minimize the metabolite leakage. Villas-Boas and Bruheim (2007) have proposed a 
quenching method using a cold glycerol-saline solution as a promising quenching agent for 
yeast and bacteria. They have shown that metabolite levels were much higher than when 
samples were quenched with the cold methanol solution, and therefore presumably there 
was less leakage due to damage to the cell wall. However, a disadvantage of this method is 
that it is impossible to get rid of the glycerol that sticks to the pellets; washing with water 
leads to loss of intracellular metabolites. A new quenching method has therefore been 
developed by (Spura et al., 2009), where they used 40% ethanol and 0.8% (w/v) sodium 
chloride as a quenching solution. This method has been tested on Gram positive and Gram 
negative prokaryotes, as well as eukaryotes. Ethanol was used instead of methanol to 
prevent damage of the cell membrane, and in a further effort to reduce membrane damage, 
the concentration of alcohol was reduced. The sodium chloride is used to produce an 
isotonic solution that should not result in osmotic shock.  More than 80% of identified 
metabolites showed higher relative concentrations in the ethanol quenching compared with 
the methanol quenching, and therefore presumably less loss of metabolites. This method 
appears to be the most reproducible, stable and fast for bacterial cells. It has therefore been 
implemented, to check if it can be used as a routine method for analysis of chemostat 
cultures. Various quenching procedures are summarized in Table 1.1. 
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Quenching agent    Temperature   Microorganisms         References 
EtOH/H2O       -23°C S. cerevisiae      Villas-Boas and Bruheim (2007) 
60% (v/v) MeOH/H2O      -40°C Yeast           de Koning and van Dam (1992) 
60% (v/v) MeOH/H2O      -40°C S. cerevisiae      Villas-Boas et al. (2005a) 
60% (v/v) MeOH/H2O      -50°C E. coli           Schaefer et al. (1999) 
60% (v/v) MeOH/H2O      -50°C E. coli                 Buchholz et al. (2001) 
60% (v/v) MeOH/H2O      -58°C C. glutamicum   Wittmann et al. (2004)       
                                                                                    Bolten et al. (2007) 
40% (v/v) EtOH/NaCl      -30°C            E. coli            Spura et al. (2009) 
(0.8%) (w/v) 
Liquid nitrogen    -150°C          E. coli                 Chassagnole et al. (2002b) 
 
Table 1.1: Comparison of quenching agents used for microbial metabolites 
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1.3.3 Extraction methods for intracellular metabolites 
 
Once metabolism has been arrested by quenching, the metabolites need to be extracted 
from the cells. The best extracting agent should extract as many intracellular metabolites as 
possible with minimal degradation and no chemical or enzymatic modification of the 
targeted metabolites. Sample cells are homogenized, sonicated or freeze-thawed in the 
presence of aqueous and/or organic solvents in order to break up the cells to release the 
metabolic compounds (Khoo and Al-Rubeai, 2009). The mixture of cell debris and extracted 
metabolite is then centrifuged to separate the liquid containing the desired metabolites. It is 
important to remove the extracellular metabolites first for proper quantification of the 
intracellular metabolites. Although generally the concentration of extracellular metabolites 
is much lower than intracellular concentrations, the amount present in the supernatant may 
still be very significant because the volume of the supernatant is two orders of magnitude 
larger than the total cell volume. This has been proved by Bolten et al. (2007), where they 
found significant amounts of several central metabolites and amino acids present in the cell 
culture filtrate.  
 
The broken cells may need to be subjected to further separation to extract the metabolites. 
The most commonly used extraction method is perchloric acid (Chassagnole et al., 2002b; 
Kayser et al., 2005; Schaefer et al., 1999). One disadvantage of perchloric acid extraction is 
that it is only suitable for nucleotides and water-soluble metabolites. Because of the pH 
extreme involved, perchloric acid extraction may cause a destruction of compounds like 
pyruvate, NAD, NADH+, phosphorylated deoxyadenosine sugars and indole compounds 
(Gonzalez et al., 1997). Maharjan and Ferenci (2003) have concluded that the use of cold 
methanol is much preferred because of its simplicity and because it allowed more 
components to be extracted. Since the extraction is carried out at -40°C, chemical and 
enzymatic changes in metabolites are likely to be minimized. An additional advantage is that 
cold methanol extraction can be used for other organisms including eukaryotes and 
mammalian cells as a general tool for quantification of metabolites. Faijes et al. (2007) have 
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made a similar observation and suggested that factors like handling and temperature should 
be carefully controlled during the procedure. Rabinowitz and Kimball (2007) have proposed 
cold acidic solvent mixtures containing acetonitrile for extraction of E. coli metabolites 
especially for nucleotide triphosphates. By contrast, Hiller et al. (2007) claimed that 
buffered hot water (30 mM triethanolamine (TEA), pH 7.5, 95°C) produced more reliable 
results for E. coli compared to buffered ethanol, unbuffered hot water or perchloric acid. 
However, treatment by water at 95° could lead to loss of volatile and reactive compounds, 
and has not been pursued further here. Based on this analysis, we have concluded that cold 
ethanol/saline followed by methanol extraction is the most promising method. In Chapter 3, 
we present some refinements of the method aimed at improving its reproducibility. 
 
1.3.4 Determination of metabolite concentration 
 
1.3.4.1 Traditional methods 
 
Traditionally, quantitative analysis of extracellular and intracellular metabolites has been 
carried out using enzyme-based assays (Hajjaj et al., 1998; Theobald et al., 1993). This 
method has the advantage of being very specific, but the main disadvantage lies in the 
relatively large sample needed for quantification, and by the fact that each metabolite must 
be assayed separately. Nowadays, many analytical techniques have been applied, including 
gas chromatography (GC), thin-layer chromatography (TLC), mass spectrometry (MS), high-
performance liquid chromatography (HPLC), nuclear magnetic resonance (NMR) and laser 
induced fluorescence (LIF) detection. All these methods can be used in measuring 
metabolite concentration, but they differ in selectivity and sensitivity, and in the need for 
pre-treatment of the sample. They also differ in the speed of the method and the ease of 
subsequent analysis.  
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1.3.4.2 System wide methods 
 
1.3.4.2.1 Nuclear magnetic resonance (NMR) spectroscopy 
 
1.3.4.2.1.1 Overview of NMR 
 
NMR spectroscopy is one of the leading technologies used to characterize a chemical 
structure and has been used extensively for metabolite profiling (Griffin, 2003; Lindon et al., 
2000). NMR was first developed in 1946 by a research group in the USA (Purcell et al., 1946) 
and was the subject of the Nobel Prize for Physics in 1952. Chemical shift (the observation 
that the resonance frequency of a nucleus is affected by its chemical environment) was 
discovered in 1950 and later it was observed that a nucleus could influence the resonance of 
another through the phenomenon of J-coupling through chemical bonds. Later, the 
chemical shift and spin-spin couplings have been proved to be related to chemical structure. 
The signal to noise ratio in NMR was significantly improved in 1970 through the introduction 
of Fourier transformation (FT) of the time-domain response resulting in a frequency domain 
spectrum. Richard R. Ernst, who pioneered this work, has received the Nobel Prize for 
Chemistry in 1991 for his contribution to the development in methodology of high 
resolution nuclear magnetic resonance spectroscopy. 
 
Recent advances in NMR techniques, software for analysis and spectroscopic libraries of 
metabolites have enlarged the potential to identify new metabolites.  NMR provides a rich 
information set for metabolic analysis, because the intensities of NMR signals are linearly 
proportional to concentration. Most NMR analyses use 1H NMR for detection of 
metabolites, meaning that any compounds containing protons can be observed by NMR. 
NMR can thus detect almost any metabolite present at sufficient concentrations. It is also 
non-destructive, non-biased, requires little or no separation and needs no chemical 
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derivatization. NMR is particularly appropriate for compounds that are less tractable for GC-
MS or LC-MS analysis, e.g. sugars, amines, volatile ketones and relatively non-reactive 
compounds. The disadvantage of NMR spectroscopy is its lack of sensitivity, with a lower 
limit of detection of about 1-5 µM. Large sample sizes (~500 µl) are typical though it is 
possible to use much smaller volumes (example 35 µl), permitting sensitive detection on 
more concentrated samples, not usually a problem since metabolites are usually soluble. 
The strong solvent signal (for example of 1H2O) must be suppressed in some way to avoid 
saturation of the analogue-to-digital converter of Fourier-transform (FT) spectrometers. To 
avoid a large water signal, D2O can be used instead of H2O (Gaines et al., 1996) or the water 
signal can be suppressed with suitable pulse sequences (Hore, 1989). The sensitivity of NMR 
has markedly improved with the introduction of higher field magnets (up to 900 MHz), 
cryogenically cooled probes and small-volume microprobes (Ehrmann et al., 2007; Robosky 
et al., 2007).  
 
Although several other important nuclides, e.g 31P, 13C and 15N can be detected by NMR, 
proton (1H) remains the most widely used to understand metabolic and physiological 
processes. It is the most sensitive nucleus, it is present at 99.98% natural abundance, and it 
is present in almost all carbon-containing biological molecules, substrates and products. 1H 
NMR spectra can be obtained in a few minutes and contain quantitative information on all 
metabolites simultaneously, making it a good high-throughput method. In 1H NMR spectra, 
metabolite signals are confined to a narrow bandwidth of roughly 10 ppm. In principle, this 
could lead to overlap of signals, but in practice, this is seldom a problem. 13C is present at 
1.1% abundance, and has a gyromagnetic ratio 25% that of 1H, which makes it considerably 
less sensitive. However, the signals are better resolved. Fluorine (19F) is less used compared 
to 1H and 13C since it is present in only about 10% of pharmaceutical compounds, even 
though it is 100% abundance. Phosphorus (31P) is one of the routine NMR nuclei that are 
less sensitive than 1H but more sensitive than 13C. It has an isotopic abundance of 100% and 
is found in many metabolites, which are not only at high concentration in the cell but also of 
importance for cell energetics (eg ATP: Table 1.2). Brown et al. (1977) applied 31P NMR to 
measure the in vivo exchange rates between inorganic phosphate (Pi) and the terminal 
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phosphate of ATP (ATPγ) in suspensions of aerobic E. coli cells. Finally, 15N is useful because 
nitrogen is present in a large number of metabolites, but isotopically enriched samples are 
almost essential for heteronuclear NMR because of its low natural abundance and low 
sensitivity.  
 
Quantification of complex biological samples by NMR is not straightforward. The problem 
with analyzing complex spectra is there are hundreds or thousands of signals, which may 
often be overlapped. There are two approaches in collecting, processing and interpreting 
metabolomic NMR data. These are called quantitative and chemometric methods (Figure 
1.2). In quantitative metabolomics, compounds are identified and quantified absolutely by 
comparing the NMR spectrum of the sample with a spectral reference of pure compounds 
(Weljie et al., 2006). By contrast, in chemometric analysis, peaks are not identified initially. 
The statistical differences between their spectral pattern and intensities are used to identify 
special features, and are treated by a variety of approaches (Winning et al., 2008) which 
may or may not involve identification of the metabolites involved. There are a few 
approaches for chemometrics that are routinely used, such as Principal Component Analysis 
(PCA), Soft Independent Modeling of Class Analogy (SIMCA) and Orthogonal Partial Least 
Squares (OPLS). By comparison to chemometric methods, the quantitative method allows 
precise compound quantification, does not require spectral alignment or binning, and 
permits immediate interpretation of metabolic pathways as we can get both compound 
identities and concentrations from this method (Weljie et al., 2006; Wishart, 2008). It does 
however require much more individual interpretation of each spectrum. In general, there 
are five main steps in quantitative spectral analysis: zero filling and line broadening, 
chemical shift referencing, phasing, baseline correction and possibly line-shape correction. 
These are not unlike the steps used to process most small-molecule NMR spectra.             
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Figure 1.2: Schematic diagram of two routes to metabolomic analysis; quantitative and 
chemometric methods. Adapted from Wishart et al. (2001) 
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1.3.4.2.1.2 The principles of NMR 
 
The NMR spectrometer consists of various pieces of equipment that provide the capability 
of various experiments. The basic spectrometer consists of a receiver, a transmitter, a 
probe, a magnet and a computer (Figure 1.3). During the NMR experiment, the computer 
instructs the transmitter to issue a radio frequency (rf) pulse to the probe. This rf pulse 
excites the spins in the sample.  A sample consisting of many nuclear spins has a 
macroscopic magnetisation, which behaves like a small magnet.  When the sample is excited 
by a radiofrequency (rf) field, the nuclear magnetisation is rotated. Usually, the rf field is 
turned off after the magnetisation has rotated 90°, after which the magnetisation rotates 
around the applied magnetic field axis.  The oscillating magnetic field creates a current in a 
coil placed around the sample. The frequency of the oscillation is detected as a Free 
Induction Decay or FID, and converted to a frequency in a spectrum using a Fourier 
transform. 
 
NMR is the observation of the spin of a nucleus, which generates a magnetic field. When an 
external magnetic field (Bo) is present, the nuclei align themselves either with or against the 
field of the external magnet (Figure 1.4b). Without an external applied magnetic field, the 
nuclear spins are random in directions (Figure 1.4a). The energy difference between the two 
states (∆E) depends on the applied field. The greater the strength of the applied magnetic 
field, the larger the energy difference between the two spin states (Figure 1.5). The resulting 
spin-magnet has a magnetic moment (µ) proportional to the spin. Spin quantum number (I) 
is related to the atomic and mass number of the nucleus. Some nuclei have integral spins 
(e.g. I= 1, 2, 3), some have fractional spins (e.g. I=1/2, 3/2, 5/2) and a few have no spin (e.g. 
12C, 16O, 32S).  
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Figure 1.3: Essential parts of an NMR spectrometer. The computer instructs the transmitter 
to issue a radio frequency (rf) pulse to the probe. The rf pulse excites the spins in the 
sample. Then the computer instructs the receiver to turn on to receive the rf energy that 
being radiated from the spins. 
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        No external magnetic field         With external magnetic field 
(a)                                                                                 (b) 
Figure 1.4: Two schematic representations of alignment in magnetic fields. In the absence 
of magnetic field (a), the nuclei are randomly oriented but when a field is applied (b), they 
line up parallel to the applied field either spin aligned or spin opposed. 
 
 
 
 
 
 
 
 
 
Figure 1.5: ΔE influenced by magnetic field strength at nucleus.  
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Nuclei in different locations in a molecule experience different local magnetic fields. These 
are measured as the difference between the resonance frequency of the nucleus and a 
standard, relative to the standard. This quantity is reported in ppm and given the symbol 
delta, δ. Important factors involved in chemical shift are electron density or 
electronegativity of neighbouring groups and anisotropic magnetic field effects. One of the 
first spectra recorded that reveal the NMR chemical shift is the proton spectrum of ethanol. 
Trends in chemical shift are explained based on the degree of shielding or deshielding. 
When a signal is found with a higher chemical shift, the nucleus is more shielded and when 
the chemical shift is low, the nucleus is more shielded. In NMR spectroscopy, the most 
common standards used are either tetramethysilane (TMS) or trimethylsilyl propionate 
(TSP), which are defined to be at 0 ppm. Spin couplings through bonds are observed in NMR. 
This effect can cause splitting of the signal for each type of nucleus into two or more lines. 
The size of the splitting (J) is independent of the magnetic field and is therefore measured as 
an absolute frequency (Hertz). Relaxation times (T1 and T2) describe how rapidly 
magnetisation returns to equilibrium (in the z and xy directions respectively) and are 
important for proper interpretation of NMR spectra, but they can vary greatly depending on 
the structure of the molecule. For example, when relaxation is very fast, NMR lines will be 
broad and the signal harder to detect. 
 
Figure 1.6 shows the most basic and common pulse sequence used in Fourier transform-
NMR experiments. This sequence is used for routine 1H and 13C acquisitions. The radio pulse 
excites the nuclei, which then precess during the acquisition time, giving an NMR signal in 
the form of an exponentially decaying sine wave. This decaying sine wave is known as the 
free-induction decay (FID). The radio pulse has a characteristic frequency, called the 
spectrometer frequency (SF), which is dependent upon the nucleus and the magnetic field 
strength of the spectrometer used. The radio pulse also has a width and it is most 
commonly described in terms of a flip angle in degrees. As shown in Figure 1.7, this is 
because of its effect on the nuclear spins. The amount of rotation is dependent on the 
power and width of the pulse in microseconds (pw). Maximum signal is obtained with a 90° 
pulse. Thus, the 90° pulse width is the amount of time the pulse of energy is applied to the 
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particular sample in order to flip all the spins into the X-Y plane. The nuclear spins are no 
longer at equilibrium and will return to equilibrium along the Z-axis. In Figure 1.6a, the 
decaying sine wave represents this process of Free Induction Decay (FID), which is a plot of 
induced voltage as a function of time. The time to acquire the FID is called the acquisition 
time (at). The signal acquired is digitised; the spectrometer represents the FID by a series of 
points along the FID curve. Fourier transforming the FID produces a spectrum which gives 
intensity as a function of frequency. The frequency domain spectrum has two important 
parameters associated with it, the frequency and the spectral width. There are many 
variations on this simple pulse sequence. A common one, used for most of the spectra 
shown here, adds a frequency-selective pulse before the 90° pulse, to suppress the intense 
signal from the water (Figure 1.6b). 
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Figure 1.6(a): Schematic presentation of one cycle of a simple one-pulse NMR. 
 
 
 
 
 
 
Figure 1.6(b): A simple 1D single-pulse experiment including a long low-power pulse on 
resonance with the water signal, to suppress the intense water signal. 
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Figure 1.7: The average nuclear spin magnetisation (bold arrow) for an NMR sample 
placed in a magnetic field aligned along the Z-axis before and after application of a pulse.  
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1.3.4.2.1.3 1H NMR Studies of Metabolism 
 
Developments in metabolomics are driven by brilliant analytical methods. 1H NMR is an 
important experimental technique that allows high-throughput quantification of small 
molecules in biological system, known as metabolites (Nicholson et al., 1999). The 
application of 1H NMR includes to characterise, diagnose and understand the metabolic 
states, and is increasingly applied in biomedical research, toxicology, drug characterisation 
and in human nutritional research (Shockcor and Holmes, 2002; Stella et al., 2006; Holmes 
et al., 2006; Winnike et al., 2009; AzaÏs et al., 2009; Jung et al., 2011). In particular, NMR is 
widely used for identification and quantification of metabolites, in which biofluids like 
plasma and urine are the most commonly used samples (Nicholson et al., 1999).  
Metabolites contain one or more protons and this/these proton(s) are detectable by 1H 
NMR as a peak. The number of peaks generated by a metabolite is determined by the 
chemical structure of the molecule. 
 
Currently, 1H NMR is being actively applied in metabolomics; particularly in metabolite 
identification and profiling. The major challenges in 1H NMR metabolic profiling are the 
assignment of metabolites from spectra due to huge data volumes and the presence of 
unknown metabolites. Many approaches have been introduced to facilitate 1H NMR in 
performing metabolic profiling. Yeom et al. (2013) have used 1H NMR and multivariate 
analysis, e.g PCA and OPLS to study the metabolic changes in biofilm-forming bacteria, 
Acinetobacter baumannii 1656-2. They have found that metabolites like acetate, pyruvate, 
succinate and glutamate were involved in the metabolism of biofilm formation. Other 
groups, e.g Barba et al. (2010) and Isern et al. (2013) used 1H NMR together with spiking 
experiments (comparison to prepared standard) to identify and quantify metabolites from 
vitreous fluid of diabetic retinopathy patients and fermentation products in 
Caldicellulosiruptor saccharolyticus. Apart from the above mentioned method, scalar 
coupling between 1H and 13C can give more detailed identification of metabolites and 
structure determination (Misra and Bajpai, 2009). Metabolites can also be identified by 
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comparing the experimental chemical shift with the published chemical shift, which helps in 
identification of metabolites (Tulpan et al. 2011). It is common practice to add a reference 
compound to the sample such as trimethylsilyl propionate. This is useful to check for correct 
alignment and referencing of spectra. It also provides a useful guide to correct setup and 
recording of the experiments, because the linewidth of the reference should remain less 
than 1 Hz for all spectra. Nowadays, 2D NMR has been widely used in metabolomics to 
achieve better results. Some 2D NMR methods, e.g 13C-1H HSQC and homonuclear 2D 
spectra (1H-1H NMR; 13C-13C NMR) have been extensively used in metabolomics. In 13C NMR, 
the chemical shift dispersion is greater and spin-spin interactions are removed by 
decoupling. This can be seen in research carried out by Kivero et al. (2008), Tredwell et al. 
(2011) and Zhang et al. (2012).  
 
The combination of NMR analysis with an in-line chromatographic separation technique has 
become a highly practical analytical method. It eliminates much of the overlap problem in 
the 1H spectrum.  The best example for this method is LC-NMR. The extracts or mixtures can 
be fractionated before NMR spectra being recorded (Lindon and Nicholson, 1997). This 
approach has been applied in the analysis of complex mixtures that contain unknown 
components, metabolites in pharmaceuticals, natural products and synthetic polymers 
(Pasch et al., 2008). LC-NMR has the ability to separate complex mixtures into individual 
components which made it as an important method in determination of structure of 
unknown compounds (Alsante et al. 2004). The highest sensitivity of LC-NMR is provided 
when all separated components are introduced into a flow-cell. Most LC-NMR operations 
used reversed-phase columns that caused problem to NMR measurement and it has been 
overcome by using other eluents and deuterated solvents. Optimisation of HPLC separation 
is important to be carried out in LC-NMR analysis (Patel et al. 2010).  
 
Both MS and NMR techniques are limited by overlapping signals. In MS, the overlapping 
signals come from the fragmentation of the mass ion, whereas in NMR multiple signals arise 
directly from the same molecule. NMR is more quantitative than MS. In MS, preparing 
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samples is more time-consuming, where frequent calibration and variable retention times 
are needed. Thus, NMR plays an important role in metabolite analysis to enrich the 
metabolomics field.  
 
1.3.4.2.2 Mass Spectrometry (MS) 
 
Currently, mass spectrometry is widely employed for analysis of metabolites because it 
provides highly selective and sensitive methods for the detection of a wide range of 
metabolites. MS measures the mass (or more specifically the mass-to-charge ratio) of 
charged metabolites. In principle, a mass spectrometer generates multiple ions from the 
sample, then separates them according to their mass, and records the relative abundance of 
each ion type (Figure 1.8). Modern MS provides highly specific chemical information that is 
directly related to the chemical structure and allows detection and measurement of 
picomole to femtomole levels of many primary and secondary metabolites. These unique 
advantages make MS an important tool in metabolomics (Bedair and Sumner, 2008). There 
are many types of MS that differ in operation and performance, such as resolving power and 
mass accuracy. In the late 1980s, electrospray ionization (ESI) and matrix assisted laser 
desorption/ionization (MALDI) were developed, and since then have become popular in 
biomolecular research (Domon and Aebersold, 2006). In ESI, the solvent passing through the 
chromatographic column is channelled through a capillary charged with a high voltage, 
either positive or negative. Fourier transform ion cyclotron resonance (FT-ICRMS), orbitrap 
MS and multi-mass TOFMS are examples of mass analyzers with different resolving power 
that have been used in metabolomics. Coupling chromatography to MS offers an excellent 
solution to complex mixture analyses.  
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Figure 1.8: Schematic presentation of the basic principle of a mass spectrometer. The first 
step in the mass spectrometric analysis of compounds is the production of gas phase ions of 
the compound. This molecular ion may undergo fragmentation, depending on how much 
energy it had when it went into the gas phase. The ions are separated in the mass 
spectrometer according to their mass-to-charge-ratio and are detected in proportion to 
their abundance. A mass spectrum of the molecule is thus produced. 
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Currently, there are three chromatography techniques that have commonly been 
incorporated into MS based metabolomics, which are gas chromatography (GC), liquid 
chromatography (LC) and capillary electrophoresis (CE). Chromatographic separation of 
metabolites prior to MS analyses has several advantages: it allows for more accurate 
quantification of individual metabolites, better separation of isomers, reduction of matrix 
and ionization suppression (Figure 1.9) (Villas-Boas et al., 2005b). In GC, the mobile phase 
carrying the metabolite is gaseous. This is why it is limited to volatile compounds and 
compounds that can be made volatile through derivatization. The disadvantage of GC is that 
the derivatization makes the querying of compounds from metabolite databases more 
difficult (Halket et al., 2005).  Nowadays, LC is often preferred to GC. In LC, the solutes are 
carried and eluted by a liquid mobile phase. High performance liquid chromatography 
(HPLC) with solid columns of porous stationary phase for trapping the metabolites is popular 
in metabolomics, because of improved separation and smaller solvent volumes. The 
stationary phase of the column separates metabolites based either on the size of particles, 
affinity of the solutes to the stationary phase or ion exchange (Wilson et al., 2005). The two 
columns used in this study are a C4 column and C18 column. The C18 column is based on 
hydrophobic interactions between the solutes and the eluent molecules. It is based on an 
18-carbon hydrocarbon attached to silica which works as a stationary phase, as the solvent 
elutes the compounds according to their hydrophobicity. The column is an example of 
reverse-phase chromatography (Dettmer et al., 2007). The C4 column is less hydrophobic 
and therefore more suitable for more polar compounds.                                                             
Desorption electrospray ionization (DESI) has been demonstrated to be robust in the 
identification of unlabeled and labelled metabolites in E. coli extracts (Jackson et al., 2008). 
Another high sensitivity instrument that is available for the quantification of extracellular 
and intracellular metabolites is LC-ESI-MS, which can analyze down to a detection limit of 8 
fmol (Carmella et al., 2005). A recent technique applied is capillary electrophoresis-mass 
spectrometry (CE-MS) (Ramautar et al., 2009). 
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Figure 1.9: Three predominant chromatographic techniques have been incorporated in 
mass spectrometry (MS) analysis of metabolites. The sample can be directly analyzed by 
MS (dashed arrow), or it can be first resolved with different on-line separation techniques 
(full arrows). Adapted from Villas-Boas et al. (2005b). 
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1.4 Escherichia coli 
 
Escherichia coli is a Gram-negative and non-spore forming rod bacterium. This bacterium is 
part of the large bacterial family, Enterobacteriaceae, most of which are harmless enteric 
bacteria and facultative anaerobes. They are part of the normal intestinal microflora found 
in the intestines of humans and animals. They also can be found in water and, soil or are 
parasites on a variety of animals and plants. Apart from E. coli, Enterobacter also colonize 
the gastrointestinal tract (Hooper and Gordon, 2001). They are beneficial to the human 
body by keeping the intestinal tract free from harmful bacterial infections, and help in 
digestion and in the absorption of many necessary vitamins, like vitamins B12 and K (Kaper et 
al., 2004). Other genera within the family such as Salmonella, Klebsiella and Shigella are 
human intestinal pathogens. When they spread throughout the body, they can cause 
diseases like diarrhoea, urinary tract infections and meningitis (Nataro and Kaper, 1998).  
Diarrhoea is a major health problem in the world with over two million deaths arising each 
year (Kosek et al., 2003). 
                                                                                                                                                         
E. coli is one of the most important model organisms that have been studied. The first 
complete DNA sequence of an E. coli K12 genome was published in 1997 (Blattner et al., 
1997). Today it is commonly used in industry as a cloning host in recombinant DNA 
technology. Genes can be introduced into the microbes using plasmids which permit high 
level expression of protein and this protein may be mass produced in industrial 
fermentation processes. It is also useful as an indicator bacterium for resistance in 
pathogenic bacteria (von Baum and Marre, 2005). This bacterium is easy to grow, can be 
manipulating genetically and has simple nutritional and cultivation technique requirements. 
It also can ferment glucose and metabolically convert it into anabolites that are used to 
build up the cell (Kaper et al., 2004). This versatile bacterium can live in the presence and 
absence of oxygen. Under anaerobic conditions, it can grow by fermentation, which 
produces acids and gas as end products, or anaerobic respiration where they use molecules 
such as nitrite, nitrate or fumarate as the final electron acceptor for respiratory electron 
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transport processes (Lupp and Finlay, 2005). This allows E. coli to adapt to both the 
anaerobic environment inside the intestine and external aerobic environments  (Hooper and 
Gordon, 2001).  
 
1.4.1 Growth of bacteria 
 
The methods for growth of bacterial cultures can be classified into two main groups, which 
are called batch and continuous culture. Batch culture can be described as a growth 
occurring in a fixed volume of culture medium that is continuously being altered by the 
metabolism of the growing organisms until it is no longer suitable for growth. During the 
early stages of exponential growth in batch culture conditions may remain relatively stable, 
but as the cell number increases drastic change in the chemical composition of the medium 
occurs. A continuous culture is a flow system of constant volume to which medium is added 
continuously and from which continuous removal of any overflow can occur. Once such a 
system is in equilibrium, cell number and nutrient status remains constant and the system is 
said to be in a steady state. Comparing to continuous culture, nutrient concentration can 
affect both the growth rate and the growth yield of bacteria in a batch culture. At very low 
concentrations of a given nutrient, the growth rate is reduced; probably because that 
nutrient cannot be transported into the cell fast enough to satisfy metabolic demand. At 
moderate or higher levels of this nutrient, growth rates may not be affected while cell yield 
continues to increase.  
 
1.4.2 Chemostat culture 
 
The most common type of continuous culture device used for producing biomass for global 
metabolic studies is a chemostat. A chemostat is a bioreactor to which fresh medium is 
continuously added, while culture liquid is continuously removed.  It provides a reproducible 
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environment and populations of cells in physiological steady state since the parameters, 
such as growth rate, dissolved oxygen and nutrient concentrations can be kept constant. 
The chemostat was developed by Monod (1950) and Novick and Szilard (1950) and permits 
control of both the population density and the growth rate of the culture. Two elements are 
used to control a chemostat: the dilution rate and the concentration of a limiting nutrient, 
which most commonly is the carbon source. However, other limiting nutrients (nitrogen and 
phosphorus) have been used as well (Kovárová-Kovar and Egli, 1998; Visser et al., 2002). In a 
chemostat, culture growth rate and yield can be controlled independently of each other. 
Growth rate can be controlled by adjusting the dilution rate while growth yield can be 
controlled by varying the concentration of the nutrient present in a limiting amount. Steady 
state relationships in a chemostat are shown in Figure 1.10. The organism cannot grow fast 
enough at high dilution rates to keep up with the dilution. The culture is thus washed out of 
the chemostat. At very low dilution rates, a large fraction of the cells may die of starvation 
because the limiting nutrient is not being added fast enough to permit the maintenance of 
cellular metabolism. The cell density in the chemostat is controlled by the level of the 
limiting nutrient. The cell density will increase when the concentration of the nutrient in the 
fresh medium is high. In a chemostat, a population may be maintained in the exponential 
growth phase for long periods. It is a stable and reproducible system, a big advantage of the 
chemostat. Prolonged chemostat cultivation also leads to evolutionary adaptation of the 
cells to the culture conditions (Steiner and Sauer, 2003; Wick et al., 2001).  
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Figure 1.10: Effect of dilution rate in chemostat bacterial growth. Because the mass of 
bacteria remains constant in a chemostat, growth of the culture is linear, not exponential. 
Hence the time required to add a volume of liquid equal to the capacity of the chemostat is 
the doubling time.                                                                      
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1.4.3 The metabolic modes of E. coli 
 
E. coli is a versatile bacterium that can sense and respond to oxygen availability in its 
environment and use different metabolic pathways to produce energy for growth. It prefers 
to grow aerobically, because the energy produced from substrates such as glucose is much 
greater in the presence of oxygen. In the middle of the gut, there is almost no oxygen and it 
has to grow anaerobically. However, close to the gut wall, the environment is microaerobic. 
E. coli is capable of changing its metabolic mode very rapidly as it encounters different 
growth conditions.  
 
Pyruvate is the key intermediate in carbohydrate metabolism because it is the switch point 
between respiratory and fermentative metabolism. When oxygen is available, maximal 
energy is generated when a growth substrate such as glucose is completely oxidised. 
Therefore, aerobic respiration is the most productive and preferred metabolic mode (Guest 
et al., 1996). Pyruvate produced by glycolysis is oxidatively decarboxylated by the pyruvate 
dehydrogenase complex (PDHC) to acetyl coenzyme A (Acetyl-CoA), carbon dioxide (CO2) 
and NADH (Figure 1.10A). The E. coli PDHC consists of three subunits, pyruvate 
dehydrogenase (E1), acetyltransferase (E2) and dihydrolipoamide deydrogenase (E3). In E. 
coli the complete oxidation of 1 mole of glucose in glycolysis and the TCA cycle generates 10 
moles of NAD(P)H and 2 moles of FADH2: 
 
Glucose + 8NAD+ + 2NADP+ + 2FAD + 4ADP+ 4 Pi          6CO2 + 8NADH + 2NADPH + 2FADH2 + 
4ATP + 10H+ 
 
The reducing equivalents produced enter an electron transport chain and are used in the 
reduction of O2 to H2O. This creates proton gradients to generate energy with 34 ATP per 
mole of glucose. This irreversible PDHC reaction shows that it is important to prevent 
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unnecessary destruction of pyruvate. Within the complex, only the E1 reaction is 
irreversible. This means that the E1 reaction is the focus of the control steps. 
 
Two alternative metabolic modes are achievable when no oxygen is present. Anaerobic 
respiration will take place if other electron acceptors, such as nitrates, sulfates, fumarate or 
trimethylamine N-oxide (TMAO) are available (Patschkowski et al., 2000) (Figure 1.10B). 
During anaerobic respiration and fermentation, the role of pyruvate dehydrogenase 
complex (PDHC) is played by pyruvate formate lyase (PFL), the citric acid cycle (CAC) is 
repressed and the metabolic flow in the C4 section of the CAC is reversed. PFL converts 
pyruvate to acetyl CoA and formate; the formate produced cannot be used by the cell and it 
is secreted out of the cell. The preference for PFL has been demonstrated with several 
bacteria under carbon limitation conditions imposed either in a chemostat or in the 
presence of a poor carbon source (Melchiorsen et al., 2001). Fumarate is reduced to 
succinate by fumarate reductase and some energy is conserved during this step. The energy 
produced is less than that achieved by aerobic respiration because the substrate (glucose) is 
only partially oxidized. Fermentation is the process by which cells release energy under 
anaerobic conditions, in the absence of any terminal electron acceptor. This involves the 
utilisation of carbon and energy sources to produce more reduced products. Energy is 
conserved by substrate level phosphorylation and formation of the overflow metabolites 
(acetate, ethanol, formate, succinate) to maintain the redox balance, which are secreted 
from the cell. However, in comparison, anaerobic respiration is more productive than 
fermentation (Figure 1.11). 
 
E. coli is able to adapt its metabolism to maximise energy production under different redox 
conditions. Although PDHC is essential for maintaining cellular redox balance in an aerobic 
cell, no PDHC-based fermentation has been demonstrated in E. coli or other bacteria 
growing anaerobically. A very high sensitivity of PDHC towards NADH inhibition is related to 
the absence of PDHC activity under anaerobic conditions. The metabolic pathways used by  
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Figure 1.11: The metabolic modes of Escherichia coli.  The main pathways of energy 
metabolism of E. coli growing under (A) aerobic respiration, (B) anaerobic respiration and 
(C) fermentation are shown in the above diagram. Under aerobic conditions, glucose is 
completely oxidized to CO2 and water. Under anaerobic conditions, glucose is partially 
oxidized to CO2 and acetate in the presence of an alternative electron acceptor such as 
nitrate. Under anaerobic fermentative conditions, glucose is converted to acetate, ethanol 
and formate and energy is conserved by substrate-level phosphorylation rather than 
oxidative phosphorylation. The enzyme activities responsible for each step are indicated: 
AckA, acetate kinase; Acn, aconitase B; AdhE, alcohol dehydrogenase; Cyd, cytochrome bd 
oxidase; Cyo, cytochrome bo oxidase; Fdn, formate dehydrogenase-N; Fum, fumarase (A, B, 
C); GltA, citrate synthase; lcdA, isocitrate dehydrogenase; Mdh, malate dehydrogenase; Nar, 
nitrate reductase; Nuo, NADH dehydrogenase I; Ndh, NADH dehydrogenase II; PCK, 
phoshoenolpyruvate carboxykinase; PDHC, pyruvate dehydrogenase complex; PFL, pyruvate 
formate lyase; Pta, phosphotransacetylase; Sdh, succinate dehydrogenase; Suc, 2-
oxoglutarate dehydrogenase/succinyl-CoA synthetase (Trotter et al., 2011). 
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E. coli are dependent on the nature of the growth substrate, oxygen availability and also the 
availability of any alternative electron acceptors, with aerobic respiration preferred to 
anaerobic respiration, with both preferred to fermentation. The ability of E. coli to adopt 
different metabolic modes is based on a number of redox-responsive regulatory 
mechanisms that manage this successful coordination (Green and Paget, 2004). Ultimately, 
this metabolic hierarchy is rooted in and maintained by altered patterns of gene expression. 
 
1.4.4 Composition of the core E. coli metabolome 
 
Knowledge of concentrations of extracellular and intracellular metabolites is important for 
quantitative analysis of the metabolic networks of microorganisms. Together with 
information about kinetic properties of the enzymes involved in specific pathways, 
information about the intermediary metabolites is of fundamental importance for 
characterization of the microbial metabolism through kinetic modelling. No single platform 
that allows a reliable analysis of a complete microbial metabolome has been described.  
 
Most reports of the effects of oxygen on E. coli are at transcription level and compare 
aerobic and anaerobic cultures (Partridge et al., 2007; Partridge et al., 2006; Sauer et al., 
1999). Thus, there is relatively little information at metabolite level either on the steady 
state or during adaptation to changes in oxygen availability. In 2007, van der Werf and 
group have developed an analytical platform that allows the detection of all metabolites 
present in microbial metabolomes, known as in silico metabolomes (van der Werf et al. 
2007). A total of 176 different metabolites were detected when applying this platform to 
mid-logarithmic E. coli cells, of which 61 metabolites currently are not present in the EcoCyc 
database (Keseler et al., 2005). Quantification of intracellular metabolites in glucose-fed, 
exponentially growing E. coli was achieved by Bennett et al. (2009). They used liquid 
chromatography-tandem mass spectrometry to quantify 103 metabolites adding up to a 
total intracellular metabolite pool of approximately 300 mM. The intracellular metabolome 
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can be divided into a few groups: amino acids, nucleotides, central carbon intermediates 
and redox cofactors and glutathione. Glutamate was the most abundant compound, 
followed by glutathione, fructose-1,6-bisphosphate and ATP. Nearly 80% of the total molar 
concentration of the measured metabolites consists of the ten most abundant compounds 
(Table 1.2). For extracellular metabolites, (Trotter et al., 2011) measured the concentration 
of extracellular metabolome of anaerobic steady state cultures by 1H NMR. The results 
showed the presence of formate, acetate, ethanol, lactate and succinate, with formate 
dominating the extracellular volume, with the highest concentration (~35.1 mM), followed 
by acetate (~18.7 mM), ethanol (~9.7 mM), succinate (~5.4 mM) and lactate (~0.1 mM). 
 
 
Metabolite      moles/l 
  Glutamate     9.6 x 10-2 
  Glutathione     1.7 x 10-2 
  Fructose-1,6-bisphosphate   1.5 x 10-2 
  ATP      9.6 x 10-3 
  UDP-N-acetyl-glucosamine   9.2 x 10-3 
  Hexose-P     8.8 x 10-3 
  UTP      8.3 x 10-3 
  GTP      4.9 x 10-3 
  dTTP      4.6 x 10-3 
  Aspartate     4.2 x 10-3 
 
 
Table 1.2: Ten most abundant intracellular metabolites in glucose-fed, exponentially 
growing E. coli (Bennett et al., 2009). 
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1.4.5 Pyruvate transport system and pyruvate levels in E. coli 
 
Pyruvate is a key intermediate in catabolic and biosynthetic reactions and is the end product 
of glycolysis. There are two metabolic routes (glycolysis and pentose phosphate pathway) 
that can deliver this compound but the main pathway to synthesize pyruvate is by activation 
of pyruvate kinase, which catalyzes the final step of glycolysis: conversion of 
phosphoenolpyruvate (PEP) and adenosine diphosphate (ADP) to produce pyruvate and 
adenosine triphosphate (ATP). Pyruvate can also be synthesized from gluconate through the 
Entner-Doudoroff pathway (Eisenberg and Dobrogosz, 1967), and from PEP by the 
phosphotransferase transport system (PTS or PT system), coupled with glucose transport 
(Flores et al., 2004). Pyruvate is the first non-phosphorylated intermediate in the glycolytic 
pathway and plays a central role in metabolism (Ponce et al., 1995; Steiner et al., 1998). 
There are specific transport systems that have been suggested for the glycolytic 
intermediates, e.g pyruvate, lactate, glycolate, phosphoenolpyruvate and lactate. All cells 
must have a pyruvate transport system, as defect in this system caused repression of 
gluconeogenesic enzymes under some growth conditions (Wills et al. 1986). Studies by 
Matin and Konings (1973) concluded that pyruvate and lactate may share the same 
transport system, from inhibition studies on the uptake of lactate and succinate in 
membrane vesicles of E. coli.  
  
Studies of the pyruvate transport system in E. coli have been carried out by Lang et al. 
(1987) and they found out that this energy requiring process is reduced when treated with 
an energy poison. Accumulation of pyruvate reached steady state at about 20 min, and after 
10 min the concentration of pyruvate was calculated to be 8.1 mM and the external 
concentration was 0.05 mM, assuming that the fluid volume of the cell was 2.7 µl/mg (dry 
weight) and the accumulated pyruvate was not significantly metabolized. This is consistent 
with an active transport process, where pyruvate is taken up against the concentration 
gradient. The Km for pyruvate uptake was 19 µM in cells grown to the mid-log or stationary 
phase. Under normal conditions, the intracellular levels of an intermediate pyruvate are 
higher than the extracellular levels (Moses and Sharp, 1972). When exogenous pyruvate was 
added to the feed medium, both intracellular and extracellular pyruvate pool levels were 
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increased (Yang et al., 2001). The pyruvate level that they measured (7 to 14 mM) was 
similar to the level reported by Lowry et al. (1971) and Snoep et al. (1992) (10 mM to 100 
mM). 
 
Pyruvate can also be metabolised by lactate dehydrogenase (LDH) to produce lactate, in the 
process regenerating NAD+ from NADH. This reaction is important for redox balance in 
anaerobic growth. Pyruvate is thus a key metabolic control point even in anaerobic cells. 
 
1.4.6 Pyruvate Kinase of E. coli 
 
Pyruvate kinase plays an important role in pyruvate synthesis. It catalyzes the conversion of 
PEP and ADP to pyruvate and ATP in the glycolytic pathway. The reaction catalyzed by 
pyruvate kinase is irreversible in vivo and appears to be a control point for the regulation of 
glycolytic flux (Pertierra and Cooper, 1977). Several mechanisms exist to control pyruvate 
kinase activity. E. coli and Salmonella typhimurium possess two types of pyruvate kinase, of 
which one is inducible and activated by fructose-1,6-diphosphate, and the other is 
constitutive and activated by AMP. Pyruvate kinase is inhibited by ATP, acetyl-CoA and 
alanine. The phosphorylated form of pyruvate kinase is more strongly inhibited by ATP and 
alanine and has a higher Km for phosphoenolpyruvate (PEP). Pyruvate kinase in tetrameric 
form (in the presence of Fructose-1,6-biphosphate) has high affinity for the substrate and is 
associated within the glycolytic enzyme complex (Jurica et al., 1998).   
 
There are two pyruvate kinase isoenzymes in E. coli, PykA and PykF, encoded by the pykA 
and pykF genes. PykF is the dominant activity when growth occurs aerobically on glucose. 
The specific activity of pykF is 15-fold higher than that of pykA (Ponce et al., 1995; Siddiquee 
et al., 2004). Many studies have been carried out to look at the function of PykF and PykA in 
metabolism. Single pyruvate kinase gene mutants under phosphotransferase system-
inducing (PTS+) conditions lead to a slight decrease in bacterial growth on glucose (Ponce et 
al., 1995). Studies by Ponce et al. (1998) and Zhu et al. (2001) showed that double knockout 
of pykF and pykA produced much less acetate than the wild type. It also demonstrates 25% 
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reduction in growth rate, indicating that the isoenzymes are not essential for growth on 
glucose.  PEP inhibits phosphofructokinase and the imported glucose to hexose 
monophosphate (HMP) pathway is and also converted directly to oxaloacetate via PEP 
carboxylase (Cunningham et al., 2009). 
 
1.4.7 Oxygen-dependent regulation of the E. coli metabolism  
 
Many environmental factors significantly affect microbial growth. The major ones however 
are temperature, oxygen, pH and osmotic effects. Studies on the adaptation of bacteria that 
lead to changes in metabolism have been growing rapidly. Oxygen tension is one of the 
most important environmental factors that can trigger major changes in gene expression 
and metabolite levels. Bacteria can respond to both excess oxygen and oxygen starvation, 
and remarkably they can survive and grow well when starved of oxygen. Oxygen availability 
plays a critical role in controlling the transcription of genes encoding these processes, 
ensuring that their expression is tightly regulated by growth conditions. All this adaptive 
process is coordinated by a group of global regulators. 
 
Much progress has been made in recent years in analyzing sensing and regulation systems 
for the rapid response to availability of oxygen and the presence of other electron acceptors 
(Lin and Iuchi, 1991; Unden et al., 1995). The adaptive responses are coordinated by a group 
of global regulators, of which the main ones are FNR (fumarate, nitrate reduction) and the 
two-component Arc (anoxic redox control) system. The Arc two-component system of 
Escherichia coli consists of ArcB and ArcA to repress aerobic respiration. ArcA is a cytosolic 
response regulator and ArcB is a transmembrane histidine kinase protein which senses 
unfavourable respiratory conditions. ArcB is activated during the transition from aerobic to 
microaerobic growth, and remains in the activated state during anaerobic growth. ArcB 
contains three catalytic domains: an N-terminal transmitter domain (H1), a central receiver 
domain and a C-terminal secondary transmitter domain (H2). ArcB is autophosphorylated at 
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the expense of ATP and the phosphoryl group is then transferred to ArcA by a His-Asp-His 
phosphorelay, which then becomes functional (Georgellis et al., 1999). ArcA generally 
behaves as an anaerobic repressor, and represses the synthesis of some enzymes, such as 
CAC enzymes and pyruvate dehydrogenase, but at the same time it activates the expression 
of other enzymes such as cytochrome d oxidase and enzymes involved in fermentative 
metabolism (Iuchi and Lin, 1988).  
 
On the other hand, the FNR system induces the expression of genes (such as pyruvate 
formate lyase, formate dehydrogenase, and fumarate reductase) under anaerobic 
conditions, which permit growing E. coli to transfer electrons to alternative terminal 
acceptors (Lin and Iuchi, 1991), while it represses the respiratory chain genes such as 
cytochrome bd  (cyd) and cytochrome bo (cyo). The FNR protein is located in the cytoplasm 
and contains a [4Fe-4S]2+ cluster that serves as a redox sensor (Unden et al., 2002). This 
cluster is assembled into FNR during its biosynthesis under anaerobic conditions. This 
assembly results in simultaneous FNR dimerization and activity of specific DNA binding and 
transcription regulation. The [4Fe-4S]2+ cluster is very sensitive to oxygen, and can be rapidly 
oxidized to [2Fe-2S]2+ when oxygen is present (Kiley and Beinert, 1998). FNR dimer then 
dissociates and is no longer active in DNA specific binding and transcriptional regulation 
(Ralph et al., 2001) (Figure 1.12). The concentration of the FNR protein is similar in both 
aerobic and anaerobic conditions (Sutton et al., 2004).  
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Figure 1.12: Different forms of FNR and their interconversion induced by oxygen as 
oxidizing agent and glutathione as reducing agent. Adapted from Unden et al. (2002). 
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1.5 Research Aims 
 
The main purposes of this thesis were to analyse the metabolite changes of E. coli during 
the transition from anaerobic to aerobic, in order to understand the adaptation process to 
the new environment using a metabolomics approach. Even though E. coli is the best 
characterised organism, metabolic activity information is still poorly characterised. 
Understanding the rapid adjustments required in the metabolic network for cells to cope 
with these conditions may give significant information on the cellular function in the 
organism.  This transition and the ability to survive in the new environment require 
significant reprogramming of the metabolic pathway. As discussed, the biggest challenge in 
this study is to determine the intracellular metabolite concentration, since the turnover 
rates are on a subsecond scale. In order to obtain reliable data, a rapid quenching method 
was developed and its error was measured, to assure data reflect the changes happening 
inside the cells. Pyruvate is a key junction in metabolism, for which the general hypothesis is 
that pyruvate responds the most to the new environment introduced to the cells. The 
experiments described in this thesis were carried out to examine this hypothesis using 
metabolomics, molecular biology and biochemical approaches. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
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2.0 Materials and Methods 
 
2.1 Media and chemicals suppliers 
 
All chemicals were obtained from BDH, GIBCO, Oxoid or Sigma-Aldrich, UK. Antibiotics were 
purchased from Sigma-Aldrich. Gases were supplied by BOC (UK), restriction enzymes; DNA 
ligase and DNA polymerase were bought from Promega, Roche or New England Biolabs 
(NEB). Oligonucleotides were ordered from Sigma-Genonsys (UK). Water was always 
deionised and distilled.  
 
2.2  Strains and plasmids 
 
Bacterial strains and plasmids used throughout this study are detailed as below.  
 
Table 2.1: List of bacterial strains and plasmid 
 Strain/Plasmid      Relevant characteristics              Source or reference 
 MG1655          F- λ- ilvG- rfb-50 rph-1    (Blattner et al., 1997) 
 pGFP3.1mut3.1    Ampicillin resistance, gfpmut3.1 Clontech  
 pKD4         Template plasmid AmpR,            (Datsenko and Wanner, 2000) 
           FRT-flanked Kan 
 pSIM18                                   (Chan et al., 2007) 
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2.3  Growth media and conditions 
 
2.3.1  Rich media 
 
Escherichia coli were grown in sterile Luria-Bertani (LB) broth medium (Miller, 1972) 
 
    Recipe (per litre) 
LB broth Tryptone (10g), Yeast extract (5 g), NaCl (10 g) 
  LB agar Tryptone (10 g), Yeast extract (5 g), NaCl (10 g),  
    Bacteriological agar (15 g) 
 
Medium was sterilised by autoclaving. Once cooled to 50°C appropriate antibiotics were 
added to LB agar and the molten agar was poured into Petri dishes and allowed to set. 
Plates were stored at 4°C and used within four weeks.  Antibiotics used include 20 mM 
glucose, ampicillin (100 µg/ml), IPTG (100 µg/ml), kanamycin (50 µg/ml) and hygromycin 
(150 µg/ml). 
 
2.3.2  Evans defined medium 
 
When a defined medium was necessary E. coli was grown in Evans medium (Evans et al., 
1970). The following components were added as indicated from stock solutions of the 
specified concentration.  
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     Stock concentration      Volume added 
  NaH2PO4   2 M   5 ml l-1 
  KCl    2 M   5 ml l-1 
  MgCl2    0.25 M   5 ml l-1 
  Na2SO4    0.4 M   5 ml l-1 
  CaCl2    0.0004 M  5 ml l-1 
  NH4Cl    4 M   25 ml l-1 
  Nitrilotriacetic acid  -   0.38 g l-1 
  Trace element solution -   5 ml l-1 
 
Components were added in the order listed above and the solution was made up to the 
required volume with dH2O with the final mix adjusted to a pH of 6.9 with 1 M KOH. 
 
          Trace element solution 
   ZnO    1.03 g l-1 
               FeCl3.6H2O   13.5 g l-1 
   MnCl2.4H2O   5 g l-1 
CuCl2.2H2O   0.43 g l-1 
CoCl2.6H2O   1.19 g l-1 
                       H3BO3    0.16 g l-1 
   Na2MoO4.H2O   0.01 g l-1  
 
HCl (37%, 20 ml l-1) was added to lower the acidity of the trace element solution, which 
helps keep the other metal ions in solution. Media were supplemented with various carbon 
sources prior to use. 
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2.3.3 Growth of E. coli 
 
Aerobically grown E. coli strains were typically cultured in 250 ml flasks, with shaking at 250 
rpm in volumes of 5-50 ml of medium. Cultures were usually grown for 16 h at 37°C. 
 
2.3.4  Measurement of bacterial growth 
 
Bacterial growth was monitored by determining the optical density at 600 nm (OD600) with 1 
ml samples using a spectrophotometer. Samples with an OD600 greater than 0.8 were 
diluted 1:10 prior to determination of the OD600. 
 
2.3.5  Storage of strains 
 
Strains were maintained for up to one month on solid media at 4°C. For long-term storage 
bacterial strains were stored as glycerol stocks. Bacterial cells from 5 ml overnight cultures 
of the strains to be stored were collected by centrifugation and resuspended in 1.25 ml LB 
broth and 1 ml 80% (v/v) sterile glycerol. Appropriate antibiotics were included and strains 
stored at -80°C, where they are viable for up to five years. 
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2.4  Metabolite analysis and measurement 
 
2.4.1 Bacteria and growth conditions 
 
E. coli strain MG1655 was grown in a 1 L capacity Labfors 3 chemostat (Infors) (Figure 2.1) at 
37°C with stirring at 400 rpm. The pH was maintained at 7.0 by automatic titration with 
sterile 1 M potassium hydroxide (KOH) or 1 M sulphuric acid (H2SO4). Carbon-limited Evans 
medium (section 2.3.2) (Evans et al., 1970) was used with 20 mM glucose as the carbon 
source. 5 ml of overnight culture was inoculated into the media vessel and the cells were 
left to grown overnight in the chemostat as a batch culture. Steady state was achieved by 
feeding growth medium at a dilution rate of 0.2 h-1 for 4-5 vessel volumes. Anaerobic 
cultures were maintained by sparging with N2 (95%) and CO2 (5%) at 0.4 L min-1. Dissolved 
oxygen levels were monitored by using a TruDO Dissolved Oxygen Sensor (Finesse). The 
change to micro-aerobic conditions was controlled by Iris software, which switching the gas 
mix ratio of N2 and CO2 to air to maintain the dissolved O2 tension in the culture at 5% (~10 
µM). 
 
2.4.2 Sampling method   
 
2.4.2.1 Extracellular metabolites 
 
1 ml samples were collected from the chemostat and centrifuged at 14000 rpm in a 
microfuge for 1 min at 20°C. The 900 µl of clear supernatant was transferred into a clean 
tube and stored at -20°C for future analysis. 
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Figure 2.1: Chemostat used to grow the bacterial culture. Growth occurs at a constant rate 
where all the parameters remain constant. 
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2.4.2.2 Intracellular metabolites (Quenching method) 
 
This quenching technique is based on the ethanol and sodium chloride (NaCl) method of 
Spura et al. (2009) and has been adapted as described in Chapter 3. Samples (20 ml) 
collected from chemostat are transferred into a 50 ml falcon tube containing 20 ml of 
quenching solution (40% ethanol v/v + 0.8% NaCl w/v), which had been precooled to -35°C by 
placing in an insulated bath containing isopropanol that had been cooled by addition of dry 
ice (Figure 2.2). The sample mixture was then mixed instantly by inversion, producing a cell 
suspension at approximately 0 C and left to cool down to -5 C in the -35°C isopropanol bath 
over the course of 2-3 minutes (Figure 2.2). The cells are stirred all the time at this stage, 
using the thermometer. Then the cells were centrifuged at 3940 x g at -11°C for 5 min in a 
precooled centrifuge (Beckman Avanti HP-25I, JLA-10.500) and the supernatant was 
removed by aspiration, ready for metabolite extraction. 
 
               
 Figure 2.2: Cold ethanol-sodium chloride quenching 
Isopropanol bath at 
-35°C 
Cells transferred 
into quenching 
solution  
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2.4.2.3 Unquenched method 
 
Samples (20 ml) were removed from the chemostat and immediately centrifuged at 5000 g 
at 4°C for 5 min. The supernatant was aspirated off and the pellet immediately frozen in 
liquid N2. Then metabolite extraction was carried out as in section 2.3.3. 
 
2.4.3  Intracellular metabolite extraction 
 
Extraction of metabolites from the cell pellets was performed with the cold methanol 
method of Faijes et al. (2007). After centrifugation, cells were air dried using a vacuum 
pump before putting into liquid nitrogen (LN2).  Then, 500 µl cold methanol (precooled to -
80°C in the -80°C freezer) was added to the cells. The suspension was vortexed, and the cells 
were freeze-thawed three times in LN2 before being centrifuged again. The supernatant was 
transferred into an Eppendorf tube and the freeze-thawing and centrifugation step was 
repeated once again. The final supernatant was transferred to the same tube as before. The 
final supernatant was concentrated for 5-6 hrs by using a cell concentrator. The pellet 
obtained was stored at -20°C awaiting further analysis. 
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2.4.4 Metabolite analysis by NMR 
 
2.4.4.1 Sample preparation 
 
For extracellular metabolite analysis, the supernatant fractions from section 2.4.2.1 were 
analysed in a volume of 500 µl containing 450 µl sample, 50 µl D2O and 1 mM 
trimethylsilylpropionate (TSP) (as 5 µl of a 100 mM stock). For intracellular samples, the 
pellet was resuspended in 500 µl D2O, and 100 µM of TSP (as 5 µl of a 10 mM stock). All 
samples were analysed in 5 mm diameter NMR tubes. All samples prepared contained D2O 
for locking on the deuterium frequency and TSP that served as a chemical shift and 
concentration reference.  
 
2.4.4.2 NMR analysis 
 
The spectra were acquired on a Bruker DRX-500 spectrometer operating at 500 MHz and 
298 K (Figure 2.3). The H2O signal was reduced by pre-saturation for 2 s applied during the 
recycle time. A spectral width of 6,256 Hz was excited using a 90° pulse. 128 scans 
(extracellular sample) and 1024 scans (intracellular sample) were used following 4 dummy 
scans, for a total experiment time of 10 min for extracellular samples and 1 hr for 
intracellular samples. For extracellular samples, a pulse program was used that included a 
Hahn echo delay before acquisition, in order to give a flatter baseline. Manual and computer 
shimming was performed for each sample and FIDs were processed by multiplication by an 
exponential function equivalent to 1.0 Hz line broadening prior to Fourier transformation. 
Spectra were processed and peaks quantified by integration by using the Bruker software 
Topspin. Chemical shifts and concentration were calculated by referencing to TSP. For 
ethanol, acetyl aspartate and lactate, signal used for quantification as follows: ethanol (both 
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of the signal were used); acetyl aspartate (only the methyl signal used) and lactate (the 
methyl signal used, the other signal is overlapped).  
 
                                      
Figure 2.3: Bruker 500 MHz NMR spectrometer, equipped with a TXI 5 mm triple resonance 
high resolution probe with z gradient. 
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2.4.5 Pyruvate assay  
 
Intracellular pyruvate concentration was measured using the EnzychromeTM Pyruvate Assay 
Kit (Bioassay Systems). Cells collected from the chemostat were quenched and extracted as 
described in sections 2.4.2.2 and 2.4.3. A pyruvate standard curve was prepared by mixing 
10 µl of 25 mM standard with 490 µl of distilled water. Then the standard was diluted in 
distilled water into a 96-well plate to obtain a range of pyruvate concentrations as shown 
below. 
 
No    Standard +  H2O   Vol (µl)       Pyruvate (µM)  
1      100µL +     0µL      100        500  
2        80µL +   20µL      100         400  
3        60µL +   40µL      100         300  
4        40µL +   60µL      100                 200  
5        30µL +   70µL      100        150  
6        20µL +   80µL      100         100  
7        10µL +   90µL      100            50  
8          0µL + 100µL     100             0 
 
10 µl volumes of samples and standards were transferred into separate wells of the 96-well 
plate. Then, 90 µl Working Reagent (prepared by mixing Enzyme Mix and Dye Reagent in a 
ratio of 94:1 (v/v) were transferred into each assay well and mixed by tapping the plate. The 
mixtures were incubated for 30 min at room temperature before the OD570 was taken in a 
plate reader. The blank OD was subtracted from the standard OD values and the OD values 
were plotted against the standard concentration to generate a standard curve. The slope 
was determined using linear regression fitting. The pyruvate concentration of sample was 
calculated using the formula below. ODsample and ODH20 are optical density values of the 
sample and water. 
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Concentration of pyruvate =   ODsample – ODH2O   
       Slope  
 
2.4.6 Pyruvate kinase enzyme assay 
 
Pyruvate kinase activity during the transition from anaerobic to aerobic was measured using 
the Pyruvate Kinase Activity Assay Kit (BioVision). Supernatant and pellet samples was 
collected at different time point, quenched and sonicated followed by use of a kit. A 
pyruvate standard curve was prepared by mixing 10 µl of 100 nmol/µl standard with 990 µl 
of Assay Buffer. The dilution of the standard was prepared by adjusting volume of 0, 2, 4, 6, 
8 and 10 µl of the diluted standard to 50 µl/well with Assay Buffer to generate 0, 2, 4, 6, 8 
and 10 nmol/well of the Pyruvate Standard. Then, sample was prepared by mixing enough 
reagents for the number of standard and assays to be performed as shown below: 
 
 Pyruvate kinase measurement Background control 
    Assay Buffer                   44 µl             46 µl 
   Substrate mix                    2  µl               ---- 
   Enzyme mix                    2  µl               2 µl 
   OxiRedTM Probe                    2  µl               2 µl 
 
50 µl of the reaction mix was added to each well containing the pyruvate standard, samples 
and control and mixed well. The OD570 was taken at T1 to read A1, and the samples was 
incubated for 10-20 min at 25°C before taking the reading at T2, to read A2. The pyruvate 
standard curve was plotted. The pyruvate kinase activity can be calculated using the formula 
below. 
(µM) 
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PK activity =  B x  Sample Dilution Factor = nmol/min/ml = mU/mL 
   (T1-T1) x V 
 
where: B is the pyruvate amount from pyruvate standard curve (in nmol) 
 T1 is the time of the first reading (A1) (in min) 
 T2 is the time of the second reading (A2) (in min) 
 V is the sample volume added into the recation well (in ml) 
 
2.5  DNA methods  
 
Plasmid DNA was isolated from 5 ml overnight cultures using QIAGEN miniprep kits 
according to the manufacturer’s instructions. Typically, 10 to 15 µg plasmid was recovered 
for 5 ml cells. 
 
2.5.1  Quantification and purity determination of nucleic acids 
 
Concentration of DNA and RNA were measured spectroscopically using an Eppendorf 
BioPhotometer. Samples of nucleic acid solutions (100 µl) were read in an Eppendorf UVette 
and the BioPhotometer was used to calculate nucleic acid concentrations using set-
programmed values. The BioPhotometer also measured the purity of the sample by 
calculating the A260/A280 ratio. A ratio of 1.8 indicated a sample of high purity. 
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2.5.2 Agarose gels 
 
Agarose gel electrophoresis was used for the analysis and purification of DNA. Gels were 
made to 1-2% agarose, depending on the size of DNA fragments to be separated, and made 
up in 1X TAE buffer (see below). The agarose was dissolved by heating and once cooled to 
approximately 50°C, 0.5 µg/ml of ethidium bromide (to enable DNA visualization under UV 
light) was added. Generally 10 µl of DNA sample including 3 µl loading buffer (Fermentas) 
was loaded per lane and run alongside the appropriate markers. This was generally 
Hyperladder I. Electrophoresis was carried out at 100 V for up to 1 h in Bio-Rad 
electrophoresis apparatus. 
 
    50X TAE 
242 g   Tris 
57.1 ml Glacial acetic acid 
100 ml  50 mM EDTA pH 8 
Made up to 1 litre with dH2O 
 
 
2.5.3 Extraction and purification of DNA from the agarose gel 
 
DNA fragments within agarose gels were visualised under UV light and excised using a clean 
scalpel blade. DNA was then purified from the gel fragments using the QIAGEN Gel 
Extraction kit, following the manufacturer’s instructions. 
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2.5.4 Purification of DNA 
 
When necessary, DNA samples were purified using a Qiagen PCR purification kit, according 
to manufacturer’s instructions. 
 
2.5.5 Digestion of DNA with restriction enzymes 
 
Restriction digests were performed in a reaction volume of 50 µl, 10 units of enzyme and 
the appropriate buffer to a final 1x concentration. BSA was added when required. Reactions 
were incubated for 1 h at 37°C. Reactions were stopped by heat inactivation or by 
separation of fragments by agarose gel electrophoresis and subsequent purification (section 
2.4.2 and 2.4.3). 
 
2.6 Gene deletion using the Lambda-Red system 
 
Gene knockout mutants of E. coli were created using a linear transformation protocol 
adapted from the method of Datsenko and Wanner (2000) to introduce a kanamycin 
cassette into the genes of interest. Two mutants were created: pykF-3xFLAG and pykF-GFP 
by using a 2-step PCR reaction.  
 
2.6.1  Primer design 
 
Oligonucleotide primers were designed manually to amplify the kanamycin cassette from 
the plasmid pKD4; such that a 3xFLAG-tag or GFP coding sequence was added at the 5’ end 
of the kanamycin cassette. The primers also added 40 bp sequences at the 5’ and 3’ ends of 
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the PCR product that was complementary to adjoining 40-bp sequences at the 3’ end of the 
pykF gene, so that the resultant PCR products would add a 3xFLAG-tag or GFP sequence plus 
a kanamycin cassette at the C-terminal end of pykF. This necessitated the use of two 
assembly PCR reactions. Primers used in creation of pykF-3xFLAG and pykF-GFP mutants 
were presented below in Table 2.2 and 2.3. 
 
Table 2.2: Primers for use in creation of pykF-3XFLAG mutant 
Primer Description 
pykF_3xFLAG_PCR1F 
TTACAAAGATCACGACGGCGATTATAAAGACCATGATAT
CGATTATAAAGATGACGACGATAAATAAtattgcttGTGTA
GGCTGGAGCTGCTTC 
 
The sequence in blue corresponds 
to the sequence of the FLAG-tag; 
the sequence in red is a stop codon; 
the lower case sequence is a linker; 
and the sequence in green is the 
start of the kanamycin resistance 
cassette sequence 
pykF-3xFLAG_PCR1R 
AAAGCGCCCATCAGGGCGCTTCGATATACAAATTAATTC
ACATATGAATATCCTCCTTTAG 
The sequence in green is 
complementary to the end of the 
kanamycin cassette; the sequence 
in black is complementary to the 
sequence immediately 3’ of the end 
of the pykF gene. 
pykF-3xFLAG_PCR2F 
ACCGAGCGGCACTACTAACACCGCATCTGTTCACGTCCT
GGATTACAAAGATCACGACGG 
The sequence in red is the last 40 
bases at the 3’ end of the pykF 
gene; the sequence in blue is the 
start of the FLAG-tag, including an 
extra GA sequence 
pykF-3xFLAG_PCR2R 
AAAGCGCCCATCAGGGCGA 
This is identical to the start of 
PCR1R. In other words, this merely 
re-amplifies the same sequence 
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Table 2.3: Primers for use in creation of pykF-GFP mutant 
Primer Description 
pykF-GFP_PCR1F 
ACCGAGCGGCACTACTAACACCGCATCTGTTCACGTCCT
GCGTAAAGGAGAAGAACTT 
The sequence in red is the 3’ end of 
the pykF gene; the sequence in blue 
is the 5’ end of the GFP gene 
pykF-GFP_PCR1R 
GAAGCAGCTCCAGCCTACACTTATTTGTATAGTTCATCCA 
The sequence in blue is 
complementary to the 3’ end of 
GFP. The region in black is 
complementary to the 5’ end of the 
kanamycin cassette 
pykF-GFP_PCR2R 
GCGCCCATCAGGGCGCTTCGATATACAAATTAATTCACA
ACATATGAATATCCTCCTTAG 
The region in blue is 
complementary to the 3’ intergenic 
region of pykF, and the region in 
black is complementary to the 3’ 
end of the kanamycin cassette 
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2.6.2 Polymerase chain reaction (PCR) 
 
A Techne TC-312 thermocycler and Extensor Hi-Fidelity DNA polymerase (Abgene) were 
generally used in PCR reactions. The standard conditions for a 50 µl PCR reactions were: 
25  µl Extensor Hi-Fi Master Mix*    
4    µl 10 pmol/µl forward primer    
4    µl 10 pmol/µl reverse primer    
4    µl Template DNA     
13  µl  sterile dH2O     
*Extensor Hi-Fidelity PCR master mix contains Taq DNA polymerase (1.25 U per reaction 
volume), dNTPs (350 µM each) and MgCl2 (2.25 mM) in Extensor Reaction Buffer. 
Amplification conditions used for pykF-3xFLAG and pykF-GFP were as below: 
 
Step pykF-
3xFLAG 
  pykF-GFP   
 Temp Time Cycle Temp  Time Cycle 
Initial denaturation 95°C 15 min 1 94°C 3 min 1 
Denaturation 94°C 45 sec  94°C 30 sec  
Annealing 55°C 1 min 35 55°C 30 sec 35 
Extension 72°C 2.5 min  68°C 2 min 45 
sec 
 
Final extension 72°C 10 min 1 68°C 10 min 1 
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2.6.3 Preparation of linear DNA 
 
2.6.3.1 pykF-3xFLAG 
 
The first PCR reaction (section 2.6.2) was carried out to amplify the kanamycin cassette from 
pKD4 using primers that add a 3xFLAG tag and a stop codon upstream of the kanamycin 
cassette and a 40 bp region of homology to the 3’ intergenic region of pykF downstream of 
the cassette. The PCR product was visualized by agarose gel electrophoresis (section 2.5.2) 
and purified using a PCR purification kit (section 2.5.3). The template DNA (pkD4 plasmid) 
was then removed by digestion by Dpn I (section 2.5.5), which digests methylated DNA, and 
the PCR product was repurified. Then, the second PCR was performed using the product 
from PCR 1 as a template. A 40 bp sequence corresponding to the final 40 3’ bases of pykF 
was added upstream (stop codon removed), and the downstream end was reamplified 
without change, before the PCR product was visualized by agarose gel electrophoresis and 
purified.  
 
2.6.3.2 pykF-GFP  
 
In the first PCR reaction, the coding sequence of GFPmut3.1 was amplified and a 40 bp 
region was added in front of the GFP gene corresponding the 3’ end of pykF (the pykF stop 
codon was removed). A stop codon and a 20 bp sequence was added by the reverse primer 
to the end of GFP to allow amplification of the kanamycin cassette from pKD4 (in the next 
PCR). The PCR product was confirmed as the correct size by agarose gel electrophoresis 
(section 2.5.2) and gel purified (2.5.3) to remove template. The purified product was then 
used as a forward primer to amplify the kanamycin cassette in the second PCR reaction. A 
40 bp sequence was added downstream of the kanamycin cassette by the PCR2R primer, 
complementary to the 3’ intergenic region of pykF. A final PCR was carried out to complete 
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the whole 2.3 kbp product efficiently and provide sufficient yield for transformation. The 
final product was visualized by agarose gel electrophoresis and purified. 
 
2.6.4 Preparation and transformation of electrically competent cells 
 
An overnight culture of SL1344pSIM18 was set up in 5 ml of hygromycin LB (LB plus 150 µg 
ml-1 hygromycin) and grown at 30°C in a shaker.  Then 4 ml of overnight culture was 
pipetted into 100 ml of hygromycin LB and grown to an OD600 of 0.3. The culture was split 
into 2 x 50 ml Falcon tubes before a heat shock step was performed in a 42°C water bath for 
15 min and then the culture was cooled immediately in an ice-bath for 10 min. Cells were 
centrifuged at 4°C for 10 min at 4000 rpm. The pellet was resuspended in 45 ml of ice-cold 
water and the cells were spun down again. The supernatant was discarded and the pellet 
was again resuspended in 45 ml of ice-cold water before centrifugation and resuspension in 
1.5 ml of ice-cold sterile water. The cells were transferred into Eppendorf tubes and washed 
5 times with 1.5 ml of ice-cold water, with the cells centrifuged each time at 10000 rpm at 
4°C for 2 min. The supernatant was decanted and the pellet was resuspended in 120 µl of 
ice-cold water. The competent cells were split into 40 µl aliquots, and used immediately.  
 
Competent cells were transformed by the addition of 3 µg of DNA to 40 µl aliquots of cells in 
an ice-cold electroporation cuvette and pulsed at 1800 V in a Hybaid Cell Shock 
Electroporator. LB medium (1 ml) was added to the cuvette and then the solution was 
transferred into a fresh tube. The suspension was incubated at 37°C  for 2 hours and then 
centrifuged at 8000 rpm for 4 min. The pellet was resuspended in 100 µl of LB broth and 
spread onto LB agar plates (section 2.3.1) containing 50 µgml-1 kanamycin. Plates were then 
incubated overnight at 37°C and colonies were checked by PCR (section 2.6.5). 
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2.6.5 PCR verification  
 
A colony was picked using a sterile pipette tip into 50 µl dH2O and vortexed before heating 
at 100°C for 10 min. Then the mixture was centrifuged at 14000 rpm for 1 min. Aliquots (4 
µl) of the supernatant were added to the standard components for a 50 µl PCR reaction 
(Section 2.6.2). Reactions were then incubated in a Techne TC-312 thermocycler using a 
programme as in Section 2.6.2. Samples (10 µl) of the resulting PCR products were visualized 
after electrophoresis on an agarose gel (Section 2.5.2) with appropriate markers.  
 
      Primers for use in PCR verification  of recombinant clones 
           pykF_CheckF     TGGCACACAAAGGTGACG 
           pykF_CheckR     GGATGCTTCCATCGGATT 
  
These amplify outside of our gene fusion from which we expected to see bigger bands. 
 
2.7 Transduction of E. coli DNA by P1vir1 phage 
 
P1 transduction was used to move the gene fusion into a fresh MG1655 background. This 
removed the possibility of secondary metabolism, caused by λ-red mediated recombination 
and removed pSIM18 contamination of the strain. 
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2.7.1 Preparation of lysate 
 
A colony from a verified plate was picked and grown overnight in 5 ml LB broth with 5 mM 
CaCl2. P1 phage stock was diluted with phage dilution buffer (10-3, 10-4, 10-5, 10-6 dilutions) 
in sterile Eppendorf tubes. Donor cells (100 µl) were mixed with 50 µl of each of the diluted 
P1 phage suspensions and incubated for 20 min at 37°C. Suspensions were then added to 3 
ml molten LB-agar soft top agar (0.65 % (w/v) containing 1% glucose and 2.5 mM CaCl2 pre-
warmed to 50°C in 4 inch glass tubes, and mixed thoroughly before pouring evenly into 
prewarmed phage lysate plates. The soft-top layer was allowed to set before incubation at 
37°C overnight. The plates were collected the next day and plaques were counted across the 
dilution series. Then 5 ml of phage dilution buffer  was overlaid on the soft-top layer of the 
plate that was nearly confluent and incubated at 4°C  for 5 h, with gentle agitation. After 5 
h, the LB broth together with the soft top layer was collected into a falcon tube, and 
vortexed before centrifugation for 15 min at 6000 rpm. The supernatant was filter sterilized 
with a 45 µm filter into a sterilized glass universal, containing water, together with a few 
drops of chloroform to prevent bacterial growth, and stored at 4°C. 
 
Phage dilution buffer  
Tris base    1.35 g 
MgSO4.7H2O    2.73 g 
CaCl2.2H2O    0.82 g 
NaCl    3.24 g 
        *pH 7.5, autoclaved 
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2.7.2 Transduction by P1 phage 
 
P1 phage lysate from 2.6.1 was serially diluted  (100-10-2) in phage dilution buffer and 100 µl 
aliquots were mixed with 100 µl recipient cells in sterile Eppendorf tubes and incubated at 
37°C for 15 min. The mixture was then plated into LB agar plates containing kanamycin (50 
µg ml-1) supplemented with 125 µM sodium pyrophosphate and grown for 16 h at 37°C. 
Sodium pyrophosphate binds Ca2+ to stop phage infection on the plates. Resistant colonies 
were purified by streaking out twice on fresh LB agar plates plus kanamycin to ensure a 
monoculture. 
 
2.7.3 Confirmation of lysogeny via streak testing 
 
Cross streaking was carried out to distinguish the true lysogens from pseudo-lysogens where 
the P1 phage shall infect the recipient cell. Each strain was cross-streaked across lines of 
wild-type phage P1. Successful transduction will be susceptible to wild-type P1. Pseudo-
lysogens will be susceptible to P1. A sterile pipette was used to dribble a thin, continuous 
line of phage P1 across the surface of each of LB plates. Another sterile pipette was used to 
repeat this procedure using a stock of P1 WT. The phage was allowed to dry completely for 
5-10 mins. Then a sterile pipette was used to pick isolated colonies of the possible 
transductants and inoculate them as a single streak across the phage stripe. The cross-
streak plate was incubated at 37°C. 
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2.8 Protein Methods 
 
2.8.1 SDS-PAGE 
 
SDS-PAGE analysis was carried out as described by Laemmli (1970) using the BioRad Mini 
Protean 3 system as described in the manufacturer’s instructions.The glass plates were 
cleaned with ethanol and locked into the clamping assembly and secured firmly to ensure 
no leakage from the base. A resolving gel mixture (10 ml) of 10% acrylamide was prepared 
and poured between the plates. Water saturated butanol (100 µl) was then layered over the 
gel, which was then allowed to set. After this time the butanol was removed before a 
prepared stacking gel mix was poured up to the plate’s rim and a comb inserted to produce 
the wells for sample loading. After the stacking gel had set, the comb was removed, wells 
rinsed thoroughly and the assembled apparatus was placed into the running tank with 
appropriate running buffer (see below). Protein samples (15 µl) were denatured prior to 
loading by the addition of 10 µl 3x loading buffer (see below) and boiling for 5 min. Samples 
were loaded and the gel was run at 200 V for the necessary duration with prestained size 
markers loaded to allow estimation of protein molecular weight and visualize successful 
bands. Following electrophoresis the gel was stained in Coomassie Blue stain for 4 h then in 
destain for 16-20 h.  
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Table 2.4: Composition of SDS-PAGE for 10% gel 
Solution     Resolving gels      Stacking gels 
H2O    4 ml   2.7 ml 
30% acrylamide  3.3 ml   0.67 ml 
1.5 M Tris pH 8.8  2.5 ml   0.5 ml 
10% SDS   0.1 ml   0.04 ml 
10% APS   0.1 ml   0.04 ml 
TEMED   0.004 ml  0.004 ml 
           
 1x SDS-PAGE running buffer       3x SDS-loading buffer 
 Glycine 14.4 g l-1  Glycerol  20% (v/v) 
 Tris  3 g l-1   Tris-HCl (pH 6.8) 100 nM 
 SDS  1 g l-1   SDS   4% (v/v) 
 *Adjust to pH 8.3   Bromophenol blue 0.02% (v/v) 
      β-mercaptoethanol 200 mM 
 
 1x Coomassie blue stain  Destain (500 ml) 
 Methanol  20% (v/v) 200 ml Methanol  40% (v/v) 
 Acetic acid  7.5% (v/v) 50 ml Acetic acid  10% (v/v) 
 Coomassie blue 0.1% (w/v) 250 ml Water        50% (v/v) 
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2.8.2 Western blot 
 
2.8.2.1 Transfer of proteins to a nitrocellulose membrane 
 
Protein under investigation was first separated by SDS-PAGE (Section 2.8.1) and then 
transferred to Immuno-BlotTM PVDF membrane (BioRad) using a BioRad Transblot 
Electrophoretic Transfer Cell in accordance with the manufacturer’s instructions. The 
membrane, gel, filter paper and sponge were soaked in the transfer buffer (see below) for 
10-20 min. The plastic clamp was opened in a large bowl, where the soaked sponge was 
added onto the negative side, followed by soaked filter paper, membrane, soaked filter 
paper and finally the soaked sponge. The clamp was closed and placed into the half-full 
blotting tank, before adding the pre-cooled Bio-Ice cooling unit to ensure the apparatus 
does not overheat as it transfers. A small magnetic stirrer was added before the lid was 
placed on the tank and the gel was run at 100 V for 1 h.  
 
2.8.2.2 Blocking the gel and antibody binding 
 
The membrane was removed from the blotting tank once blotted. 50 ml of Blocking solution 
(5% Marvel in PBS-Tween) was added to the membrane in a 9 cm by 9 cm square petri dish 
and left  overnight at 4°C with gentle shaking. Next day, the Primary antibody-Binding 
solution was prepared by adding 15 µl of primary antibody (Anti-Flag, Sigma) to a 15 ml of 
Binding solution (1:10000 dilution) and briefly mixed. The Blocking solution was then 
removed and the Binding solution was placed onto the membrane and left to shake for 1 h 
at room temperature. The primary antibody binding solution was tipped off and the 
membrane was washed three times with PBS-Tween (PBS with 0.05% Tween-20). Each wash 
was left for 15 mins on a shaker before being drained off 2 µl secondary antibody (ECL-
Peroxidase labelled anti-rabbit antibody) was added to 50 ml of Binding solution (1:25000 
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dilution), mixed briefly  and transferred onto the membrane after the wash solution was 
removed. After 1 h (leave on the shaker), the secondary antibody binding solution was 
removed and the membrane was washed three times with PBS-Tween, with each wash 
being left for 15 min on the shaker. Then, the wash step was repeated with PBS twice. Just 
prior to the end of the washes, a working solution was prepared by mixing an equal volume 
(1:1) of the stable peroxide solution and the luminal/enhancer solution. The excess wash 
buffer was drained off from the washed membrane and they were placed, protein side up, 
on a sheet of SaranWrap. The mixed detection reagent was pipetted on to the membrane 
and incubated for 5 min at room temperature. During this 5 min, the reagents should cover 
the entire surface of the membrane. The excess detection reagent was drained off by 
holding the membrane with forceps and touching the edge against a tissue. The protein blot 
was placed side down onto a fresh piece of SaranWrap, and the blot was wrapped up (any 
air bubbles were gently removed using an absorbant tissue). Then, the wrapped blot, 
protein side up, was placed in an X-Ray film cassette. A sheet of autoradiography film was 
placed on top of the membrane. The cassette was closed and exposed for 10 second. This 
step was carried out in a dark-room, using red safelights. The film was removed and 
replaced with a second sheet of unexposed film. The first film was developed immediately. 
Second exposures can vary from 1 min to 1 h, depending on the appearance of the first film.  
 
Transfer buffer (1 litre)  
    3.0 g Tris-base  25 mM  
    11.3 Glycine  150 mM   
    200 ml Methanol 20% (v/v)   
      
77 
 
2.9 Fluorescence microcopy 
 
2.9.1 Poly-L-Lysine slides preparation 
 
The slide was cleaned using 70% ethanol. Then 10 µl of 0.01% poly-L-lysine (Sigma) was 
placed in the centre of the slide and  left to air dry for 15 min at room temperature. A 
washing step was carried out next by depositing 100 µl of dH2O on top of the dried drop and 
removing again. This step was repeated three times and the slide was left to air dry at room 
temperature. 
 
2.9.2 Sample preparation  
 
To describe localization of protein inside the cell, GFP-expressing cells were examined under 
fluorescence microscopy. The cells were grown in the chemostat (section 2.4.1) until they 
reached steady state. The cells were sampled and mixed directly into quenching-fixing 
solution (40% ethanol; 15% paraformaldehyde; 0.8% saline; 25% glutaraldehyde) precooled 
to -35°C and left in a -35°C isopropanol bath with stirring to reach -5°C. Samples were kept 
cooled at 4°C in a shaker for 1 hr before being centrifuged at 13200 rpm for 2 min. Then the 
cells were washed with 1x PBS (137 mM NaCl; 2.7 mM KCl;  10 mM NaH2PO4; 2 mM KH2PO4) 
and centrifuged again. Supernatant was discarded and the process was repeated twice. 
Then, the cells were resuspended in an appropriate amount of GTE solution (50 mM 
glucose;  10 mM EDTA; 20 mM Tris pH7.5). 5 µl of the cells were placed on top of a dried 
poly-lysine spot (section 2.9.1) and allowed to dry at room temperature. The dried spot was 
then washed with dH2O by placing 10 µl of water on top of it and the dH2O was then 
discarded. The washing step was repeated twice before leaving to air dry. Then 10 µl of 
dH2O was used to mount the coverslip and the slides were sealed with DPX Mountant 
(Sigma).  
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2.9.3  Image processing 
 
Fixed cells were imaged on standard microscope slides as described in section 2.9.1 and 
2.9.2. The images were acquired on an Olympus BX61 upright microscope fitted with a 100x 
(NA 1.4) oil objective with help from Dr Darren Robinson from Light Microscopy Facility, 
University of Sheffield. 
 
2.10 Transmission electron microscopy analysis and gold-labeling 
 
This experiment was carried out with help from Dr Chris Hill from Electron Microscopy Unit, 
University of Sheffield. A purified pykF-3xFLAG construct was examined by transmission 
electron microscopy (TEM) followed by immunogold analysis. Sections were cut at 
approximately 85 nm thickness (Lowycril Mono-step HM 20 Resin Agar Scientifc, Stansted, 
England) onto fomvar coated nickel grids. The sections were rinse on distilled water drop for 
at least 10 min prior to staining. Then the sections were incubated in Tris buffered saline pH 
7.4 containing 5% normal goat serum (Vector Labs, England) for 30 min. The sections were 
washed two times with TBS pH 7.4 (by drops), 4.5 min per wash. To gold-label, construct 
was incubated for 2 hr with Rabbit anti-FLAG (Sigma Aldrich), diluted 1:50 with TBS pH 7.4 
containing 0.1% bovine serum albumen. After two washing steps (the first wash was done 
with TBS pH 7.4 while the second wash was done in TBS pH 8.2; 1 min for each wash), 
sample was incubated with 10 nm immunogold conjugated goat anti rabbit secondary 
antibody (Biocell, England) at 1:50 dilution in TBS pH 8.2 containing 0.1% bovine serum 
albumen for 30 mins. This incubation process was carried out in a darkened chamber. The 
grids then washed two times with distilled water (5 min for each wash). The sample was 
stained in 5% aqueous uranyl acetate for 2 min and washed in distilled water before being 
stained again in 0.5% alkaline lead citrate Ph 12 for 2 min. The sample was washed well after 
that with distilled water. Grids were imaged using FEI tecnai TEM at 80 Kv, and images were 
recorded using Gatan multiscan 600 digital camera.  
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CHAPTER 3 
 
RAPID SAMPLING 
AND QUANTITATION 
METABOLITES 
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3.0 Rapid sampling and quantitation of metabolites 
 
3.1 Introduction 
 
Metabolome analysis has become an important tool for profiling biological systems. The 
study of the metabolome will provide useful information about biological processes since it 
represents the metabolic state of the microorganism. Although transcriptomics and 
proteomics provide a useful description of the RNA and proteins present in the cell, this is 
not a complete picture of cellular activity. A more complete description of the state of the 
cell can only be determined using metabolomics as well. There are many analytical 
techniques that have been used in metabolite analysis, in particular nuclear magnetic 
resonance (NMR) and mass spectrometry (Rui et al., 2010; Smart et al., 2010; Villas-Boas et 
al., 2005b). Sampling, followed by separation of cells and medium, is an important step in 
the above methods.  
 
The measurement of extracellular metabolites is straightforward, because the extracellular 
volume is much larger than the intracellular volume in typical culture densities, and 
therefore changes due to leakage from cells do not lead to significant changes in the 
concentrations of extracellular metabolites. Thus all that is necessary is to spin down 
cultures and remove cells. 
 
Intracellular metabolite quantification is more difficult due to rapid turnover and small pool 
sizes. Thus, metabolic activity needs to be stopped as quickly as possible so that collected 
samples represent the in vivo conditions. This can best be achieved by rapidly decreasing 
the sample temperature to values below 0°C. The most popular method for quenching of 
microbial cells is rapid cooling by plunging the cells into cold methanol, where the bath 
temperature is kept below -20°C in order to cool the cells rapidly to close to 0°C (de Koning 
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and van Dam, 1992). After this, metabolism is stopped and the cells can be harvested by 
centrifugation prior to extraction with minimal further metabolic change. This approach was 
originally developed and applied for yeast, but has later also been used in studies of 
different bacteria (Buchholz et al., 2001; Letisse and Lindley, 2000; Zhu and Shimizu, 2005).  
 
This chapter describes work carried out to develop an effective and reproducible method for 
quenching E. coli cells, and for quantitating metabolite levels. 
 
3.2 Quenching method 
 
The major requirement of a reliable quenching method is that the sampling and quenching 
method is fast enough to stop the metabolism. This means that we should stop all metabolic 
activity inside the cells and prevent any further conversions of metabolites by enzymatic 
reactions. Quenching of metabolism should ideally be achieved within a second to get the 
samples to reflect the biological status of interest. For this, several methods have been 
proposed. One of these uses cold glycerol-saline solution (Villas-Boas and Bruheim, 2007). 
However this method is not suitable for our use because it is impossible to get rid of the 
glycerol that sticks to the pellets. A more suitable quenching technique has been described 
that uses ethanol and sodium chloride (NaCl) (Spura et al., 2009). In this method, an isotonic 
solution containing 40% ethanol v/v + 0.8% NaCl w/v is cooled to -30°C, and 20 ml samples 
from the chemostat are added to 20 ml of cooling solution. The resulting mixture is thus 
instantly cooled to close to 0°C. This method gives a high concentration of metabolites, 
assumed to mean that it leads to a small amount of damage to the cell membrane and thus 
only a small amount of leakage of intracellular contents. 
 
To verify the quenching efficiency, and to establish the best method, cells were sampled and 
quenched in various ways, and compared to cells that were sampled and centrifuged 
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without being quenched first.  NMR spectra taken of cells grown in different ways showed 
that the most reliable way to compare them was to use cells grown aerobically or 
microaerobically. Typically, E. coli WT MG1655 was grown aerobically in a 1 L chemostat 
until it reached a steady state (section 2.4.1). Then the cultures were shifted to a 
microaerobic condition by being perturbed by the introduction of air at 5%. Cultures were 
sampled from the chemostat and immediately transferred into the precooled quenching 
solution, or analysed without quenching (sections 2.4.1-2.4.2.3). Incomplete quenching 
followed by centrifugation results in anaerobic metabolism occurring in the cells. This is 
evident from the presence of succinate at 2.4 ppm in the spectra of incompletely quenched 
cells (Figure 3.1). Other metabolite peaks like acetate are also higher in unquenched cells 
compared to quenched cells. 
 
This technique cools the cells within 1-2 seconds to inactivate the metabolic activity. The 
temperature of the medium reached approximately 5°C following the method of Spura et al. 
(2009). In order to cool the cells further, different temperatures for the cooling solution 
were tried. Too low a temperature leads to a risk of freezing the cells, and the creation of ice 
crystals, which can rupture the cell membrane and lead to leakage of metabolites. To 
investigate whether this quenching method could lead to cell leakage, we analysed the 
extracellular (Figure 3.2a) and intracellular (Figure 3.2b) metabolites grown under anaerobic 
conditions to identify the metabolites that leaked during the quenching process. Use of a 
cooling solution at -40°C led to measurable leakage of cell contents. However, a bath at -
35°C meant that no intracellular metabolites, such as those found in the glycolytic pathway, 
could be detected. On mixing, the medium was cooled immediately to 0°C. Interestingly, no 
glutamate was detected in the extracellular fraction, which was reassuring, as glutamate is a 
highly abundant intracellular metabolite (Bolten et al., 2007).  
 
In the method of Spura et al. (2009), samples are further cooled down to -5°C (and 
therefore further slow down the metabolism) before centrifugation to separate the pellet 
(intracellular) from the supernatant (extracellular) fractions. Several variations on this were 
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tried, of which the most successful was to essentially reproduce their method, by leaving 
the Falcon tube in the cold isopropanol bath for a further 2 minutes (approximately) until 
the temperature of the medium reached -5°C. Measurements of the reproducibility of the 
method were carried out, described below, and it was shown that it was essential to stir the 
medium during this cooling process in order to prevent local cold spots developing and 
potentially leading to ice crystals. Once the medium reached -5°C, it was transferred to an 
ice/salt mixture to keep it at -5°C until ready for centrifugation. Centrifugation was carried 
out using a centrifuge precooled to -11°C, using 5 min at 3940 xg. After removing 
supernatant, the centrifuge bottle is then placed immediately in LN2 to quench metabolism 
completely, after which the cold methanol extraction method was used (section 2.4.3) 
before analysis by 1H NMR (sections 2.4.4.1-2.4.4.2).  
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Figure 3.1: Comparison of NMR spectra of microaerobic E. coli WT MG1655 cells, 
quenched and unquenched. The unquenched cells are shown in red while the quenched 
cells are shown in blue.  The succinate peak (2.4 ppm) was detected only in unquenched 
cells.  
Succinate 
Unquenched cell 
       Quenched cell 
 
Acetate 
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Figure 3.2: NMR spectra of (a) extracellular and (b) intracellular fractions obtained from E. 
coli WT MG1655 during anaerobic growth. Glutamate was detected only in intracellular 
fractions, suggesting that the metabolites remain in the cells during the rapid quenching. 
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3.3  Measurement reproducibility 
 
A study was carried out to identify the magnitudes of errors from different sources during 
the measurement of metabolite concentrations by NMR. In order to obtain reproducible 
results, it is important to know how big the errors are, and to minimise the large ones. We 
have separated the errors into four types; integration, sampling, biological variation and 
quenching errors.  
 
Integration error is the error in integrating the NMR signals, and can be estimated by 
repeated processing and integrating of the same FID (in our case, 5 times). Errors of this 
type have been analysed in detail in the past (Lindon and Ferrige, 1980) and these errors are 
usually small provided that the signal-to-noise ratio of the NMR spectra is adequate and 
peaks are reasonably sharp. The NMR lab in Sheffield typically processes spectra using a 
convolution difference method to remove the water signal from the spectrum (Craven and 
Waltho, 1995). However, this method has the effect of reducing the intensity of signals close 
in frequency to the water. All spectra here were therefore acquired and processed by simple 
presaturation of the solvent signal, and exponential multiplication of the FID before Fourier 
transformation. The Sheffield lab also typically processes spectra and analyses them using 
the program Felix (Felix NMR Inc, San Diego, CA). This program has the potential for a more 
automated approach to analysing spectra (for example, by baseline correction and setting 
integral limits in a standard way for all spectra). However, it proved to be much less 
reproducible than processing manually using Bruker software. 
 
Sampling error is the error arising from independent sampling and handling of the same 
biological sample, and was measured by collecting several samples from the same culture at 
the same time and measuring them independently. The error obtained from this procedure 
should be the sum of integration and sampling errors. The error from this source was not 
expected to be large, and indeed is not (Table 3.1).  
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Biological variation error is the variation arising from the fact that different biological 
samples may be different, for example from variation in the genome, biological 
contamination, small changes in pH, temperature etc. This error is measured from steady–
state cultures starting off from different starter cultures, and can be observed either in 
supernatant or intracellular samples.  
 
Finally, quenching error is the error arising from the quenching procedure. It can only be 
observed on the intracellular samples, because in sampled cell suspensions the intracellular 
volume is much smaller than the supernatant, so small amounts of leakage or crossover 
from intracellular samples will only have a very small effect on supernatant measurements, 
whereas they will have a much larger effect on intracellular measurements. Quenching 
errors can be observed from measurement of intracellular metabolites obtained from 
repeated samples of the same steady-state culture (in which case the observed error is the 
sum of integration, sampling and quenching errors) or from measurement of intracellular 
metabolites from steady-state cultures in different growth runs (in which case the observed 
error is the sum of integration, sampling, quenching and biological variation errors). This 
error is expected to be the largest source of error in the measurements, because bacterial 
metabolic rates are fast, and the physical processes involved in quenching and extracting 
intracellular metabolites have lots of possibilities for variation to occur. 
 
Measurements were performed on samples from chemostat cultures grown at microaerobic 
steady state. Table 3.1 presents a summary of the errors and shows that the errors from 
most sources are small except for quenching. The error for biological variation is calculated 
as 0 using supernatant and 4.5% using intracellular samples. It is reasonable to expect a 
larger variation using intracellular samples, because in a chemostat in which the medium is 
replaced at a rate of 0.2 h-1, extracellular concentrations only change slowly with time and 
are effectively averages over time. By contrast, the intracellular concentration is more likely 
to vary. Nevertheless, an error from biological variation of zero is unlikely. We can therefore 
conclude that errors increase in the order integration < sampling < biological variation <  
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Table 3.1: The percentage of errors measured on samples from chemostat growths at 
microaerobic steady state. The biggest error is coming from quenching with 14%.  
 
Error 
% of errors 
(Total)* 
% of errors 
(Individual)* 
Integration 0.62 0.6 
Sampling 1.8 1.2 
Quenching 16.03 14.2 
Biological variation (supernatant) 2.12 0 
Biological variation (intracellular) 20.57 4.5 
*The total error is the error as measured. However this total is usually the sum of several 
individual sources, as discussed above. The individual error is obtained by subtracting 
known individual errors: for example, the individual error for quenching is obtained by 
taking the total quenching error and subtracting the individual errors for integration and 
sampling. 
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quenching. This means that the process that we should worry about most is the quenching, 
because this is what gives rise to most of the error. An internal standard is used in a proton 
NMR experiment to provide a chemical shift reference, which represents the frequency 
difference relative to the reference proton, measured in ppm. TSP has been chosen as an 
internal standard because it is very stable and has a chemical shift of 0.00 ppm, which is a 
smaller chemical shift than that for any other metabolite. TSP has 9 equivalent protons 
which resonate at the same frequency and result in one intense signal. The relative intensity 
of signals in the NMR spectrum provides information on the concentration of the 
compound. When we integrate the signal, the area under the curve of each signal is 
proportional to the number of equivalent protons creating the signal. Accurate 
proportionality requires a long relaxation delay to avoid errors arising from different 
relaxation rates. In this study, relaxation delays of 3 seconds were used. Proportionality was 
further tested by running spectra of the major metabolites identified at known 
concentrations, and using this to correct the measured intensities. 
 
In the present study, there are two different samples involved; extracellular and intracellular 
samples. The chemical shifts of extracellular metabolites are quite easy to measure 
compared to intracellular metabolites, where some signals are overlapped. We use TSP as 
an internal standard for the extracellular sample. The integrated signals were scaled to the 
TSP, so that peak intensities represent intensity relative to the TSP. The concentration of 
metabolites can be calculated by comparing the intensities of metabolite signals with the 
intensities of TSP and multiplying by the concentration of TSP used.  
 
3.4 Measurement of intracellular metabolite concentration 
 
The measurement of intracellular metabolite concentrations can be carried out based on 
one of two different calibration methods: relative to an internal standard of known 
concentration, or calculation based on knowledge of numbers of cells in the sample plus an 
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assumption about cell volume. It was a challenge to choose the right internal standard 
because it is necessary to identify a metabolite whose concentration is constant under both 
aerobic and anaerobic conditions. Further explanation about these two methods is reported 
in sections 3.4.1 and 3.4.2. 
 
3.4.1 Measurement based on internal standard 
 
For calibration of the concentration of intracellular metabolites, it is challenging to find a 
suitable internal standard to be used in measurement of metabolite concentration. 
Previously, TSP was used as an internal standard for both extracellular and intracellular 
metabolites, but this gives no absolute value for the concentration without further 
information. The reference for the intracellular sample must be able to present the changes 
happening inside the cells, of which the most suitable one must be located inside the cells. 
Based on this fact, glutamate was chosen as an internal standard. Glutamate is the most 
abundant compound in aerobically grown cells (Bennett et al., 2009) and investigations have 
been carried out to look at the stability of the glutamate level inside the cells. The 
observations suggested that the concentration of glutamate does not change much during 
cell growth, which means that glutamate might be an appropriate internal standard.  
 
In order to perform the measurement of metabolite concentration, a set of metabolite 
references with known concentration (100 mM) has been run in NMR and integrated. For 
extracellular samples, the measurement was done by comparing the intensities of 
metabolite signals with the intensities of a known concentration of TSP and multiplying by 
the concentration of TSP. For intracellular metabolites, the intensities of metabolite signals 
were compared with the intensities of known concentrations of glutamate and multiplied by 
the concentration of glutamate in the cells (~ 96 mM); (Bennett et al., 2009).  The formulas 
used in measuring the extracellular and intracellular metabolite concentrations are shown 
as below: 
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Extracellular sample 
[metabolite] = Metabolite sample x TSP reference    x 100 mM 
              Metabolite reference x TSP sample 
Intracellular sample 
[metabolite] = Metabolite sample x Glutamate reference    x 96 mM 
              Metabolite reference x Glutamate sample 
 
3.4.2 Measurement based on cell volume 
 
Intracellular metabolite concentration can be calculated on the basis of cell volume. The cell 
volumes of E. coli were reported to be in a range from 0.5 to 4 µm3 (Churchward et al., 
1981; Loferer-Krossbacher et al., 1998), with the lower value being the more generally 
accepted one.  Determination of cell volume is one of the biggest challenges to get an 
accurate measurement of intracellular metabolite concentration. For each metabolite, the 
intracellular concentration can be calculated as follows: 
 
                   mmoles in NMR tube 
                                       Cells in 20 ml  
                                                Cell volume 
 
 
X  1012 [Metabolite] Molar = 
10-15 
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The mmoles of metabolite in NMR tube was calculated, and the amount of cells in 20 ml 
(volume of samples taken for analysis) was determined. The fmoles of metabolite per cells 
was calculated by dividing the mmoles of metabolite in the NMR tube with the amount of 
cells in 20 ml, and multiplied by 1015. The concentration of metabolite was then calculated 
by dividing the fmoles of metabolite per cell by the total cell volume of 0.5 fL (Neidhart and 
Umbarger, 1996) and the result were further multiplied by 10-15 to get the concentration of 
metabolite in Molar. This total cell volume (0.5 fL) is an estimated number calculated based 
on volume of water per cell. The number could be changed as the cell varies depending 
upon growth rate, different medias, temperature and other factors.   
 
3.4.3 Comparison of intracellular metabolite concentrations calculated based on internal 
standard and cell volume.  
 
The concentration of intracellular metabolites is normally calculated on the basis of cell 
volume. This method is well established and has been used by researchers to measure 
intracellular concentration. Another method is to use an internal standard that is located 
and present in the cells, which is more direct but relies on knowing the concentration of an 
intracellular metabolite. Therefore we performed both calculations and compare the 
metabolite concentrations derived in Table 3.2. 
 
The concentrations calculated based on internal standard are higher than the calculation 
based on cell volume, by a factor of 2-3. The relative concentrations are fairly constant: over 
all the values except for those at t=0, the ratio is 2.6 ± 0.9. The result also demonstrates that 
the concentrations at 0 min are all roughly twice as big as for every other time point (ratio 
5.2 ± 1.3). This can be explained by the observation that the glutamate concentration 
roughly doubles from 0 min to 30 and 60 minutes (based on the calculation using 
intracellular volume), meaning that the concentration of glutamate is not constant. These 
two methods therefore present a different pattern of numbers. We have decided to use a  
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Table 3.2: Comparison of intracellular metabolite concentrations calculated using two 
methods, based on (a) internal standard, (b) cell volume  
 
Time          0 min     10 min        30 min           60 min              120 min 
Metabolite     (a)            (b)          (a)         (b)         (a)          (b)          (a)           (b)          (a)           (b)          
Acetate       269.8       65.5      155.4      52.4     155.7      46.1      156.1       56.8     202.4       56.8 
Formate     765.7      143.4      486.4    125.7    567.7    127.7      541.5     152.4     467.6       96.8 
Succinate   234.7        71.0      120.3     50.4      129.2     46.3      101.8       45.8        70.2       23.0 
Pyruvate      17.6           5.9          8.1       6.9        13.2        6.5       10.14       7.8           1.9         6.0  
Lactate         35.8        12.8         28.0     13.9       26.1      10.7         23.9      12.5        31.9       12.4 
Putrescine   39.6      13.4         39.7       18.7       43.8      16.7         36.9      18.1        37.1       14.6 
Acetyl           37.2      13.4         25.9     12.7       29.2      11.8         36.6      19.3        34.1       13.2 
aspartate 
Fumarate      1.0          0.3            1.0       0.4         3.5        1.0           4.0        1.4          2.8         0.7 
The concentration unit is millimolar (mM) 
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calculation based on cell volume to measure the concentration of intracellular metabolites. 
The method chosen is far better established compared to the other one and we are lacking 
important information on the stability of glutamate inside the cells. Ratios of concentration 
between these two methods imply that metabolite concentration in anaerobic cells is bigger 
than in aerobic cells. This clarified that concentration of glutamate in the cells is not 
constant. 
 
Analysis of the values calculated by method (b) shows that the values obtained at t=0 are 
consistently low. This can be seen most easily for lactate, putrescine and acetyl aspartate, 
which remain approximately constant from t=10 min onwards but are lower at t=0. The 
most obvious explanation for this observation is that the relationship between OD and 
intracellular volume is different for anaerobic and aerobic cells: for example either because 
aerobic cells have a larger volume than anaerobic cells, or because they scatter light less. 
Our observations of cells by electron microscopy and fluorescence microscopy (Chapter 5) 
do not suggest any gross changes in cell size after the introduction of oxygen, although it 
does appear that the size and shape of the periplasm is different following introduction of 
oxygen. It is also possible that aerobic growth causes the cells to scatter light differently. 
The calculated metabolite concentrations at t=0 have therefore been multiplied by 1.5 in 
the subsequent analysis in Chapter 4, to reflect this anomalous value. 
 
3.5 Identification of metabolites 
 
Assigning NMR peaks can be challenging, especially in spectra with overlapped peaks and 
crowded regions. Many approaches have been proposed to facilitate the identification of 
NMR peaks, of which the most common are; spiking with reference compounds and 
computational methods.  Spiking with reference compounds is a common way to identify 
metabolites, where NMR samples are spiked with a small volume of a respective metabolite. 
Basically the metabolite can be identified by matching the observed spectra to the reference 
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spectra. This technique is used as evidence for the presence and absence of the metabolite. 
It is also useful for confirming the assignment of peaks in ambiguous regions. 
 
NMR peaks in this study were assigned by spiking NMR samples with metabolite reference 
and by comparing the chemical shift obtained from the spectra with the chemical shift from 
the database. Figure 3.3 shows two examples of NMR spiking in order to facilitate the 
identification of metabolite. NMR spectra are collected after both or more respective 
metabolites were put in NMR tubes and observed by NMR. TSP was added as a chemical 
shift reference.  For example, the pyruvate (Figure 3.3a) molecule has two resonances in 
proton NMR; at 2.37 ppm and 1.47 ppm. In water, pyruvate is in equilibrium between 
CH3.CO.COO- and the hydrated form, CH3.C(OH)2.COO-.  The two signals are coming from the 
two CH3 groups in these two forms. Because in water, pyruvate is present as an equilibrium 
mixture of pyruvate plus the hydrate, it is necessary to correct for this in the calculation of 
pyruvate concentration. This can be done either by adding together the intensities of the 
two methyl signals, or by measuring the ratio of pyruvate to pyruvate hydrate at 
equilibrium, and using this to correct the concentration obtained by using only one of the 
two peaks. The peak for the hydrate is sometimes hidden by other signals and is thus 
difficult to measure accurately. We therefore measured the ratio of pyruvate to hydrate at 
equilibrium (1:0.58) and multiplied the concentration of pyruvate obtained from the 
pyruvate peak by 1.58 to obtain the total concentration of [pyruvate + hydrate] in the cell. 
Since the glutamate peak (triplet) has a similar chemical shift as pyruvate (at 2.37 ppm), this 
assignment confirmed the presence of pyruvate. For acetyl aspartate, only one peak is 
identified even though this molecule has several other signals. Figure 3.3(b) showed that the 
signal comes at the right place but it is possible that the signal observed is something else 
with a very similar shift.  
 
Oxaloacetate is an important intermediate in the citric acid cycle and gluconeogenesis. In 
the citric acid cycle, oxaloacetate is formed by the oxidation of malate and reacts with 
acetyl-CoA to form citrate while in gluconeogenesis, oxaloacetate is formed by the 
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carboxylation of pyruvate. To prove that pyruvate is the metabolite present in the NMR 
spectrum from the experiment and not oxaloacetate, NMR spiking was carried out. 
Oxaloacetate was added to the samples and the spectrum is presented in Figure 3.4. It is 
clear that the oxaloacetate peak is at different place from pyruvate, proving that pyruvate 
and oxaloacetate are not identical. The chemical shift of oxaloacetate is not identical to that 
found in databases, but the values in databases are not identical anyway due to different 
experimental conditions or referencing. NMR is thus able to distinguish between pyruvate 
and oxaloacetate. These spectra also show that pyruvate and succinate can be clearly 
distinguished. In Figure 3.3(a), pyruvate is indicated by the arrow at 2.37 ppm, while 
succinate is the intense peak at 2.42 ppm. 
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           (a) 
           (b) 
Figure 3.3: Analysis of spiked samples by 1D NMR of (a) pyruvate- arrows in black; 
acetate- arrows in green; succinate-  arrows in red and (b) acetyl aspartate- arrows in 
orange; ethanol- arrow in purple; lactate- arrows in brown; pyruvate- arrows in blue. 
Untreated spectra are shown in blue and spiked spectra are overlaid in red. 
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Figure 3.4: Analysis of spiked sample by 1D NMR of oxaloacetate – arrows in purple. 
Untreated spectra are shown in red and spiked spectra are overlaid in blue.  
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3.6 Discussion 
 
In this study, E. coli was used as a model organism to understand more about changes in 
metabolism during oxygen stress, and more generally to investigate how much can be 
understood about system-wide regulation of metabolic processes. Metabolic measurements 
have been carried out under steady-state conditions, and it needs information of both 
extracellular and intracellular metabolites. Extracellular metabolites were quantified in the 
cell-free supernatant by centrifugation at a low temperature while intracellular metabolite 
detection needs a faster quenching technique to arrest the metabolism.  
 
Spura et al. (2009) have shown that a quenching solution with 0.8% (w/v) salt concentration 
gives reproducible results with highest detection of metabolite concentration. The cold 
methanol quenching method showed leakage of intracellular metabolites (Bolten et al., 
2007; Faijes et al., 2007; Maharjan and Ferenci, 2003; Wittmann et al., 2004)  due to the 
inherent differences in cell wall structure and membrane composition in these organisms. 
Therefore, Spura et al. (2009) proposed that ethanol should be used, because it should 
damage the cell membrane less, and the concentration of alcohol was reduced to prevent 
damage and retain the cell integrity before the cell extraction was performed. Ethanol was 
also shown to produce an efficient quenching with the xanthan-producing organism 
Xanthomonas campestris, where it quenches rapidly and produced polymer-free 
supernatants of better quality than methanol (Gonzalez et al., 1997) . The concentration of 
salt in the cooling medium should be adjusted to minimise the risk of the cell membrane 
breaking due to osmotic shock. The concentration proposed by Spura et al. (2009) is close to 
isotonic and was found to produce the least leakage.  Metabolites were extracted using a 
cold methanol method. During this step, freeze-thaw processes were performed six times as 
suggested by Theobald et al. (1993) to achieve a complete metabolite extraction. Both 
samples then were analyzed using NMR (section 2.4.4.2). Basically, the optimal extraction 
method is depending on the targeted metabolites. For example, boiling ethanol was used as 
an extracting agent for study of amino acid pools and pathway intermediates by Gonzalez et 
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al. (1997) while perchloric acid was used to extract acid-stable metabolites (Buchholz et al., 
2001; Chassagnole et al., 2002b).  
  
Previous studies have demonstrated that quenching of S. cerevisiae cells with cold methanol 
damages the cell integrity which permits leakage of the metabolites (Villas-Boas et al., 
2005a). The use of saline quenching solution was proved to reduce leakage of metabolites 
(Bolten et al., 2007). The quenching method of Spura et al. (2009) has been tested and leads 
to no detectable leakage from cells. It also produces no detectable metabolism after 
sampling. The method was modified slightly, because of large random errors in initial trials. 
For example, the cells (after transferring to the quenching solution) are stirred all the time 
(to let the cells cool homogeneously and prevent damage by freezing), and the quenching 
solution is precooled to -35°C, to give more rapid quenching. Using this method, the 
temperature of the culture is reduced to 0°C in 1-2 seconds, which should be short enough 
that metabolism is stopped almost completely. It is possible that metabolism can continue 
even at 0°C, and hence it is important to separate cells and supernatant, and get the cells 
into LN2, as quickly as possible after quenching.  
 
The efficiency of the quenching method can be checked by comparing quenched and 
unquenched cells. Succinate was found in a significantly higher concentration in 
unquenched samples where no succinate was present in quenched cells. The results suggest 
that the unquenched cells become anaerobic during the centrifugation step, because 
succinate is a typical metabolite under anaerobic conditions, and is produced because after 
sampling the cells are still close to 37°C and only cool gradually during the centrifugation. 
One should be aware that during extraction metabolite levels were not changed by 
enzymatic or chemical conversion, and they were not destroyed during extraction. 
 
During anaerobic respiration, succinate is produced from the reduction of fumarate by 
fumarate reductase, when the citric acid cycle (CAC) is repressed and the metabolic flow in 
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the C4 section of the CAC is reversed. Studies by Vemuri et al. (2002) proved that fumarate 
reductase activity was increased at both oxygen transfer rates as fermentations became 
increasingly oxygen limited. Under oxygen limitation, FNR protein (regulator of fumarate 
and nitrate reduction) triggers the expression of fumarate. Apart from succinate, acetate is 
another metabolite that appeared high in unquenched cells. This verifies that the 
metabolism is not stopped properly in the unquenched cells, thus will affect the 
measurement of intracellular metabolites. 
 
Metabolomics, analytical platforms such as NMR, GCMS or LCMS, are able to measure many 
metabolites in biological samples but various error sources can contribute to the error of 
measurement of each metabolite analysed. These variations might have been caused by the 
different sampling/quenching techniques, and the different analysis procedures applied. 
Measurement error can be defined as an error related to the repeated analysis of the same 
sample. Different metabolites may have measurement errors that correlate with each other. 
The initial data on using the unchanged Spura et al. (2009) method exhibited large errors, of 
the order of 40% (data not shown). After refinement of the procedure, the error for 
quenching is still big (13%), but acceptable. The results indicate that overall the method is 
robust and reliable. Each experimental condition was independently repeated three times 
to make sure to prevent inaccuracy while doing the experiment. The high turnover of 
intracellular metabolites highlights the need for reliable and reproducible quenching 
techniques for microbial metabolomics. 
 
Apart from having better quenching and extraction techniques, how the measurement of 
intracellular concentration is carried out is of utmost importance since an accurate 
measurement will give valuable information on the metabolic reaction inside the cells. 
Initially, a calculation method was attempted using one of the metabolites present inside 
the cell as an internal standard to provide a simple yet better method to calculate the 
intracellular metabolite concentration. The only concerns of this approach would be finding 
a stable standard, which is not going to change inside the cell. Not much information on the 
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stability of the concentration of glutamate can be found at the moment. Measurements 
based on cell volume are the most common method used but quite challenging as 
information on the total cell volume of E. coli is still inconsistent. Many researchers have 
been carried out to determine the total cell volume; often by using coulter counter 
measurements or by electron microscopy (Kubitschek, 1969). This method is much more 
promising since a lot of scientific report can be found on the cell volume of E. coli.  Analysis 
on the concentration of intracellular metabolites calculated from these methods shows that 
the relative concentrations are fairly constant but that the ratios at the 0 min timepoint is 
bigger than at other timepoints, suggesting that the concentration of glutamate is not stable 
inside the cells. This argument made us to decide to choose measurement based on cell 
volume to present the data of concentration of intracellular metabolite. This measurement 
will provide much information on the metabolism of E. coli during the transition from 
anaerobic to aerobic in the next chapter.   
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CHAPTER 4 
 
ANALYSIS OF E. COLI 
METABOLITES AT DIFFERENT 
LEVELS OF OXYGENATION 
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4.0 Analysis of E. coli metabolites at different levels of oxygenation  
 
4.1 Introduction 
 
The Escherichia coli system has been studied extensively, especially its physiology, genetics 
and metabolism. This metabolically versatile bacterium is able to grow in the presence or 
absence of oxygen. When oxygen is available, aerobic respiration allows the complete 
oxidation of glucose and generates maximal energy in the form of energy-carrying 
molecules (ATP). In the absence of oxygen, two separate pathways can occur; anaerobic and 
fermentation, depending on the electron acceptor present. For anaerobic respiration, 
nitrate, sulphate or fumarate can act as a terminal electron acceptor, while in fermentation, 
NADH gets reoxidised by the metabolites of the pathway, which are then secreted into the 
medium to maintain the redox balance. The energy produced by anaerobic respiration is 
less than that achieved by aerobic respiration, but is greater than that produced by 
fermentation (Partridge et al., 2006). The major factor that controls the switching between 
these metabolic modes is oxygen availability. The change from anaerobic to aerobic or 
microaerobic metabolism can be very rapid and leads to alterations in the rate, route and 
efficiency of pathways of electron flow (Sawers, 1999). 
 
Under aerobic conditions, E. coli synthesizes two main cytochrome oxidases, cytochrome bo 
and cytochrome bd-I, as major terminal electron acceptors in the electron transport chain. 
Cytochrome bo is synthesized maximally under conditions of high oxygen availability, and is 
regarded as a proton-pumping oxidase (Poole et al., 1994), where it catalyses the two-
electron oxidation of ubiquinol within the membrane and the four-electron reduction of 
molecular oxygen to water. Cytochrome bd in comparison is prominent under microaerobic 
conditions and does not function as a proton pump. There is a cytochrome bd-II but this is 
largely uncharacterised (Poole and Cook, 2000).  
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In response to lower oxygen concentrations, the role of pyruvate dehydrogenase complex 
(PDHC), which oxidises pyruvate to acetyl-CoA and CO2, is replaced by pyruvate formate 
lyase (PFL), which converts pyruvate to acetyl-CoA and formate (Murarka et al., 2010). This 
change is regulated by the FNR and ArcBA systems. FNR is a direct oxygen sensor while 
ArcBA senses oxygen availability indirectly by monitoring the redox state of the quinone 
pool (Georgellis et al., 2001).  
 
The steady-state metabolism of E. coli under anaerobic and aerobic conditions is well 
understood. Partridge et al. have characterised the changes during the transition from 
anaerobic to aerobic (2006) and aerobic to microaerobic (2007) at the transcriptome level. 
However, the change at the metabolome level is still not analysed. The objective of this 
chapter is to characterise the metabolite changes of E. coli at different level of oxygen and 
analyse the metabolites during the transition from anaerobic to aerobic. 
 
4.2 Results 
 
4.2.1 Metabolic profile of cells grown under anaerobic and aerobic steady-state culture 
 
The chemostat is the most suitable method of analysing cells under steady-state conditions. 
It has been widely used in transcriptomic, proteomic and metabolomic studies (Hayes et al., 
2002; Hoskisson and Hobbs, 2005; Partridge et al., 2006). The importance of chemostat 
cultures resides in the fact that they allow growth of microorganisms under constant and 
well-defined conditions. In particular, the results from chemostat cultures can be compared 
readily between different laboratories, compared to the same studies using batch cultures 
(Piper et al., 2002). In the present work, we use chemostat cultures of E. coli MG1655 with 
NMR analysis to compare the metabolic profiles of anaerobic and aerobic chemostat 
cultures grown in steady-state conditions. Steady-state cultures provide reproducible 
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starting points, with growth rate, medium composition, pH value and aeration of the culture 
controlled (Hoskisson and Hobbs, 2005). Glucose (20 mM) was used as the carbon source 
and the dilution rate chosen was 0.2 h-1. Thus, cultures have the potential to respond to 
changes in O2 availability without changes in growth rate. 
 
To compare the metabolic profiles of cells growth under aerobic and anaerobic conditions, 
extracellular and intracellular samples from steady-state cultures were collected rapidly and 
quenched before being analysed using NMR. During aerobic metabolism, pyruvate (the end 
product of glycolysis) is completely oxidised by the pyruvate dehydrogenase complex 
(PDHC) to yield acetyl-CoA, CO2 and water. The other carbon atoms are converted ultimately 
to cell mass, implying that the cell does not need to produce secreted over metabolites in 
order to achieve redox balance. The role of PDHC is replaced by pyruvate formate lyase 
(PFL) under anaerobic conditions, where pyruvate is converted to acetate, ethanol, formate 
and succinate (Figure 4.1). This process prevents the build-up of NADH in the cytoplasm and 
provides NAD+ to be used in glycolysis again.  
 
Figure 4.2 shows NMR spectra of extracellular (Figure 4.2a) and intracellular (Figure 4.2b) 
extracts from cells grown under aerobic conditions. In the extracellular extract, the largest 
signals are from water (reduced by presaturation), the NTA buffer, and added TSP. Secreted 
metabolites are present at very low concentrations. None of the glucose added to the 
medium is detected, meaning that the cells have taken up all the glucose in the medium. In 
the intracellular extract, there are a large number of peaks, as expected. Many of these are 
derived from TCA cycle intermediates like α-ketoglutarate, fumarate and oxaloacetate. 
There are again no signals detected from glucose, showing that the glucose is fully oxidised 
by glycolysis and the TCA cycle to produce water and carbon dioxide. 
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Figure 4.1: Schematic pathways of glucose metabolism. The glucose molecule is broken 
down into pyruvate during glycolysis. In the presence of oxygen, pyruvate enters the TCA 
cycle to produce more energy in the form of ATP than can be obtained from any anaerobic 
pathway. When no oxygen or alternative electron acceptor are present, fermentation 
pathways are important and are the sole source of ATP for some anaerobic bacteria. 
Anaerobic cells need to produce NAD+ to maintain redox balance, which they do by 
fermentation of pyruvate to produce ethanol, or reduction to lactate. Anaerobic respiration 
leaves a lot of energy in the ethanol or lactate molecules that the cell cannot use and must 
secrete. (LDH: lactate dehydrogenase; PDHC: pyruvate dehydrogenase complex; PFL: 
pyruvate formate lyase; AdhE: aldehyde dehydrogenase; PTA: phosphotransacetylase). 
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(a)                                                                                (b) 
Figure 4.2: NMR spectra of (a) extracellular and (b) intracellular metabolites of E. coli WT 
MG1655 grown under aerobic steady state. 
 
 
 
 
 
 
 
 
(a)                                                             (b) 
Figure 4.3: NMR spectra of (a) extracellular and (b) intracellular metabolites of E. coli WT 
MG1655 grown under anaerobic steady state. 
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In comparison, NMR spectra of extracellular and intracellular extracts from cells grown 
under anaerobic conditions are presented in Figure 4.3 (a) and (b). Both spectra show the 
presence of acetate, succinate and formate. Ethanol is only present in extracellular extracts 
but not in intracellular extracts since ethanol inside the cells is volatile and is evaporated 
during the extraction process (section 2.4.3). These results show that aerobically grown cells 
are able to use all their carbon source for growth, but anaerobically grown cells oxidise 
NADH to maintain a redox balance through the production of these overflow metabolites. 
The large number of metabolites present in the NMR spectra of intracellular extracts make 
the spectra difficult to integrate and quantify compared to NMR spectra of extracellular 
extracts. 
                       
The concentrations of extracellular and intracellular metabolites of the anaerobic steady-
state grown cultures were measured (Table 4.1). No measurement of metabolite 
concentrations can be done for aerobically grown extracellular extracts since glucose is fully 
oxidised to carbon dioxide and water. For cells grown under anaerobic conditions, acetate, 
succinate and formate were detected in both extracellular and intracellular extracts, of 
which formate has the highest concentration (63 mM extracellular; 96 mM intracellular), 
followed by acetate (25 mM extracellular; 44 mM intracellular), ethanol (16 mM; which can 
be detected only extracellular) and succinate (6 mM extracellular; 47 mM intracellular). 
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Table 4.1: Concentration of extracellular and intracellular metabolites for cells grown 
under anaerobic condition. 
 
   Cells grown under           Concentration (mM) 
   anaerobic conditions       Extracellular       Intracellular 
   Ethanol    16       - 
  Acetate    25             44 
   Succinate     6             47 
   Formate     63             96 
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4.2.2 Steady-state metabolite analysis at different level of oxygenation 
 
Oxygen plays an important role in the regulation of various cellular processes. The 
availability of oxygen is the major factor that determines which metabolic modes (aerobic 
respiration, anaerobic respiration and fermentation) will be adopted by the organism. 
Alexeeva et al. (2002) defined 100% aerobiosis as the minimal oxygen input rate that results 
in undetectable secretion of the fermentation product acetate. Figures 4.2 and 4.3 show 
that aerobic cells secrete no acetate, whereas anaerobic cells secrete a large amount of 
acetate. This aerobiosis scale only applies to carbon-limited cultures as used in this study. 
The specific rate of acetate production (qacetate) increases to a maximum under anaerobic 
conditions, when the amount of oxygen supplied to cultures decreases (0% aerobiosis). The 
microaerobic range lies between these limits (0-100% aerobiosis), which is defined by a 
linear decrease in qacetate as the oxygen transfer rate increases (Figure 4.4).  
 
To determine at what level of oxygenation the E. coli start to experience microaerobic 
conditions, the metabolism of E. coli was analysed at different levels of oxygenation. 
Previously 5.4% dissolved oxygen (25.7% air) has been used as a standard microaerobic 
condition (Trotter et al., 2011), based on the data in Figure 4.4. However, transcriptomic 
and proteomic results (Partridge et al., 2006) suggested that this may not be properly 
microaerobic, possibly because the periplasm of E. coli contains cytochrome bd, which has a 
very high affinity to oxygen, and may reduce it all before it can reach the cytoplasm. E. coli 
wild-type strain (MG1655) was used throughout this study. Cells were grown in chemostat 
cultures under glucose-limited conditions at a constant dilution rate of 0.2 h-1 at variable 
oxygen supply rates. Oxygen supply was controlled by varying the percentage of oxygen in a 
gas mixture of air and N2 while stirring the culture at a constant speed (400 rpm). A culture 
was grown at 0% air to steady state, and sampled. The proportion of air was then increased 
to 5%, cells were allowed to come to steady state (24 hr), and sampled. Samples were taken 
at 5%, 10%, 15%, 20%, 40%, 60% and 80% air. In order to check whether this gradual  
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Figure 4.4: Effect of oxygen supply on steady-state acetate production rate (qacetate) at two 
different stirring rates. Acetate shows a linear decrease in production when fermentative 
metabolism is replaced by aerobic metabolism. Fully respiratory catabolism could be 
achieved by varying either the oxygen concentration in the inflowing gas or the stirring rate 
(adapted from Alexeeva et al. 2002). 
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increase in oxygenation produced acclimatisation, fresh cell cultures were also grown to 
different oxygenations and compared. No significant differences were observed depending 
on the process, and results for the same oxygenation levels from different cultures were 
therefore pooled. The cells were harvested using the unquenched method as described in 
section 2.4.2.3. 
 
Table 4.2 summarises the concentration of formate and acetate in WT E. coli at different 
levels of oxygenation. Since formate and acetate are the major products of fermentation, 
only these two metabolites were measured in this study as it is easier to integrate the NMR 
peaks in order to obtain reproducible data. Examination of formate and acetate in 
intracellular samples by proton NMR showed the level of acetate and formate decreased 
significantly after 40% air and nearly disappeared at 60 and 80%. There is not much 
difference in the concentration of metabolites between 0, 5 and 10% air. From this result, it 
can be concluded that cells need more than 40% air in order to experience aerobic 
conditions, presumably because of the action of periplasmic cytochromes in absorbing 
ambient oxygen. This result will be useful in future studies aimed at characterising changes 
during microaerobic growth.  
 
 
      Air (%)    0%   5% 10% 15% 20% 40% 60% 80% 
Formate  0.20 0.22 0.24 0.26 0.14 0.18 0.03 0.03 
Acetate   0.14 0.28 0.25 0.47 0.34 0.29 0.04 0.05 
 
Table 4.2: Summary of metabolite concentrations of formate and acetate at different level 
of oxygenation. Concentrations are in arbitrary units. 
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4.2.3 Metabolite changes during transition from anaerobic to aerobic growth 
 
4.2.3.1 Extracellular metabolite  
 
There is not much information on transcriptome dynamics and metabolic profiling of E. coli 
during adaptation to changes in oxygen availability.  Earlier reports on the effects of oxygen 
on transcription in E. coli have compared separate aerobic and anaerobic cultures, regularly 
grown as batch cultures (Constantinidou et al., 2006; Salmon et al., 2005). Partridge et al. 
have characterised the changes during the transition from anaerobic to aerobic (2006) and 
aerobic to microaerobic (2007) at the transcriptome level. Recently, Trotter et al. (2011) 
reported the changes of E. coli from aerobic to microaerobic at metabolome level, focusing 
on extracellular metabolites. Here the adaptation process was investigated by determining 
the changes in metabolites when anaerobic steady-state cultures were perturbed by the 
introduction of air. Transition was followed at 10, 30, 60 and 120 minutes by looking at the 
metabolite profile by NMR. The metabolite changes resulting from introduction of air to the 
anaerobic steady-state cultures were monitored by looking at the extracellular and 
intracellular 1H NMR profile.  For this study, it was very important to quench the metabolism 
as rapidly as possible after sampling, because of the fast rate of pyruvate turnover in cells. 
The method described in Chapter 3 (section 3.2) was therefore used. 
 
Changes in extracellular metabolite concentrations are shown in Figure 4.5, and listed in 
Table 4.3. The 10-minute time point is consistently low for all metabolites, although this 
could be an artifact. Different metabolites have very different profiles. The group of 
overflow metabolites (acetate, formate, succinate and ethanol) is secreted by anaerobic 
cells to maintain redox balance and is not produced by aerobic cells. The concentrations of 
formate, succinate and ethanol drop steadily after introduction of air. If cells stop secreting 
these overflow metabolites immediately on introduction of air, then we would expect that 
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their concentrations in extracellular medium will decrease by 20% hr-1 because of washout 
by fresh medium.  
 
This behaviour can be observed in Figure 4.6 (a), (b) and (c), implying that they are not 
secreted once the transition to aerobic growth has begun. For ethanol, it should go down 
faster than 20% hr-1 because of evaporation during growth in the chemostat. However, the 
decrease in ethanol is in fact very close to 20% hr-1. This result suggests that the cells are still 
producing ethanol. However, some other metabolites like acetate (Figure 4.7a) are almost 
steady at the same level, suggesting that acetate is still being secreted by aerobic cells, 
roughly at constant rate. Fumarate (Figure 4.7b) increases from a small initial level, implying 
that it is not produced by anaerobic cells but is produced by aerobic cells. The same 
behaviour is also seen for a small number of other metabolites, in particular putrescine and 
a signal which best matches the frequency of acetyl aspartate, based on metabolomics 
databases and spiking (Figure 3.3). Pyruvate and lactate show unusual behaviour, with 
transient secretion by the culture. As can be seen in Figure 4.7c, pyruvate was undetectable 
in the anaerobic steady-state culture and increased initially but then decreased. This 
indicates that it is produced immediately after the transition to aerobic growth but is taken 
up again once the cells are adjusted to aerobic growth. This behaviour is observed because 
PFL is expected to be destroyed during the transition to aerobic growth but it will take some 
time for PDHC to be induced (see discussion). Lactate (Figure 4.7d) showed a similar profile 
as pyruvate, where the metabolite level increases initially but decreases again at 120 min. 
Lactate is secreted as a fermentation product under anaerobic condition under control of 
lactate dehydrogenase promoter (ldhA). Studies done by Bartosiak-Jentys et al. (2012) 
suggested that ldhA promoter is less active under fully fermentative anaerobic conditions 
than under oxygen limitation but is inactive under fully aerobic condition. This may explain 
the up and down pattern of lactate secretion.  
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Figure 4.5: Metabolite concentrations of extracellular metabolites: (a) acetate and 
formate; (b) ethanol and succinate; (c) putrescine, acetyl aspartate and fumarate; (d) 
lactate; (e) pyruvate during the transition from anaerobic to aerobic. These data were 
obtained from three independent cultures. Error bars show the standard deviation. 
118 
 
 
     
     
Time 
after 
transition 
 
Ethanol 
(mM)  
Acetate 
(mM)  
Formate 
(mM)  
Succinate 
(mM)  
Lactate 
(mM)  
Putrescine 
(mM) 
Acetyl 
aspartate  
(mM) 
Fumarate 
(mM)  
Pyruvate 
(mM)  
0 min 16.4 25.4 62.7 5.8 0.15 0.02 0.02 0.03 0.00 
10 min 13.6 21.8 53.1 5.0 0.12 0.02 0.02 0.11 0.69 
30 min 15.7 25.2 59.0 5.1 0.29 0.03 0.05 0.28 2.54 
60 min 13.9 24.1 53.1 4.3 0.30 0.04 0.07 0.39 3.15 
120 min 10.8 24.3 42.0 2.8 0.13 0.04 0.18 0.45 0.78 
 
Table 4.3: Summary of extracellular metabolite concentrations during the transition from 
anaerobic to aerobic.  
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                  (a) 
                                   
                  (b) 
                                   
                 (c) 
Figure 4.6: Extracellular metabolites that decrease at 20% h-1; (a) ethanol, (b) formate and 
(c) succinate. The dashed line shows the behaviour expected for a decrease of 20% hr-1.  
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                       (a) 
              
                     (b) 
                                       
                 (c) 
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                  (d) 
Figure 4.7: Extracellular metabolites that do not decrease at 20% h-1; (a) acetate; (b) 
fumarate, (c) pyruvate and (d) lactate. The dashed lines are merely a guide for the eye: in 
Fig 4.8a the line has a constant value. 
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A two-tailed t test analysis was performed to check whether the above data is consistent 
with the concentration decreasing at the same rate as medium replacement. For ethanol, 
formate and succinate, this test has proved that the data are consistent with the 
concentration decreasing at 20% % hr-1 (the calculation t value is less than t statistic; so the 
null hypothesis cannot be rejected) (Table 4.4). Therefore these data are consistent with 
results reported by Trotter et al. (2011). However, acetate production was maintained as 
the t statistic value is higher than the calculation t. 
 
           Calculation Ethanol Formate Succinate Acetate 
  t statistic    2.16     2.16     2.16    2.16 
          calculation t    1.75     1.97     1.64    60.31 
 
Table 4.4: A two-tailed t test (p = 0.05). This test was performed to calculate the 
significance of data decreasing at 20% h-1. Calculation of t statistic was done by using this 
formula;  
t=(slope-target slope)/error in slope 
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4.2.3.2 Intracellular metabolite 
 
Intracellular metabolite concentration can be measured based on one of two methods: 
relative to an internal standard of known concentration, or based on cell volume. Measuring 
intracellular metabolite concentration is challenging compared to extracellular metabolites 
since no internal standard can be used directly in order to perform the measurement. 
Previously, TSP was used as an internal standard for both extracellular and intracellular 
metabolites, but this gives no absolute value for the intracellular concentration without 
further information. As discussed in section 3.4 and 3.6, measurement based on cell volume 
was chosen to present the intracellular metabolite concentration data. This well-established 
method presents a more consistent result compared to the other method based on internal 
standard. Information on the stability of the concentration of the internal standard is 
lacking, which indicated that we cannot use that method to measure the metabolite 
concentration.  The measurement was used to calculate an intracellular concentration as 
described in section 3.4.2.   
 
Similar to extracellular spectra, formate is dominating the intracellular extracts with the 
highest concentration, 96 mM. It was concluded above that the extracellular metabolite 
profile was consistent with immediate cessation of secretion of succinate and formate on 
introduction of oxygen. We may therefore expect that intracellular concentrations of 
formate and succinate would decrease rapidly on introduction of oxygen. As shown in Figure 
4.8, the concentrations of these two metabolites do indeed decrease at approximately 20% 
hr-1 after the start of the transition to aerobic growth. The concentration of intracellular 
ethanol cannot be determined because it is lost during the extraction process.  
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      (a) Formate 
                                                          
               (b) Succinate 
Figure 4.8: Intracellular metabolites that decrease at approximately 20% hr-1; (a) formate; 
(b) succinate. The green curve shows the behaviour expected for a decrease of 20% hr-1. 
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The concentration of intracellular acetate does appear to drop slightly after start of the 
transition, but then remains approximately steady. This is again consistent with the 
observations of extracellular acetate, which remained roughly constant, suggesting 
continued production of intracellular acetate. The concentrations of intracellular putrescine 
and acetyl aspartate, and probably also of fumarate, remain constant during the transition. 
This is by contrast to the extracellular concentrations, which increase. This is discussed 
below. 
 
The most interesting result is that the concentration of pyruvate remains approximately 
constant across the time period.  Considering the very large changes in fluxes through 
metabolic pathways, this result is a surprise. As oxygen is introduced, we expect PFL to be 
inhibited instantly, stopping metabolism of pyruvate by this route. Although PDHC is 
expressed even under anaerobic conditions (Trotter et al 2011), it is at low levels, and a 
change to aerobiosis leads to a marked upregulation of PDHC expression over approximately 
the first 30 minutes (Partridge et al. 2006). Thus, transcriptomic data implies that PDHC 
should be present only at low levels under anaerobic conditions, and would rise to typical 
aerobic levels 30-60 minutes after the introduction of oxygen. In turn, this implies that for 
the first 30 minutes, the pyruvate produced continuously by glycolysis should have almost 
no route to further metabolism and should rise to very high concentrations in the cell. An 
analysis of gene activity in the cell after transition to aerobic conditions found a pattern of 
gene expression consistent with PdhR being inhibited by high concentrations of pyruvate 
(Trotter et al., 2011). In addition, the rise and subsequent fall of pyruvate concentration 
outside the cell over the first 2 hours after transition implies very significant amounts of 
secretion of pyruvate from the cells: the obvious cause being a high level of pyruvate inside 
the cell. Thus, a large number of results imply that the concentration of pyruvate inside the 
cell should rise to very high levels (of the order of 500 mM) soon after introduction of 
oxygen. However, the results shown in Figure 4.9c show this not to be the case. There are 
several possible explanations of this discrepancy. These are discussed below. However first 
it was thought sensible to check whether pyruvate levels are in fact high using an assay for 
pyruvate. 
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             (a): Formate, Acetate and Succinate 
 
                                  
                                  (b): Lactate, Putrescine and Acetyl aspartate 
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                        (c): Pyruvate and Fumarate 
 
Figure 4.9: Metabolite concentration of intracellular metabolites; (a) formate, acetate and 
succinate; (b) lactate, putrescine and acetyl aspartate; (c) pyruvate and fumarate during 
the transition from anaerobic to aerobic. These data resulted from three replicates. 
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4.2.4 Pyruvate assay 
 
This experiment was performed to measure the pyruvate concentration inside the cell 
during the transition from anaerobic to aerobic, because it is not clear how extracellular 
pyruvate can increase significantly and then decrease if the intracellular concentration 
apparently remains very low. Pyruvate concentration was measured by rapid quenching 
followed by use of a kit. This pyruvate assay kit (BioAssay System) used a single Working 
Reagent that combines pyruvate oxidase and hydrogen peroxide determination in one step. 
The principle of the kit is that pyruvate is oxidised by pyruvate oxidase via enzyme reactions 
to generate acetate, carbon dioxide and hydrogen peroxide (H2O2). H2O2 then reacts with 
the Dye Reagent to form the colour. The colour intensity of the reaction was measured at 
570 nm, which is directly proportional to pyruvate concentration in the sample. The OD of 
the samples was plotted against pyruvate standard curves (Figure 4.10a) and the pyruvate 
concentration was calculated. Figure 4.10b shows that the level of pyruvate is highest at 0 
min (12 mM) and decreases after the introduction of air to 6 mM at 120 min. This result 
compares reasonably well with the result from NMR (Figure 4.11). Table 4.5 summarises the 
intracellular pyruvate concentration from the assay during the transition. The significance of 
this result is discussed in Section 4.3. 
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                                       Figure 4.10a: Pyruvate standard curve 
 
                               
Figure 4.10b: Pyruvate assay on WT intracellular extracts on transition from anaerobic to 
aerobic. The cells were assayed at 570 nm and the concentration of pyruvate was 
measured. 
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Figure 4.11: Graph comparing the concentration of intracellular pyruvate and the pyruvate 
concentration obtained from assay. 
 
  Time after transition (min)   Pyruvate concentration (mM) 
   0    13.8 
    10    10.6 
    30    12.3 
    60    11.4 
   120    6.9 
 
Table 4.5: Pyruvate assay on WT intracellular cells on transition from anaerobic to aerobic. 
The cells were assayed at 570 nm and the concentration of pyruvate was measured. 
Pyruvate 
concentration 
from assay 
Intracellular 
pyruvate 
concentration 
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4.2.5 Detection of unknown peak 
 
A possibly significant observation that can be seen by NMR is the presence of an unknown 
peak after the introduction of air (Figure 4.12). The peak was detected at 30 and 60 min 
while no peak appears at 0 min. It had disappeared again by 120 minutes. This kind of 
behaviour is what was expected for pyruvate based on the time dependence of the 
extracellular pyruvate (a transient rise followed by decay), although with much higher 
concentration than the unknown peak here, which only reaches about 1 mM maximum. This 
is the only signal in the intracellular spectra that shows behaviour like this. The peak may 
therefore provide some clue about changes in metabolism. Further identification of the 
unknown peak was attempted using HPLC and NMR. 
 
                     
Figure 4.12: Detection of unknown peak at 30 and 60 min after the transition from 
anaerobic to aerobic. No peak was detected in the 0 min sample, and it had almost 
disappeared again by 120 minutes. 
Unknown peak 1.53 ppm 
   0 min 
   30 min 
   60 min 
  120 min 
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The chemical shift of the unknown peak varied with the pH of the sample, implying that it 
may be from a metabolite with a titratable group, such as a carboxylic acid. The chemical 
shift, together with its lack of observable J coupling, implies that it is a methyl signal. A 
natural abundance 13C HSQC spectrum (Figure 4.13) shows that the attached carbon has a 
chemical shift of 25.9 ppm, confirming its likely assignment as a methyl group. A long-range 
HMQC spectrum (Figure 4.14) is ambiguous, but implies that the methyl carbon is 1-2 bonds 
away from other carbons with chemical shifts of 61.3 and 39.0 ppm. 
 
It would help a lot to get an NMR spectrum of the pure compound. Therefore the 30-minute 
sample was run down an HPLC column. If this is a low molecular weight carboxylic acid then 
it may be possible to separate it either using an anion exchange column, or a reverse phase 
column at low pH where the carboxylic acid should be protonated. Separations were 
therefore tried using a C-18 column. The unknown peak is quite likely to have no UV 
absorbance, and so NMR spectra were run on freeze-dried fractions from the column. 
Spectra acquired at 4, 5 and 6 minutes are shown in Figure 4.15. It can be seen that there is 
a small degree of purification of the unknown, but not enough to identify the signals from 
the unknown. The results shown in Figure 4.15 are the best separation achieved. 
Accordingly, to date it has not been possible to purify the unknown peak to any useful 
degree. 
 
There are now a number of databases of metabolites, which may be useful for identifying 
the unknown from the small number of chemical shifts available. The shifts obtained were 
put through a range of databases, namely Biological Magnetic Resonance Data Bank (BMRB, 
http://www.bmrb.wisc.edu/metabolomics/), Spectral Database for Organic Compounds 
(SDBS, http://riodb01.ibase.aist.go.jp/sdbs/cgi-bin/cre_index.cgi?lang=eng), COLMAR 
(http://spinportal.magnet.fsu.edu/), the Human Metabolome Database 
(http://www.hmdb.ca/), the Metabolomics Database of Linkoping (MDL, 
http://www.liu.se/hu/mdl/main/), and the PRIME database (http://prime.psc.riken.jp/). A 
number of hits were found, but most were chemically unreasonable. The most promising 
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results came from using the ACD/Labs software, generously made available by Dr V Paget of 
ACD/Labs. This software suggested that possible matches might be the types of compounds 
shown in Figure 4.16a. These compounds share a common structural feature as shown in 
Figure 4.16b, which is interesting because it could be formed by reaction of pyruvate. It is 
therefore possible that the unknown is some kind of adduct of pyruvate. One obvious 
possibility is that the unknown peak could simply be the hydrate of pyruvate, which in water 
is in equilibrium with the non-hydrated form, as discussed in Chapter 3. This was checked by 
spiking and shown not to be the case (chemical shift for pyruvate hydrate is 1.47 ppm, and 
unknown peak is 1.53 ppm). The similarity in shifts does however strengthen the possibility 
of the unknown being an adduct of pyruvate. This result therefore again provides indirect 
evidence to suggest that intracellular pyruvate concentrations could be high during the 
transition and then decrease after the first 60 minutes, in contrast to the intracellular NMR 
measurements, which suggest a fairly steady decrease. 
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Figure 4.13: A 13C HSQC spectrum of the unknown peak. The correlation for the 1H 
signal at 1.53 ppm (shown by an arrow) is at a 13C shift of 25.9 ppm. 
                     
Figure 4.14: A long-range HMQC spectrum of the unknown peak. The spectrum in 
black is the HSQC spectrum from Fig. 4.13. The spectrum in magenta is the long-
range HMQC. The possible long-range correlation is marked by a green arrow. 
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Figure 4.15: NMR spectrum of purified samples at 4, 5 and 6 mins separated by 
reversed phase chromatography. The purified samples were compared with non-
purified sample as shown above. 
 
 
   
 
 
  
Figure 4.16: (a) Structure of expected compound, (b) Structure of pyruvate 
Non-purified 
sample 
Sample at 4 min 
Sample at 5 min 
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4.3 Discussion  
 
Metabolomics aims to quantify the level of all intermediates of metabolism. Intracellular 
metabolites of selected pathways have been measured for several decades, mostly by 
enzymatic assays. The novel feature of metabolomics is the quest for system wide coverage 
of all metabolites. The increased coverage is facilitated by the recent advances in high-
throughput analytics. Metabolomics thus complements genomics, transcriptomics and 
proteomics in the systems biology approach to studying organisms.                                                                                                                                                                            
 
To gain better understanding into the regulation of E. coli metabolism, we studied the 
metabolic profile of E. coli at different oxygenation levels using NMR. The bacterial cultures 
were grown in a glucose-limited chemostat at a dilution rate of 0.2 h-1, where glucose is 
used as a cell-mass precursor and energy source. This was felt to be a suitable dilution rate 
because at higher dilution rates (above 0.4 h-1), glucose and acetate concentrations are 
increased while at low dilution rate, metabolism is oxidative and no formation of acetate 
occurs (Kayser et al. 2005). Steady-state chemostat cultures are an important tool for the 
study of metabolic changes because chemostats permit the system to be regulated to 
achieve a desired glucose consumption rate through the selection of dilution rate and also 
permit collection of metabolite information which represents itself at a steady state. Results 
in this chapter provide insights into metabolic regulation in E. coli as a model during the 
transition from fermentative to respiratory metabolism.  
 
Almost no metabolite accumulation was observed in the extracellular extracts during 
aerobic steady state compared to cells grown during anaerobic conditions (Figure 4.2a and 
Figure 4.3a). When oxygen is available, aerobic respiration allows the complete oxidation of 
glucose to yield CO2, NADH and acetyl-CoA, with the help of pyruvate dehydrogenase 
complex (PDHC) to generate ATP via electron transport chains. In fermentative metabolism, 
redox balance is achieved by the formation of the overflow metabolites acetate, ethanol, 
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formate and succinate (Figure 4.3a) to regenerate the NAD+ needed for use in glycolysis, as 
it is not going to be regenerated by electron transport chains, as happens in aerobic 
respiration. Anaerobic respiration is the incomplete oxidation of glucose and results in less 
energy production per glucose than aerobic respiration. This makes aerobic respiration the 
most preferred and productive metabolic mode when compared to anaerobic respiration. A 
large number of metabolites are present in the intracellular extract as presented in Figure 
4.2b. Bennett et al. (2009) have observed 103 metabolites that are present in glucose-grown 
E. coli cells, with a total observed intracellular metabolite pool of approximately 300 mM. 
Glutamate was the most abundant compound, followed by glutathione, fructose-1,6-
bisphosphate and ATP. Glutamate is derived from transamination of α-ketoglutarate, 
together with other products, like pyruvate and oxaloacetate. 
 
In order to understand more about adaptation of E. coli to low oxygen levels, the 
metabolites of this organism were analysed at different levels of oxygenation (section 4.3). 
The results show a decrease in formate and acetate production above 40% air. Both formate 
and acetate are major products of fermentative metabolism where pyruvate formate lyase 
(PFL) converts pyruvate to acetyl-CoA and formate. At higher oxygen concentration, the PFL 
activity is repressed and pyruvate dehydrogenase complex (PDHC) is activated, hence the 
aerobic pathway is activated too. A PFL-repair protein, YfiD, plays a major role during 
microaerobic condition as PFL has been destroyed by the lower amount of oxygen presence 
in this condition. Transcriptome studies by Partridge et al (2007) shows that yfiD is 
expressed maximally under microaerobic condition. Glucose consumed will be fully oxidised 
to water and carbon dioxide, which explains the decrease in concentration of formate and 
acetate at higher concentrations.  
 
This study shows that microaerobic condition is fully achieved with a rapid onset between 
40 - 60% air. It has previously been observed that under aerobic conditions FNR activity 
rapidly reduced ~ 15-fold lower than the anaerobic activity which indicates that the cell 
membrane has consumed sufficient oxygen to lower oxygen concentrations in the 
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cytoplasm (Trotter et al. 2011). This is consistent with transcriptome analysis on cytochrome 
bd terminal oxidase that has high affinity for oxygen, and is only upregulated under lower 
oxygen levels but not in anaerobic cultures (Partridge et al. 2006, 2007).    
 
The chemostat is working at a replacement rate of 0.2 hr-1. This means that if intracellular 
metabolism/secretion stops abruptly on introducing air, extracellular metabolite levels 
should decrease at 20% hr-1. This behaviour can be observed for formate and succinate, and 
approximately for ethanol, implying that they are not secreted once the transition to 
aerobic growth has begun.  
 
Formate is produced by PFL, and is a waste product, required for redox balance. It is 
therefore secreted by the cell. The stopping of formate secretion is therefore expected. 
Similarly, ethanol is produced by fermentation for redox balance. Succinate is another redox 
balance compound and is secreted during anaerobic growth. During early adaptation to 
aerobic conditions the dctA transcript (which encodes the C4-dicarboxylic acid transporter 
that transports succinate) increased 2-fold (Partridge et al. 2006), in agreement with the 
expectation that succinate could be taken up by the cell from the medium to be used again 
to feed the Krebs cycle. This may explain why the concentration of extracellular succinate 
appears to decrease by more than 20%/hr (Figure 4.6c).  
 
As can be seen in Figure 4.7a, the level of acetate remains stable, suggesting that acetate is 
being produced by the cells throughout the transition. Transcriptomic analysis showed that 
poxB transcripts were increased 2-5 fold at 15 and 60 min after the transition, which is 
consistent with the above results that acetate is generated in the presence of oxygen 
(Partridge et al. 2006). poxB is a gene that encodes pyruvate oxidase, which converts 
pyruvate to acetate  and CO2. 
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A small number of extracellular metabolite signals increase during the transition, in 
particular putrescine, acetyl aspartate and fumarate. Their concentrations are low, but 
significant. Surprisingly, the intracellular concentrations of these metabolites does not alter 
during the transition. Thus, it is not likely that the extracellular concentrations increase 
simply because the intracellular concentrations increase. Putrescine functions to bind to 
DNA and help to package it in the bacterial chromosome. During gene expression, 
putrescine is released from DNA. Thus, the secretion of putrescine from cells during the 
transition may be a consequence of increased gene transcription: although the 
concentration of intracellular putrescine does not change much, the amount of free 
putrescine (ie, not bound to DNA) may change significantly. The increase of fumarate during 
the transition may be related to the role of fumarate in anaerobic growth: fumarate is 
reduced to succinate in order to regenerate NAD+, and the succinate is secreted. When the 
cells start to grow aerobically, this pathway is no longer needed. Acetyl aspartate is not a 
known metabolite of E. coli (based on the EcoCyc E. coli database, www.ecocyc.org). It is 
therefore likely that this metabolite is not in fact acetyl aspartate, but we have not been 
able to identify a more likely candidate. 
 
The most interesting observation is the concentration of pyruvate. Extracellular pyruvate 
rises for the first hour of the transition and then decreases again. However, intracellular 
pyruvate is approximately constant in the NMR spectra, despite several indirect 
experimental results that suggest that it should increase to about 500 mM. Possible 
explanations for this behaviour include: 
 
a) NMR spectra only detect mobile molecules. If the pyruvate is somehow made 
immobile, for example by packaging into vesicles, polymerisation, or binding to some 
storage molecule, then it would not be seen. This explanation seems inherently 
unlikely: firstly because no such storage system is known (nor is one observed by 
transmission electron microscopy of these cells, as shown in Chapter 5), and 
secondly because even if such a system operated one would expect a transient 
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increase in pyruvate concentration to be visible by NMR. The fact that the pyruvate 
assay did not detect any increase in pyruvate inside the cell makes this idea even less 
likely. If pyruvate were involved in some sort of storage, then one would expect this 
to be in equilibrium with free pyruvate, so that removal of pyruvate by the assay 
should lead to release of pyruvate and thus a steady increase in observable pyruvate.  
 
b) Pyruvate could be secreted directly from the cell without going first into the 
cytoplasm. The most obvious way in which this could occur is that the enzymes 
involved in glycolysis could associate to the cell membrane and function to secrete 
pyruvate directly through a channel. It is remarkable that no pyruvate transporter in 
E. coli has been identified, but it would be surprising if such a channel did not exist. 
Precedents for such behaviour do exist, and are discussed in more detail in the next 
chapter. 
 
Because (a) seems so unlikely, and there are no other obvious explanations that we can 
think of, it is possible that (b) is the true explanation. If so, this would be a very interesting 
observation, being a striking metabolic change, with a good explanation (ie, to keep the 
intracellular concentrations of metabolites roughly constant and to prevent pyruvate 
concentrations building up to excessive levels), and an unusual phenomenon, particularly in 
bacteria. Therefore, further experiments were carried out to test the hypothesis that 
glycolytic enzymes associate with the cell membrane on introduction of air, leading to direct 
secretion of pyruvate. These experiments are described in the next chapter. 
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CHAPTER 5 
 
METABOLITE CHANELLING 
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5.0 Metabolite channelling 
 
5.1 Introduction 
 
The previous chapter showed that although extracellular pyruvate rises and then falls 
significantly during the transition of E. coli from anaerobic to aerobic growth, the 
intracellular concentrations are essentially unchanged, despite an expectation that levels of 
pyruvate could rise to as high as 500 mM because of loss of the activity of pyruvate formate 
lyase before the activity of the PDH complex is sufficient to deal with the flux through the 
glycolytic pathway. Thus the cells appear to work very hard to maintain homeostasis. The 
hypothesis to be investigated in this chapter is that a complex of glycolytic enzymes moves 
from a cytoplasmic location (where it is located during anaerobic growth) to the cell 
membrane, in order to be able to pump pyruvate directly out of the cell. In the present 
study, we investigated the movement of the pyruvate kinase enzyme pykF during the 
transition, whether it remained located in the cytoplasm or moved to the cell membrane. 
Possible movement of pykF following the transition from anaerobic to aerobic growth was 
investigated in three ways: first, by assaying pyruvate kinase activity in cytoplasmic and 
membrane fractions; second, by labelling chromosomal pykF with green fluorescent protein 
(GFP) and using fluorescence microscopy; and third, by labelling chromosomal pykF with a 
FLAG-tag and using immunohistology to determine the location of pykF. 
 
Modification of chromosomal genes is not simple. A recently developed powerful technique 
for efficient in vivo genetic manipulation of bacteria, termed recombineering 
(recombination-mediated genetic engineering), has the advantage of using short 
homologous DNA. It is mediated by bacteriophage-based recombination systems such as 
the Red system, RecET or others. The system was first described in E. coli (Datsenko and 
Wanner, 2000), but has since successfully been applied to other bacteria, for example, 
Salmonella (Husseiny and Hensel, 2005), Shigella (Beloin et al., 2003), Serratia (Rossi et al., 
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2003) and Yersinia (Derbise et al., 2003). It is now widely used for a variety of purposes: the 
construction of chromosomal gene knockouts, deletions, insertions and point mutations. 
Briefly, recombineering is performed by introducing linear DNA substrates containing the 
desired change and short homologies to the target DNA into cells expressing the phage-
encoded recombination enzymes. These enzymes recombine the linear DNA at the target, 
yielding recombinant molecules. 
 
Normally, linear DNA introduced into E. coli is degraded by the powerful RecBCD nuclease. 
Linear DNA recombination systems in E. coli were developed by finding ways to inhibit the 
intracellular exonucleases. In the Red system, the Gam protein inhibits the RecBCD nuclease 
and prevents it from attacking the linear DNA fragments, and Exo (a 5’-to-3’ exonuclease) 
and Bet (a single-strand DNA binding protein) generate recombination activity for the linear 
DNA. The length of the homologous region used for homologous recombination can be as 
short as 35-50 bp (Poteete, 2001; Court et al., 2002). Zhang et al. (1998) showed that RecET 
recombinase could be used to disrupt plasmid-borne genes with linear DNA fragments. 
Other researchers (Datsenko and Wanner, 2000; Yu et al., 2000) have made use of the 
advantages of the phage lambda Red (gam, bet, exo) that promotes a greatly enhanced rate 
of recombination when using linear DNA. Datsenko and Wanner (2000) used Red-mediated 
recombination for efficient deletion of specific genomic segments in E. coli, by replacing a 
chromosomal target with a linear DNA fragment that carries a selectable antibiotic 
resistance gene flanked by 50-nucleotide (nt) extensions that are homologous to selected 
sequences in the bacterial chromosome (Figure 5.1). Linear DNA is required for Red-
mediated recombination. This can be either a linear double-stranded DNA (dsDNA) 
generated by PCR or a short single-stranded DNA (ssDNA) oligonucleotide carrying 
homology to the target (Court et al. 2002). 
 
In yeast, genes can be directly disrupted by transformation with double-stranded DNA 
(dsDNA) fragments, created with PCR, that encode a selectable marker and have only about 
50 bp of flanking DNA that are homologous to the chromosome region of interest. However,  
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Figure 5.1: A simple gene disruption strategy. H1 and H2 refer to the homology extensions 
or to priming sites (Adapted from Datsenko and Wanner, 2000). 
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in E. coli, intracellular exonucleases, such as RecBCD, degrade linear DNA (Yu et al., 2000) 
and inhibit recombination with the PCR products.  
 
Here we describe an adaptation of the lambda Red-based methodology for use with E. coli, 
in which chromosomal single gene deletions were generated using a 2-step PCR product 
containing 40-nucleotide flanking regions that are homologous to the target sequence. 
Pyruvate kinase is the key enzyme in this study as it catalyses the transfer of phosphate 
group from PEP to ADP generating pyruvate and ATP in the final stage of the glycolytic 
pathway. There are two isoenzymes of pyruvate kinase; PykF and PykA. PykA contributes 
little to pyruvate kinase activity and the specific activity is much lower compared to PykF 
(Garrido-Pertierra and Cooper, 1983; Ponce et al., 1995). Therefore pykF was targeted in 
this study. 
 
5.2  Results 
 
5.2.1 Pyruvate kinase (PK) enzyme assay 
 
An experiment was carried out to look at the pyruvate kinase activity of E. coli during the 
transition from anaerobic to aerobic, by assaying supernatant and pellet samples at 0, 10, 
60 and 120 min. PK activity was measured by rapid quenching and sonicating followed by 
use of a kit (Pyruvate kinase assay kit, Abcam). In the assay, the reaction between PEP and 
ADP is catalysed by PK to generate pyruvate and ATP. The generated pyruvate is oxidised by 
pyruvate oxidase via enzyme reactions to generate acetate, carbon dioxide and hydrogen 
peroxide (H2O2). H2O2 then reacts with the Dye Reagent to form the colour. The colour 
intensity of the reaction was measured at 570 nm. Since the increase in color intensity is 
proportional to the increase in pyruvate amount, the PK activity can be accurately 
measured. Figure 5.2 shows that the PK activity goes up 10 min after introduction of air for 
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both pellet and supernatant samples. The graph also shows that the PK activity in 
supernatant is higher than in the pellet. The hypothesis suggests that PK activity should 
move to the membrane shortly after introduction of air, and thus that the PK activity in the 
pellet should become much higher after the introduction of air, and conversely the activity 
in the soluble fraction should be reduced. However, the results clearly do not show the 
expected result. There are many possible reasons for this, of which a likely one is that the 
cell breakage and subsequent washing steps needed to separate the supernatant from the 
pellet disrupted any membrane complexes formed. In other words, it may be necessary to 
use a more in vivo-like measurement. We therefore decided to tag the PK enzyme with 
either GFP or 3XFLAG in order to get a clear picture of the location of pyruvate. 
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Figure 5.2: Pyruvate kinase assay on WT during the transition from anaerobic to aerobic 
cells. Both the supernatant and pellet samples were assayed at 570 nm and the 
concentration of pyruvate was measured at 0, 10, 60 and 120 mins. 
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5.2.2  Creation of mutants by linear transformation 
 
To investigate the movement of pyruvate through the cell, two mutants (pykF-GFP and 
pykF-3xFLAG) were constructed by the method of linear transformation (Section 2.6). The E. 
coli strain MG1655 was selected as the parental strain and resulting mutants were created 
through the insertion of a kanamycin resistance cassette, which not only disrupted the gene 
of interest but also facilitated mutant isolation as a selectable marker (KanR). Constructions 
of the two different pykF-tag mutants were achieved in collaboration with Dr Matthew Rolfe 
and Prof Jeff Green at the University of Sheffield. The schematic diagram for creating the 
fusions is presented as below (Figure 5.3). 
 
 
 
 
 
 
 
 
 
Figure 5.3: Construction of pykF-tag fusions. The linear PCR product is introduced by 
electroporation into cells induced for the Red recombineering functions. The Red functions 
catalyse the insertion of the cassette at the target site, which is on the bacterial 
chromosome.  
E. coli chromosome 
pykF STOP 
Linear PCR product 
Intergenic 
region 
pykF 
STOP 
TAG kanr 
pykF-tag 
pykF STOP 
Intergenic 
region TAG kan
r 
λ-red mediated recombination 
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For pykF-GFP fusion, oligonucleotide primers (pykF-GFP_PCR1F, pykF-GFP_PCR1R) were 
used to amplify (Section 2.6.2) the coding sequence of GFP from a plasmid (pGFPmut3.1), 
using high fidelity Taq polymerase. The forward primer has a 5’ end that is identical to the 
end of the pykF gene (40 bp) while the reverse primer has a 5’ end that would amplify the 
kanamycin resistance cassette from pKD4 (20 bp). The purified PCR products were then 
used as a forward primer to amplify the kan cassette. A 40 bp region of homology was 
added to the end of the kan cassette by pykF-GFP_PCR2R, which is homologous to the 
intergenic region downstream of pykF. The respective 2.3 kbp PCR products were purified 
(Figure 5.4a), treated with DpnI, and then transformed into bacteria carrying the Red helper 
plasmid (Section 2.6.3.2 and 2.6.4). Kanamycin resistant colonies were selected and 
chromosomal disruption of pykF was confirmed by PCR using the primer pair, pykF_CheckF 
and pykF_CheckR (Section 2.6.5). Reaction products were analysed by agarose gel 
electrophoresis (Section 2.5.2) to confirm the region (Figure 5.5).  
 
For pykF-3XFLAG fusion, the first PCR reaction was to amplify the kanamycin resistance 
cassette from pKD4 using primers that add a 3XFLAG tag and stop codon (pykF-
3XFLAG_PCR1F), and a 40 bp region of homology (using primer pykF-3XFLAG_PCR1R) 
downstream of the cassette. The purified PCR products from PCR 1 were used as a template 
to add a 40 bp region of homology upstream (using primer pykF-3XFLAG_PCR2F) and the 
downstream end was simply reamplified by using primer pykF-3XFLAG_PCR2R. The purified 
PCR product (1.7 kbp) (Figure 5.4b) was introduced by electroporation into competent cells 
expressing the lambda-red recombinase from the pKD46 plasmid. Disruption was again 
confirmed by PCR using the same primer pair, pykF_CheckF and pykF_CheckR, and analysed 
by agarose gel electrophoresis (Figure 5.5). A schematic diagram for both pykF-GFP and 
pykF-3XFLAG mutants is shown in Figure 5.6 (a) and (b). 
 
P1 phage was used to transduce the constructs into the bacterial chromosome as stable 
single-copy insertions (section 2.7.2). The presence of a single-copy chromosomal fusion 
was confirmed by streak testing (section 2.7.3).  The constructs were further verified by DNA 
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sequencing. The sequences were analysed and aligned manually using the Bioedit program 
(Figure 5.7a for pykF-GFP and Figure 5.7b for pykF-3xFLAG). The results confirmed the 
presence of the fusion constructs on the chromosome.  
 
 
                                          
        (a) pykF-GFP                                                         (b) pykF-3xFLAG   
Figure 5.4: PCR purification of (a) pykF-GFP, lane 1: DNA markers; lane 2: Negative control; 
lane 3-4: pykF-GFP and (b) pykF-3XFLAG, lane 1: Negative control; lane 2-3: pykF-3XFLAG; 
lane 4: DNA markers.  
*Primers used to generate (a) pykF-GFP are: pykF-GFP_PCR1F, pykF-GFP_PCR1R and pykF-
GFP_PCR2R; and (b) pykF-3xFLAG are: pykF-3XFLAG_PCR1F, pykF-3XFLAG_PCR1R, pykF-
3XFLAG_PCR2F and pykF-3XFLAG_PCR2R.  
 
 
          1          2        3         4     1         2           3           4 
2.3 kb 
1.7 kb 
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Figure 5.5: PCR verification of E. coli mutants. Lane 1: DNA markers; Lane 2: WT (control); 
Lane 3-4: pykF_GFP; Lane 5-6: pykF_3XFLAG. Results confirmed the tagging of GFP and 
3xFLAG to the pykF sequence and insertion of the linear DNA into the chromosome by PCR 
using the primer pair, pykF_CheckF and pykF_CheckR. 
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Figure 5.6a: Creating the pykF-3xFLAG linear PCR product. A linear PCR product containing 
the regions of homology, the kanamycin resistance marker, 3xFLAG tag and stop codon was 
generated using two-step PCR. 
PCR 1 Incorporate ‘forward’ 3xFLAG-STOP 
& ‘reverse’ region of homology 
Linear PCR product 
pykF 3xFLAG STOP kanr 
Intergenic 
region 
PCR 2 Incorporate ‘forward’ region of 
homology (removing 
chromosomal stop codon) 
Primer 2R 
Primer 2F 
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Figure 5.6b: Creating the pykF-GFP linear PCR product. A linear PCR product containing the 
regions of homology, the kanamycin resistance marker, GFP tag and stop codon was 
generated using two-step PCR. 
PCR 1 Amplify GFP from pGFPmut3.1 
adding a ‘forward’ region of 
homology to pykF (removing 
chromosomal stop codon) and 
adding ‘reverse’ sequence 
corresponding to kanr 
PCR 2 Amplify kanr from pKD4 using 
product from PCR1 as the 
forward primer and adding a 
‘reverse’ region of homology to 
pykF 
pGFPmut3.1 
GFP Primer 1R 
Primer 1F 
pKD4 
kanr 
Primer 2R 
Primer 2F 
PCR 3 Amplify the whole linear product 
in a single PCR allowing efficient 
yields to be obtained 
Linear PCR product 
pykF GFP STOP kanr 
Intergenic 
region 
Primer 3R 
Primer 3F 
154 
 
 
   
               Gene layout before 
 
     
    Gene layout after 
 
AGCGGCACTACTAACACCGC ATCTGTTCACGTCCTGCGTA AAGGAGAAGAACTTTTCACT 
GGAGTTGTCCCAATTCTTGT TGAATTAGATGGTGATGTTA ATGGGCACAAATTTTCTGTC 
AGTGGAGAGGGTGAAGGTGA TGCAACATACGGAAAACTTA CCCTTAAATTTATTTGCACT 
ACTGGAAAACTACCTGTTCC ATGGCCAACACTTGTCACTA CTTTCGGTTATGGTGTTCAA 
TGCTTTGCGAGATACCCAGA TCATATGAAACAGCATGACT TTTTCAAGAGTGCCATGCCC 
GAAGGTTATGTACAGGAAAG AACTATATTTTTCAAAGATG ACGGGAACTACAAGACACGT 
GCTGAAGTCAAGTTTGAAGG TGATACCCTTGTTAATAGAA TCGAGTTAAAAGGTATTGAT 
TTTAAAGAAGATGGAAACAT TCTTGGACACAAATTGGAAT ACAACTATAACTCACACAAT 
GTATACATCATGGCAGACAA ACAAAAGAATGGAATCAAAG TTAACTTCAAAATTAGACAC 
AACATTGAAGATGGAAGCGT TCAACTAGCAGACCATTATC AACAAAATACTCCAATTGGC 
GATGGCCCTGTCCTTTTACC AGACAACCATTACCTGTCCA CACAATCTGCCCTTTCGAAA 
GATCCCAACGAAAAGAGAGA CCACATGGTCCTTCTTGAGT TTGTAACAGCTGCTGGGATT 
ACACATGGCATGGATGAACT ATACAAATAAGTGTAGGCTG GAGCTGCTTCGAAGTTCCTA 
TACTTTCTAGAGAATAGGAA CTTCGGA 
     
Figure 5.7a: Manual alignment of DNA sequence of pykF-GFP by using BioEdit software. 
Sequence in grey respresents pykF sequence; green: GFP; red: stop codon and blue: 
kanamycin resistance cassette. 
pykF GFP STOP kanr 
Intergenic 
region 
pykF STOP 
Intergenic 
region 
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Gene layout before 
 
 
Gene layout after 
 
AGCGGCACTACTAACACCGC ATCTGTTCACGTCCTGGATT ACAAAGATCACGACGGCGAT 
TATAAAGACCATGATATCGA TTATAAAGATGACGACGATA AATAATATTGCTTGTGTAGG 
CTGGAGCTGCTTCGAAGTTC CTATACTTTCTAGAGAATAG GAACTTCGGAATAGGAACTT 
CGAGATCCCCCACGCTGCCG CAAGCACTCAGGGCGCAAGG GCTGCTAAAGGAAGCGGAAC 
ACGTAGAAAGCCAGTCCGCA GAGACGGTGCTGACCCCGGA TGAATGTCAACTACTGGGCT 
ATCTGGACAAGGGAAAACGC AAGCGCAAAGAGAAAGCAGG TAGCTTGCAGTGGGCTTACA 
TGGCGATAGCTAGACTGGGC GGTTTTATGGACAGCAAGCG AACCGGAATTGCCAGCTGGG 
GCGCCCTCTGGTAAGGTTGG GAAGCCCTGCAAAGTAAACT GGATGGCTTTCTTGCCGCCA 
AGGATCTGATGGCGCAGGGG ATCAAGATCTGATCAAGAGA CAGGATGAGGATCGTTTCGC 
ATGATTGAACAAGATGGATT GCACGCAGGTTCTCCGGCCG CTTGGGTGGAGAGGCTATTC 
GGCTATGACTGGGCACAACA GACAATCGGCTGCTCTGATG CCGCCGTGTTCCGGCTGTCA 
GCGCANGGGCGCCCGGTTCT TTTTGTCAAGACCGACCTGT CCGGTGCCCTGAATGAACTG 
CAGGACGAGGCAGCGCGGCT ATCGTGGCTGGCCACGACGG GCGTTCCTTGCGCAGCTGTG 
CTCGACGTTGTCACTGAAGC GGGAAGGGACTGGCTGCTAT TGGGCGAAGTGNCGGGGCAG 
GATCTCCTGTCATCTCACCT TGCTCCTGCCGAGAAAGTAT CCATCATGGCTGANGCAATG 
CGGCGGCTGCATACGCTTGA TCCGGCTACCTGCCCATTCN ACCACCAAGCGAAACATCGC 
ATCGAGCGGGCACGTACTCG GATGG 
   
Figure 5.7b: Manual alignment of DNA sequence of pykF-3xFLAG by using BioEdit 
software. Sequence in grey represent pykF sequence; yellow: 3xFLAG tag; red: stop codon; 
black: a linker and blue: kanamycin resistance cassette. 
pykF 3xFLAG STOP kanr 
Intergenic 
region 
pykF STOP 
Intergenic 
region 
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5.2.3 Functionality of the tags 
 
Functionality of the tags was checked by looking at the constructs under fluorescence 
microscope (for pykF-GFP) and western blotting, as well as transmission electron 
microscopy (TEM) (for pykF-3xFLAG). 
  
5.2.3.1 Western blotting 
 
After verification by PCR amplification and DNA sequencing, the functionality of 3xFLAG tag 
was analysed by Western blotting. Whole cell extracts were separated by SDS-PAGE and 
proteins transferred to nitrocellulose membranes, which were then probed with primary 
antibody specific to the tag (section 2.8.2.2). The membranes were then washed and probed 
with secondary antibody conjugated to horse-radish peroxidase. Figure 5.8 shows the 
Western blot of the purified constructs that was probed with Anti-FLAG (Sigma). The result 
clearly indicates a detection of pykf-3xFLAG tag fusion protein with exposures as short as 1 
min. Positive control used is pET-21a(FLAG). It is an expressed FLAG tag in E. coli and was 
obtained from Lab F10, University of Sheffield (Lanes 3 and 7). This positive control should 
give a band, but after several trials, we were unable to observe any band for it. Even though 
there is no positive control to compare with, we strongly believe that the bands observed 
were the expected pykF-3xFLAG as it was consistently detected from several trials. 
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Figure 5.8: Western blot analysis of pykF-3xFLAG construct using Anti-Flag antibody. Lane 
1 and 5: Prestained protein marker (Bio-Rad), Lane 2 and 6: pykF-3xFLAG, Lane 3 and 7: 
positive control {pET21-a(FLAG)}, Lane 4: WT.  
     1         2          3         4         5          6          7       
~ 53 kDa 
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5.2.3.2 Fluorescence microscopy (GFP tag) 
 
The green fluorescent protein (GFP) from jellyfish retains its ability to fluoresce in vivo when 
expressed in other organisms, including bacteria (Chalfie et al. 1994). GFP has several 
features that make it an attractive candidate for protein localisation studies in bacteria. 
Several studies have demonstrated the applications of GFP as a reporter in protein 
localisation in E. coli (Feilmeier et al. 2000; Renzette et al. 2005). In this study, GFP was used 
to examine the movement of pykF enzyme inside the cell. To do this, a fusion construct of 
pykF with GFP was made as described in section 5.2.2. The verified construct was then 
grown in the chemostat and sampled at 0 and 30 min after the introduction of air. The cells 
were fixed immediately in paraformaldehyde-glutaraldehyde solution and placed on poly-L-
lysine microscope slides (section 2.9). The images were acquired on an Olympus BX61 
upright microscope fitted with a 100x (NA 1.4) oil objective with help from Dr Darren 
Robinson from the Light Microscopy Facility, University of Sheffield. Figure 5.9a shows a 
fluorescence microscopy image for the 0 min sample while Figure 5.9b shows an image for 
the 30 min sample. We expected to see that the fluorescence is uniformly distributed on the 
0 min cells, while the fluorescence in the 30 min cells will move to the cell membrane.  
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       Figure 5.9a: Fluorescence microscopy images of pykF-GFP fusion protein at 0 min.   
                       
        Figure 5.9b: Fluorescence microscopy images of pykF-GFP fusion protein at 30 min.   
6 µm 
6 µm 
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The fluorescent E. coli cells can be seen clearly, although the intensity of fluorescence is not 
very great, possibly because pykF is not over-expressed, but is present simply at the same 
abundance as the chromosomal copy. This leads to rather high background in these images. 
The disappointing result is that no change in the location of fluorescence can be observed. 
The optimal resolution obtainable from this microscope is approximately 0.2 μm (200 nm), 
being limited by the diffraction limit, a consequence of the wavelength of green light. The 
width of an E. coli cell is approximately 1 μm, implying that it should be possible to see a 
relocalisation of the fluorescence. However, the cell dimensions are close to the resolution 
of the technique, and it was therefore not unexpected to have no observable effect using 
this method. 
 
5.2.3.3 Transmission electron microscopy (TEM) 
 
We therefore took advantage of immunogold labeling to visualise the movement of pykF-
3xFLAG inside the cells. As in the previous section, cells were grown anaerobically in a 
chemostat, and then sampled either during anaerobic growth or 30 min after the transition 
to aerobic growth. The cells were fixed immediately (during the quenching) using 
paraformaldehyde – glutaraldehyde, and then dried, embedded in resin, and sectioned.  The 
ca. 75 μm thick sections were deposited on fomvar coated nickel grids and immunogold 
labeled with primary anti-FLAG and secondary antibodies conjugated with 10 nm gold 
particles. Primary anti-FLAG antibody has been used successfully in a non-denaturing 
application, namely immunoprecipitation (Civiero et al. 2012). The fractions were then 
negatively stained with uranyl acetate and observed directly under TEM.  
 
Figure 5.10 shows TEM images of immunogold labeled samples; (a) and (b) represent 0 min 
samples and (c) and (d) represent 30 min samples. The nanogold label was observed to be 
uniformly distributed, mainly within the cytoplasm but also close to the cell and outer 
membrane, on the 0 min samples (Figure 5.10a and 5.10b), suggesting that the pykF enzyme 
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is located mainly inside the cells during anaerobic conditions. But pykF was observed to 
move significantly to the cell membrane during the transition to aerobic growth (Figure 
5.10c and 5.10d). Approximately 102 images from the 0 and 30 min samples were analysed 
and scored based on the location of the gold particles (Table 5.1). The scoring shows that 
most of the enzyme was located inside the cells during anaerobic conditions (82%), 10% in 
the cell membrane and 7% in the outer membrane. Thirty minutes after introduction of air, 
the percentage of gold particles on the cell membrane is increased to 17%, as well as on the 
outer membrane with the same percentage. This suggests that the enzyme did move to the 
cell membrane when oxygen is present, though not to such a large extent as expected. 
Although the observation of nanogold particles in the outer membrane is unexpected, this 
result does support the hypothesis that the pykF enzyme is associated with cell membrane 
after the introduction of air.   
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(c)        (d) 
Figure 5.10: Transmission immunogold electron micrographs showing the location of pykF-
3xFLAG inside E. coli cells. The arrows show immunogold labelling of 0 min (a and b) and 30 
min samples (c and d). The sections were labeled with anti-FLAG antibodies coupled to 10 
nm nanogold particles, which are observable as intensely black circular particles. The yellow 
arrow shows a cell membrane and the blue arrow shows an outer membrane. The white 
circular objects inside the cells are probably artifacts of incomplete penetration of resin (Dr 
Chris Hill [EM facility], personal communication). 
(a) (b) 
(c) (d) 
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                                 Table 5.1: Percentage of scoring of gold particles in E. coli cells 
Location 0 min (%) 30 min (%) 
Intracellular     82     64 
Cell membrane     10     18 
Outer membrane     8     18 
   
 
5.3 Discussion 
 
The most important objective of this chapter is to look at the localisation of the pykF gene 
product inside the cells during the transition from anaerobic to aerobic. Results from the 
previous chapter (Chapter 4) show that the metabolome doesn’t do much during the 
transition.  Trotter et al. (2011) has shown that PFL (active under anaerobic conditions) is 
instantly killed when oxygen is introduced. The increases and decreases of external pyruvate 
(section 4.2.3.1) are consistent with the immediate loss of PFL and slow increase of PDHC 
activity as reported by Trotter et al. (2011). But our metabolic observation doesn’t show a 
very high level of internal pyruvate. This is a surprise as the growing cells continue to 
metabolise glucose to pyruvate, thus we expect the concentration of internal pyruvate 
should be high.  
 
The discrepancy may be explained in several ways. It is possible that the metabolism of 
pyruvate is so fast that even using the rapid quenching technique, it is metabolised away 
before it can be seen inside cells. There is however no sign of potential metabolic products 
of pyruvate, except  for the very small rise and fall in the unknown metabolite signal in 
Chapter 4. There is a possibility that pyruvate is being stored or transported out. Storage 
granules are not common in bacteria, and there is no sign of such granules in the EM images 
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obtained (assuming that the white regions in the cells are artifacts and not granules).  The 
hypothesis behind the transport theory is that glycolytic enzymes may relocate to the cell 
membrane from the cytoplasm. In order to do this, we examined  the movement of pykF 
inside the cells. pykF is an isoenzyme of pyruvate kinase (with pykA), of which pykF is 
considered the main activity in E. coli (Emmerling et al. 2002; Siddiquee et al. 2004). It is a 
key enzyme that catalyses the conversion of PEP to pyruvate and ATP. The work started by 
making two pykF fusions; one with 3xFlag and another one with GFP.  
 
We have adapted recombineering technology to efficiently construct targeted mutations on 
the chromosome of E. coli. It was felt to be important to use chromosomally regulated and 
synthesised genes, to avoid potential problems from unphysiological concentrations of pykF. 
This strategy has been shown to promote high efficiency gene replacement with such 
substrates in E. coli K-12. (Murphy, 1998). The mutagenesis process could be simplified by 
electroporating a PCR product that contains an antibiotic cassette flanked by sequences 
homologous to the targeted DNA into a strain expressing the lambda red system.  The 
presence of the specific PCR product promotes the deletion of the chromosomally located 
targeted region via homologous recombination. A two-step strategy of PCR was performed 
to create pykF-GFP and pykF-3XFLAG fusions. The linear DNA substrate is made by PCR 
amplification of flanking regions that are homologous to the target sequence. These primers 
consist of 40 bases of homology to the target region, where the tag is to be inserted, 
followed by 20 bases to prime the antibiotic cassette. The PCR fragment is introduced via 
transformation into competent cells that have been induced for the Red system. We 
encountered considerable difficulty to electroporate the constructs into the bacterial 
chromosome with the λ Red proteins encoded on a temperature sensitive, ampicillin 
resistant plasmid pKD46. In the final successful strategy we used SL1344pSIM18, in which 
pSIM18 is a temperature-sensitive origin (ori101) and compatible with both ColE ori and 
oriS. This temperature-sensitive origin is useful for removing the pSIM plasmid itself. As 
shown by Chan et al. (2007) the PL promoter in pSIM is controlled by a temperature-
sensitive lambda phage cI857 repressor. 
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Recombination with long (~1 kb) linear dsDNA carrying flanking target homologies requires 
all three λ Red functions, Gam, Beta and Exo (Murphy, 1998; Zhang et al. 1998; Yu et al. 
2000). The λ Red system has been shown to be efficient to work on short homologies. β 
protein promotes efficient in vivo recombination with ssDNA (Ellis et al 2001). 
Recombineering requires that the single-strand regions of the incoming linear DNA bound 
by the Beta protein are annealed to complementary single-strand gaps arising at the 
replication fork during DNA replication. The Gam protein inhibits the E. coli RecBCD and is 
not absolutely required for recombineering but increases the frequency of dsDNA 
recombination up to 20-fold (Datta et al. 2008).  Host DNA polymerases like PolA and DNA 
ligase play an important role in the recombination process completion (Yu et al. 2003). 
 
The pykF fusion constructs were verified by PCR and DNA sequencing analysis. For pykF-
3xFlag, it has been detected by Western blot analysis (section 5.2.3.1) with an anti-Flag 
antibody. Localisation of pykF in E. coli during the transition was observed by TEM (section 
5.2.3.3). In anaerobic conditions, the nanogold label was distributed uniformly inside the 
cells but moved to the cell membrane when oxygen is present. There is a significant 
redistribution of the gold label to both the cell and outer membranes 30 min after 
introduction of air. The reason why the enzyme moves to the outer membrane is unknown, 
but this result does support our initial hypothesis and may explain the missing pyruvate. The 
relocation of pykF to the cell membrane is less dramatic than expected. It is possible that 30 
min is too late: transcriptional changes were observed as early as 30 s after the introduction 
of air, and by 30 min many of the metabolic changes are complete (Trotter et al. 2011). This 
investigation will therefore be extended to look at 2 and 5 min time points to get a clearer 
picture of the movement of pykF after the transition. 
 
Investigation of the pykF-GFP fusion by fluorescence microscopy did not give much 
information on the localisation of pykF due to limitations on the microscopy that cannot 
resolve the GFP very well. The cells were expressing GFP but we cannot see any change in 
the distribution of the enzyme inside the cells. The cells were initially fixed in 0.2% 
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glutaraldehyde but we have increased this to 10% to have more rigid cross-linking and 
cytoplasmic detail. Glutaraldehyde in particular provides a rapid cross-linking but causes 
high background fluorescence compared to formaldehyde fixation. It is not unexpected to 
be unable to see any change in the fluorescence. Similarly, the lack of any effect in the 
enzyme assay was expected because this procedure requires cell disruption and physical 
separation of the membrane fraction from the cytoplasm, which could easily disrupt any 
membrane complexes formed. 
 
The potential relocalisation of pykF (and thus possibly of the entire glycolytic complex) to 
the cell membrane is a novel and very interesting observation. The existence of a glycolytic 
metabolon has been postulated for many years but has been a very controversial topic 
(Srere, 1987; Srere, 2000; Ovádi and Srere, 1992; Knowles, 1991). If such a complex can be 
clearly demonstrated, and shown to be regulated by oxygen, this would be an important 
advance in our understanding of bacterial metabolic regulation. In plants, there is 
reasonably good evidence for a regulatable glycolytic metabolon. 13C labelling studies 
showed that in Arabidopsis and potato roots, there is regulatable channelling all the way 
through from glucose in the cytoplasm to pyruvate within the mitochondrion, as well as 
colocalisation of glycolytic enzymes to the mitochondrial membrane (Graham et al. 2007). 
Mitochondria are generally believed to be derived from bacterial cells, and thus the 
mitochondrial membrane is similar to the bacterial cell membrane. Regulatable metabolic 
pathways have been demonstrated in other systems, for example in purine biosynthesis (An 
et al. 2008). In most of these examples, metabolite channelling is thought to work by the 
enzymes involved binding to membrane proteins and assembling into a complex on the 
membrane surface (Williamson, 2011). 
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CHAPTER 6 
 
GENERAL DISCUSSION AND 
CONCLUSION 
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6.0 General Discussion and Conclusion 
 
The work presented here has observed the metabolic changes of E. coli during the transition 
from anaerobic to aerobic conditions. The change at proteomic and transcriptomic levels 
has been well described (Partridge et al. 2006, 2007) but the changes at the metabolome 
level have not been characterised, as not much information on intracellular and 
extracellular metabolites is available. Extracellular metabolites are easy to quantify 
compared to intracellular metabolites, which have a very rapid turnover and sometimes low 
pool sizes, as well as requiring extraction and quantitation, and being much more varied in 
number and chemical composition. The concentration of intracellular metabolites is 
important information, because it is one of the best ways of representing the in vivo 
conditions. A rapid quenching method has been developed based on the method by Spura 
et al. (2009). The method was improved, as discussed in Chapter 3, and the effectiveness of 
this method has been proved by measuring its reproducibility, which shows that the errors 
are small from most sources except for quenching (which has acceptable error). 
 
The work described here has raised questions mainly about the regulation of metabolism 
inside the cells. Surprisingly, not much change can be seen intracellularly even though a big 
change happened outside the cells (discussed in Chapter 4), and we know (for example from 
previous transcriptomics and proteomics results) that the major metabolic pathway 
occurring inside the cells, namely glycolysis, has been perturbed in a major way. The results 
described in Chapter 4 demonstrate that pyruvate shows a unique profile during the 
adaptation to oxygen changes (Trotter et al. 2011). This highlights the key role of pyruvate 
as an important key junction in the E. coli metabolism and provides useful information 
about the metabolic activity inside the cells (as discussed in Chapter 1). Pyruvate 
concentration inside the cells during the transition from anaerobic to aerobic showed a 
relatively low concentration compared to its concentration outside the cells (after taking 
into account the different volumes of intracellular and extracellular spaces), and has been 
further confirmed with a pyruvate assay. If we look at the glycolysis process, pyruvate is 
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converted to acetyl-CoA and formate during anaerobic conditions. When oxygen is 
introduced, PFL which catalyses the above reaction is immediately damaged since PFL is 
extremely sensitive to oxygen (Takahashi et al. 1987) but the PDHC does need time to get 
fully activated to metabolise the pyruvate (Partridge et al. 2006). The level of pyruvate is 
expected to rise very high (of the order of 500 mM) since it cannot be metabolised until 
PDHC becomes fully functional. Therefore the movement of pyruvate kinase inside the cells 
was examined. 
 
The role of pykF in E. coli metabolism remains as an important gene in catalysing the last 
step in glycolysis, the conversion of PEP to pyruvate and ATP. pykF is the best candidate to 
look at possible metabolite channelling of pyruvate inside the cells during the transition. 
This has been done by tagging pykF with 3xFLAG and GFP. The GFP results did not have 
sufficient resolution to be useful, but data presented in Chapter 5 shows the nanogold-
labeled secondary antibody to the FLAG-tag is distributed evenly on the cells at 0 min but 
moves to the membrane when oxygen is introduced. This suggests that the glycolytic 
enzyme is moving to the membrane. The result is so far preliminary and requires further 
confirmation, but is one of the strongest pieces of experimental evidence yet for metabolite 
channelling in bacteria.  
 
The approach adopted here has provided new insight into the metabolic adaptations of E. 
coli during the transition from anaerobic to aerobic environment. Although there are major 
changes to extracellular metabolites during the transition, these are mainly to 
overmetabolites, which are effectively waste products of anaerobic metabolism. By 
contrast, the data provided in this thesis suggest that cells are genetically programmed to 
maintain a remarkably constant level of central metabolites inside the cell. Therefore, 
understanding the movement of pyruvate may contribute to developmental adaptations by 
E. coli in response to oxygen changes. 
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The results reported in this thesis raise many questions. The percentage of pyruvate kinase 
enzyme localised to the cell membrane is significantly higher 30 minutes after introduction 
of air, but it is far from being 100%: yet we expect that the introduction of air will 
completely kill the activity of PFL and thus lead to a rapid increase in intracellular pyruvate 
concentration. Transcriptomic analyses show that gene transcription is altered within 30 s of 
the introduction of oxygen, and it may therefore be that more dramatic changes in 
localisation will be observable closer to the start of the transition. Experiments to 
investigate this question are under way. The results shown here demonstrate that pyruvate 
kinase is localised to the cell membrane. Is this also true for all of the enzymes within 
glycolysis? In other words, do all the enzymes within the glycolytic pathway form a single 
metabolon, or is it limited only to pyruvate kinase? This can be investigated by tagging other 
enzymes in the same as was done here for pykF. What is the signal for the relocalisation of 
pyruvate kinase? An obvious candidate is the transcription regulator PdhR, which regulates 
the activity of PDHC depending on the concentration of pyruvate in the cell, and is also 
linked to the oxygen-sensing regulator FNR (Trotter et al. 2011). If glucose metabolism in E. 
coli is a regulatable metabolon, is this also true for other metabolic pathways, such as for 
example the Krebs cycle? 
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